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SUMMARY
The experiments described in this thesis investigated aspects
of immunity and chemotherapy in mice infected with brucei and
Te. Congo lens C o
It was found that mice with infections of T. brucei of less 
than 7 days duration were completely cured if treated at this stage 
with trypanocidal drugs. However, if treatment was delayed beyond 
14 days, a proportion of the mice relapsed, in some cases more than 
3 months after chemotherapy* This was not due to drug resistance of 
the parasite, and tissue transfer experiments during the aparasitaemic 
period following chemotherapy indicated the presence of trypanosom.es 
only in brain tissue*
Transmission of immunity from mother to offspring was
investigated in mice* Mothers with a T * brucei infection conferred
immunity to homologous challenge of approximately 3 weeks duration in 
newborn mice* This immunity was by way of colostrum/milk after birth,' ■ 
since fostering experiments showed that'mice born of infected mothers 
but suckled by an uninfected mother were susceptible to challenge* 
Furthermore there was an augmentative effect when chemoprophylaxis 
was given on the day of birth* This on its o^ vn afforded protection 
against infection for a similar period as passively acquired antibody, 
but young mice which received both drug and antibody resisted challenge 
for over 6 weeks.
Genetic resistance to T, congolense infection was studied in 
C57B1 mice, which are able to repeatedly limit the numbers .of 
circulating parasites and survive for approximately 80 days, and CFLP mice 
which die within 10 days with an uncontrolled fulminating parasitaemia*
No evidence was found to implicate pathophysiological factors in this
(iv)
resistance, but C57B1 mice were able to remove -radiolabelied para­
sites from their circulation, and their immune response, as judged 
by vitro immunological methods, was superior to the CFLP strain* 
Attempts to enhance the response of susceptible mice by passive 
immunisation, priming of the immune system and activation of the mono­
nuclear phagocytic system were unsuccessful, and it was concluded that 
the ability to produce and maintain levels of IgM in the plasma was 
essential for resistance*
Finally, a reliable and simple technique for the in yiyo
("75 1
labelling of trypanosomas with Se|-methionine was developed* The 
fate of such trypanosomes after injection into normal and immune mice 
V7as investigated, and it was found that in immune mice the liver was 
the principal site of uptake* From this finding, studies were done 
on the mechanisms of hepatic uptake, which was found to be antibody 
dependent, and at lov? antibody titres also C3 dependent* No evidence 
was found to suggest that intravascular lysis or activated macrophages 
were involved in immune clearance*
GENERAL INTRODUCTION
The disease
Animal trypanosomiasis is one of the major constraints to 
the economic development of animal production in Africa, Because 
of the widespread distribution of the insect vector and the limit­
ations of current control measures, it is estimated that 10 million 
square kilometres of tropical Africa, approximately 40% of the land 
mass (Buxton, 1955; Ford, 1975), suffer the consequences of the 
disease* Of all the livestock diseases endemic to the African 
continent, trypanosomiasis has been regarded as the biggest single 
factor which limits the numbers and productivity of cattle, sheep and 
goats (Urquhart, 1974)* It is largely responsible for the inability 
to realise the enormous potential assets of savannah grazing in 
Africa, and in consequence contributes greatly to the serious 
nutritional and economic situation in these areas, and on a lesser 
scale also causes loss through morbidity and mortality of livestock 
in those areas which marginate fly belts*
Hornby (1952) stated "Trypanosomiasis is unique among 
diseases in that it is the only one which by itself has denied vast 
areas of land to all domestic animals other than poultry"* As a 
social hazard its potential has also been stressed; "Sleeping 
sickness (African trypanosomiasis) constitutes a permanent and 
serious risk to the health and well-being of at least 35 million 
people, and animal trypanosomiasis is the main obstacle to the 
development of the vast potential for livestock development in the 
(African) continent" (MIO, 1976),
Lumsden (1968), discussing the economic importance of trypanosom­
iasis, detailed certain facts: the area in Africa virtually devoid
of livestock from this cause is 10*4 x 10^ sq km, and it was 
estimated in 1963 that this would be capable of supporting 125 x 10^ 
cattle, which was considerably more than the total population in 
Africa at that time (Wilson, Morris, Lewis and Krog, 1963)* Finelle 
(1974) estimated the consequences of trypanosomiasis control on 
cattle numbers, and by assuming a mean carrying capacity of 20 cattle 
per sq lun in the 7 million sq km which he regarded as being tsetse 
infested, calculated a production potential of 140 million head if 
the disease were controlled, a seven-fold increase over the 20 million 
head quoted as the population at that time* Using a similar argu­
ment, but calculating from the tsetse infested area quoted by Lumsden 
(1968), Jasiorowski (1972) concluded that with trypanosomiasis 
control, 120 million cattle could be raised, assuming a mean carrying 
capacity of 12 head per sq 1cm* He included in his estimate, 
however, 3 million sq km of equatorial rain forest which Finelle 
(1974) excluded as being unsuitable for livestock production.
According to published figures, (FAG, 1976), the total cattle popu­
lation of Africa in 1973 was 145 million, and in 1975 tsetse-infested 
regions were carrying 52.5 million head, but despite these discrep­
ancies in numerical terms, the hypothetical estimates emphasise the 
importance of the disease in limiting livestock production and also 
how difficult it is to calculate its economic impact on Africa.
It has been stated that at least half the world's 
population is either undernourished or suffering from malnutrition
(Wright, 1961), and that the average daily intake of protein in 
underdeveloped countries is insufficient for normal growth and 
mental development (Jasiorowski, 1972), According to FAQ, 
however (FAO, 1976), 37,57, of the w o r l d l i v e s t o c k  resources are 
located in underdeveloped countries, therefore it is not the number 
of animals which is responsible for the low level of animal protein 
production in these countries, but their lack of productivity.
Thus, it is clear that the benefits resulting from 
effective trypanosomiasis control lie not only in increased live­
stock numbers and a reduction in the mortality due to the disease, 
but also in improved carcass quality and increases in growth rate, 
milk production and fertility (Finelle, 1974),
The parasite
The causative agent of trypanosomiasis (or nagana as the 
cattle disease is called) which affects man, his domestic livestock, 
and wildlife are protozoqn haemoflagellates comprising several 
species of the genus Trypanosoma, They are blood-borne parasites 
ranging from 8 to 39 pm (Mulligan, 1970), spindle shaped with a 
centrally placed oval nucleus, and they possess a single elongated 
mitochondrion which extends along much of the length of the cell. 
Towards the posterior end of the cell is a small, densely-staining 
structure known as the kinetoplast which contains DNA, In close 
proximity to the kinetoplast is a small pocket (flagellar pocket) 
from which emerges a single flagellum which is attached along the
longitudinal axis of the cell. The trypanosome also possesses a 
prominent layer of microtubules which lie just beneath the plasma 
membrane. The organisms are extremely motile by virtue of their 
flagellum and it is. thought that the microtubules help to maintain 
cell shape during locomotion. Several of the structural features, 
such as the size and position of the kinetoplast and the presence 
or absence of a free flagellum at the anterior end of the organisms 
are used to distinguish the different species of trypanosomes in 
stained thin smears (Table 1)* Perhaps the most important struct­
ural feature of the trypanosome, with regard to its ability to 
induce persistent infections in its mammalian host, is the possession 
of a surface coat. This cell coat, which is approximately 15 nrn 
in depth and is only visible at the ultrastructural level, covers 
uniformly the entire plasma membrane and is composed predominantly of 
a single glycoprotein molecule of M,Wt, 55,000-65,000 K, It is 
this glycoprotein on the surface of the trypanosome which changes
antigenically during the process of antigenic variation (Cross,
1978).
For practical purposes, Hoare (1972) proposed a classifi­
cation restricted to those trypanosomes infecting mammals and
therefore of medical and veterinary importance (Fig 1). He
proposed two "sections" at a level between genus and subgenus: 
the Stercoraria, comprising species whose developmental cycle in 
the insect vector is typically completed in the rectum (or 
posterior station) and in which transmission is "contaminative", 
ie, by infective forms contained in the faeces of the vector
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invading the new host via skin abrasions or mucous membranes; and 
the Salivaria, those species whose developmental cycle is typically 
completed in the mouth parts (or anterior station) of the vector 
and whose transmission is "inoculative", ie. by infective forms being 
injected into the new host by a bite or in the saliva of the insect 
vector* Both sections are represented in Africa, although only 
the salivarian parasites are of medical and veterinary importance, 
causing sleeping sickness in humans and nagana in domestic animals.
No major disease is associated with Stercorarian 
parasites in Africa, although T* (Megatrypanum) theileri infections 
are frequent but usually asymptomatic and undetectable* However, 
Stercorarian parasites do cause serious problems elsewhere, especially 
in South America where American human trypanosomiasis is the result 
of T, (Schizotrypanum) cruzi infection* This parasite is trans­
mitted in the faeces of reduviid bugs and seriously affects many 
millions of people.
Three distinct species, belonging to different 
sub-genera, are the major pathogens in cattle in Africa* These are 
T* (Nannomonas) congolense, T* (Puttone11a) vivax and T*b* brucei 
which belongs to the subgenus Trypanozoon* All 3 species are found 
in cattle throughout the tsetse infested areas, and it is not 
uncommon to find all 3 trypanosomes in the same animal. The 3
species can be distinguished on morphological grounds and by 
characteristic behaviour when observed in a fresh wet blood film 
(Table 1)*
T*b, brucei is closely related to and morphologically
indistinguishable from the human pathogens T.b. gambiense and 
T.b. rhodesiense which belong to the same subgenus. Unlike
T.b. brucei these subspecies are not found throughout the tsetse 
belt but are restricted to loca lised foci. While the evidence 
as to whether or not T. gambiense can Infect cattle is conflicting, 
infections with T, rhodesiense have been confirmed (B,T, Wellde, 
personal communication). In such situations, when trypanosomes 
with the morphological characteristics of T.b. brucei are isolated, 
the only certain way at present of distinguishing the subspecies is 
to ascertain whether or not the organisms are infective for man.
Over the years these organisms have been regarded as separate 
subspecies, but more recently, it has been suggested that .they 
belong to the same species and that through time T.b. brucei may 
give rise to variants which are infective for humans (Robertson 
and Pickens, 1975 ; D.D. Whitelaw, unpublished observation).
It is known that human plasma can be cytotoxic for T.b. brucei, 
while certain T.b. rhodesiense and T.b. gambiense strains are 
resistant; thus the blood incubation infectivlty test (BLIT) was 
devised in an attempt to distinguish between these subspecies 
(Rickman and Robson, 1970).
When examining blood samples from cattle in endemic areas 
of trypanosomiasis, T. congolense and T. vivax are usually found 
more frequently than T. brucei, and in general are considered to be 
more pathogenic. However, by subinoculation of blood into laboratory 
animals, a much higher incidence of infection with T. brucei may be 
found, and results of a number of studies indicate that T, brucei can
be pathogenic in its oi-m right (Murray, Murray, Wallace, Morrison 
and McIntyre, 1979; Morrison, Murray, Sayer and Preston, 1981).
The African trypanosomes are cyclically transmitted by 
tsetse flies, genus Glossina (Mulligan, 1970), which become infected 
after feeding on an infected animal* The organism undergoes a 
number of developmental stages in the tsetse (trypomastigote, 
èpimastigote, and metacyclic forms) before becoming infective once 
more for the mammalian host, there are marked morphological and 
structural alterations experienced by the trypanosome which occur 
within the fly, and for each trypanosome species there are differ­
ences in the sites in which some of the developmental stages occur 
(Table 1)* The length of the life cycle within the tsetse also 
varies with each species*
Control of the disease
Since the precolonial days of African exploration when 
men such as Burton and Livingstone first brought the tsetse fly 
problem to the attention of the world, attempts have been made to 
control or eliminate the disease, with varying degrees of success* 
Phillips (1959) estimated that an expenditure over 50 years of one 
thousand million pounds would be required to eliminate the fly, 
and in the current economic climate this figure would have to be 
increased severalfold. Despite extensive control efforts this 
century, it was the opinion of Ford (1971). that "the area infested 
with tsetse in Africa is larger than it was in 1900 after the 
passage of the rinderpest"*
10
The elimination of larger African mammals as a means of 
controlling trypanosomiasis has proved successful in the past. It 
was first advocated by.. Bruce, but the game slaughtering campaign 
between 1930 and 1950 in Rhodesia was based not on Bruce's thesis 
but on the historical evidence of the Rinderpest panzootic (1895-96) 
and the virtual extermination of the fly's favoured hosts* Ten 
thousand sq miles in Rhodesia were reclaimed from Glossina morsitans 
by game slaughter, land which had been reinfected following the 
recovery of the wild animal population after the rinderpest outbreak 
(Chorley, 1958; Cockbill, 1960)* Despite this success however, 
the effectiveness of such control methods is limited due to the 
rapid recovery of game populations after culling (Percival, 1918) 
and the attendant fly reappearance* Unless game eradication is 
repeated, for the method provokes powerful opposition (Ford, 1970), 
its effect is transient, and despite its success in particular 
locations (Bursell, 1960), extensive use in the future is unlikely 
(Harley, 1978)*
Vector control has in general been carried out either by 
spraying residual insecticides or by bush clearing* Ground spraying 
of insecticides on resting sites favoured by tsetse after its blood 
meal can be a very successful method of control, although the pro­
cedure is manpower intensive, and more recently aerial spraying has 
become the preferred method of dispersal (Burnett, 1970), However, 
controversy over residual insecticides has meant that alternative 
chemicals which are less persistent are now more commonly used*
As a consequence, more frequent spraying campaigns are required and 
this has escalated the already high cost*
11
Bush clearing (Ford, Nash and Welch, 1970) provides a 
rapid decrease in the breeding sites available for the tsetse*
This method can also be used to form a corridor to separate land 
cleared of tsetse from uncleared areas, provided livestock move­
ment across these corridors is strictly controlled* Similarly, 
the culling of wildlife must be done to maintain the integrity of 
the corridor, as these animals are regarded as an important 
reservoir of the disease*
Several interesting alternatives have been employed in 
recent years, including the use of the sterile male technique 
(Dame, 1970)* However, one major constraint on this method of 
control is that there is rarely a defined boundary to prevent 
sterile males leaving or non-sterile males entering the control 
area* Thus, a considerable amount of the available resources have 
to be diverted into the maintenance of boundaries by insecticide 
spraying*
Total freedom from the disease is not a guaranteed 
consequence of an effective vector control campaign, as mechanical 
transmission is kno\m to occur in the field (Baker, 1968) and has 
been demonstrated experimentally (Duke, Mettam and Wallace, 1934; 
Heisch, 1952)* The influence that this has on the epidemiology 
of human and animal trypanosomiasis is unkno\7n, but it is certain 
that in the absence of the tsetse fly the disease would remain a 
problem* Indeed, continued mechanical passage can lead to 
increasing virulence (Mesnil, 1912), and in pleomorphic strains 
there is also a tendency for them to become monomorphic (Oehler,
12
1914)* This is typified by T« evansi which is thought to have 
arisen from T* brucei (Hoare, 1972) but is now virtually completely 
monomorphic and extremely virulent as a result of its extensive 
mechanical transmission by haematophagous Diptera* . .
Therefore, in conjunction with vector control, it is 
necessary to control the bloodstream parasite, and this has mainly 
been achieved by chemotherapy or chemoprophylaxis*
Arsenic compounds were used as early ago as the raid 19th 
century to combat nagana in Africa* However, it was recognised at 
the beginning of this century that some drugs produced as a by­
product of the German dye industry had trypanocidal activity*
Thus, research was stimulated by the discovery that Trypan Red was 
both curative and prophylactic in experimental trypanosomiasis and 
had potential in the treatment of the human disease* Further 
advances led to the development of Atoxyl, an organic arsenical 
derived as a by-product of the triphenylmethane dye industry, which 
was shown to be trypanocidal and non-toxic to humans. The develop­
ment of these aromatic arsenicals led to an expansion in the 
therapeutic use of arsenic culminating in the development of 
Tryparsamide (Williamson, 1970),
Trials using Tryparsamide were commenced in 1920 in a 
campaign against human sleeping sickness in the Belgian Congo, and 
by 1925 it was reported that the drug was highly effective (Williamson, 
1970)* The successful treatment of a French medical officer with 
Atoxyl and intravenous tartar emetic led Bevan (1928) to try these
13
new drugs in Southern Rhodesia against animal trypanosomiasis with 
great success, and despite the discovery of other related compounds 
such as Antimosan, tartar emetic continued to be used against 
cattle infections on a large scale for many years (Jussiant, 1948)*
In contrast to the measures against sleeping sickness in 
humans, chemotherapeutic and chemoprophylactic agents against 
trypanosomiasis in animals were not developed until relatively 
recently* As a result of the large range of species of animals 
susceptible to trypanosomiasis, the multiplicity of strains of 
trypanosomes and the different pathogenicity of the individual 
species, the problems involved in the chemotherapy and chemoprophyl­
axis of animal trypanosomiasis are more difficult, more complex 
and more serious than those involved in human trypanosomiasis*
The few trypanocides which have been used in practice for a signifi­
cant period beyond the testing stage are tartar emetic, antrycide, 
the phenanthridine derivatives ethidium, prothidium and samorin 
(isometamidium), as well as berenil and suramin*
In general terms, the most commonly used trypanocides in 
use at present are Berenil (diminazene aceturate), Samorin (iso­
metamidium) and Ethidium (homidium chloride)* Except in the case 
of long-standing infections, there is usually a good response to 
treatment: parasites are rapidly cleared from the blood and this
is accompanied by a return to normal haematological values*
However in endemic areas, reinfection can occur after treatment, 
'depending on the degree of challenge*
14
In endemic tsetse areas where cattle populations are 
reasonably stable and animals can be easily identified by careful 
ear-tagging, chemoprophylaxis is a preferable approach to the 
control of trypanosomiasis* Thus, at present, cattle exist 
profitably on ranches which otherwise could not support cattle 
(ego Wilson, Paris, Luckins, Dar and Gray, 1976)* Samorin is the 
drug of choice, and in areas of constant heavy challenge, treatment 
may be required every 6 to 8 weeks * Less rigorous regimes can be
worked out only after careful monitoring of each situation, but
this approach utilising efficiently operated chemoprophylaxis should 
be considered in areas where eradication of tsetse is not feasible*
The principal problem associated with long term chemo­
therapy and chemoprophylaxis is the generation of drug-res is tant 
parasites (Whiteside, 1963; MacLennan and Jones-Davies, 1967), but
this can be minimised by the alternate use of different drugs and
also by proper administration of drugs at the correct dosage levels. 
Unfortunately, Berenil has been the only new trypanocide to be made 
commercially available since the late 1950's, and in the event of 
the current drugs becoming ineffective, it is extremely doubtful 
that a new compound would become quickly available, since the demand 
for these drugs is limited and the potential profit too low to 
warrant expensive research and development*
Immunity to African trypanosomes
A typical trypanosome infection comprises a series of 
rising parasitaemias between which are periods of remission when
15
few, if any, parasites can be detected in the peripheral circulation* 
Each new parasitaemia is produced by a variant trypanosome population 
with a slightly altered surface antigen.
This antigenic variation is now considered to be one of the 
crucially important mechanisms involved in the parasite's escape from 
the host's response* Vickerman (1969) described the existence of a 
coat surrounding the bloodstream forms of T, brucei which was lost 
when the parasites were grown in culture or in the mid-gut of the 
tsetse but was regained by the metacyclic trypanosomes in the salivary 
glands* He therefore suggested that the coat was in some way an 
adaptation to allow the parasite to survive in the plasma of its 
host, Weitz (1960) had previously described an exoantigen from the 
plasma of infected blood* This exoantigen was sho-wn to produce 
protective antibodies against the infecting parasite from which it 
was derived (Weitz, 1960; Seed and Weinman, 1963)* The secretion of 
this exoantigen from the surface of the parasite into the plasma 
in vivo was considered to be one mechanism by which the parasite was 
able to avoid the antitrypanosome antibody (MacAdam and Herbert, 1970)  ^
Whether secretion of the surface coat does occur during an infection, 
however, is still in dispute*
The ability to produce an immune response against a trypano­
some infection has been regularly demonstrated either by infection 
followed by drug treatment (Bevan, 1936; Fulton and Lourie, 1945), 
vaccination with exoantigen (Herbert and MacAdam, 1971; Duxbury,
Sadun, Schoenbechler and Stroupe, 1974) or vaccination with radio­
attenuated. trypanosomes (Duxbury and Sadun, 1969; Duxbury, Sadun and
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Anderson, 1972; Wellde, Schoenbechler, Diggs, Langbehn and Sadun, 
1975)0 This immunity is, however, only directed against the 
antigenic variant used for the vaccination (Gray, 1967; Herbert 
and Lumsden, 1968; Wellde _et aj^ , 1975; Terry, 1976). Thus the 
immune response of the host can successfully eliminate the pre­
dominant variant from the circulation* It is however unsuccessful 
in controlling the infection as a new variant repopulates the blood.
The process of antigenic variation is now thought to be 
the result of selective expression and suppression of genes 
controlling the formation of the surface coat (Van Meirvenne, Magnus 
and Vervoort, 1977) rather than by a series of random mutations 
arising from cellular division (Watkins, 1964)* The series of 
variations occurring during an infection is apparently limitless 
but there are a few reports of the recurrence of certain variants 
within a few weeks of one another (Wilson and Cunningham, 1972; 
Nantulya, Doyle and Jenni, 1980), A clone of T, equiperdum has 
been sho\fn to generate 101 different variants (Capbern, Giroud,
Baltz and Mattern, 1977), There also appears to be a degree of 
consistency in the order of appearance of different variable antigen 
types (VATs) during infection so that certain VATs tend to be found 
during the early stage of infection while others tend to be present 
later.
One defect in the armoury of the. trypanosome.during its 
cyclical transmission in the tsetse has been described. This is 
the tendency for trypanosomes to resort back to a basic antigenic type, 
Thus, there is now evidence that the antigenic composition of the
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metacyclic trypanosomes extruded by the tsetse fly is always 
similar for a given serodeme (Gray, 1965, 1975; Cunningham, 1966; 
Jenni, 1977; Nantulya, Musoke, Barbet and Roelants, 1979), even 
though it probably consists of a mixture of VATs (Barry and Hajduk,
1979), and the possibility that the number of serodemes may be 
limited in some location may offer the hope that immunization with 
metacyclic trypanosomes may be feasible.
In recent years, considerable progress has been made in 
the biochemical characterization of the variable antigen* Although 
initial studies, based on serological cross-reactivity and amino 
acid sequencing of the N-terminal end of the molecule, failed to 
demonstrate any homology between different variant antigens, more 
recent investigations have demonstrated the existence of cross- 
reactive determinants in variant surface antigen both within and 
between trypanosome species and the possibility of common structural 
regions has been suggested (Barbet and McGuire, 1978)* However, 
it may be that these "common regions" are not exposed on the 
surface of the living organism* It is still uncertain whether 
the trypanosome possesses the genetic information necessary to code 
for the complete VAT repertoire or whether mutation or reassortment 
of genetic material occurs each time the antigen changes* However, 
in view of the marked heterogeneity between different variant antigens 
and the finding of some consistency in the order of appearance of 
different VATs, the former possibility appears more likely*- The 
question still remains as to what triggers the change in surface 
antigen* While the disappearance of a particular VAT is associated
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with the appearance of specific antibody in the serum, it is still 
uncertain if this acts as the primary stimulus for the surviving 
trypanosomes to change their variable antigen.
Protective Immunity against a particular variant can be 
readily induced by a variety of vaccination procedures (vide supra; 
also Terry, 1976; Clarkson, 1976a; Murray and Urquhart, 1977)o 
Such immunity is thought to depend largely on serum antibody.
Thus humoral responses to specific antigenic variants can be demon­
strated ^n vitro by a variety of methods including agglutination 
(Soltys, 1957a; Cunningham and Vickerman, 1962), trypanolysis 
(Lourie and 0*Connor, 1936), infectivity neutralisation (Soltys,
1957) and metabolic inhibition (Desowitz, 1956; Diggs, Flemings, 
Dillon, Snodgrass, Campbell and Esser, 1976), The important role 
of the humoral response in the control of the parasitaemia has been 
further demonstrated by the use of various immunosuppressive regimes 
(Luckins, 1972; Balber, 1972; Ashcroft, 1957; vide infra) which 
showed that failure to produce detectable antibody results in the 
host*s inability.to control the infection. While these results 
are indicative of a failure in the humoral response, the methods 
used in these studies may not only have interfered with B cell 
responses but probably also affected the co-operation between various 
cell populations which is known to regulate the immune response 
(Allison, Denham and Barnes, 1971)» However, subsequent experiments 
using cyclophosphamide at doses known to suppress B cell responses 
(Turk and Poulter, 1972; Kolb, Poupon, Lespinats, Sabolovic and
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Loisillier, 1977) have confirmed the earlier findings (Vickerman, 
Sless, Hasten and Edwards, 1977; vide infra)„ Furthermore, the 
success of passive immunization using immune serum to confer 
protection strongly supports the importance of the humoral response 
(Seed and Gam, 1966; Patton, 1972; Takayanagi, Kambara and 
Enriques, 1973a; vide infra)»
Transfer of immune spleen cells can also produce strong 
immunity (Takayanagi ejt al, 1973a; Takayanagi and Nakatake, 1975; 
Campbell and Phillips, 1976)o In addition, suppression of B cells
by anti-p. antibody administration from birth has been shown to
prevent an effective immune response* Thus it was found that 
anti-ji treated mice had a decreased survival time compared to 
control mice and failed to respond to an irradiated trypanosome 
vaccine (Campbell, Esser and Weinbaum, 1977)* An intact B-cell 
response would appear to be essential for the development of an 
immune response to trypanosome infection*
It is of interest to note that all of these previous
studies were done either with T* lewisi or T, brucei-group parasites, 
and there is little comparable information on T* congolense infection 
(vide infra)*
The effectiveness of the humoral response in controlling 
a trypanosome infection is apparently dependent on the availability 
of IgM, IgG and complement* There is a well-documented rise in 
serum IgM during infection (Mattern, 1964; Lumsden, 1965; Kobayashi 
and Tizardp 1976; Clarkson, 197 6)* The continually changing
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antigenic stimulus during trypanosome infection presumably stimu­
lates only the primary immune response, ie, predominantly IgM (Seed, 
Cornille, Risby and Gam, 1969), This means that the immune response 
is essentially restricted to the circulation, as the large IgM 
molecule is slow to come to equilibrium with tissue fluids (Goodwin 
and Guy, 1973; Terry, 1976)* Thus parasites circulating in blood 
vessels will be removed, although parasites which occupy tissue 
sites may escape the trypanocidal effects of the circulating anti­
body (Seed and Effron, 1973), Furthermore, Takayanagi and Enriques 
(197 3) have suggested that IgM is more efficient than IgG in 
protecting the host from infection* IgM is also recognised as being 
a better activator of the complement system than IgG, Trypanolysis 
may be therefore one possible mechanism by which parasites can be 
removed from the circulation* Trypanolysis occurs readily in the 
presence of guinea pig serum (Lourie and O'Connor, 1936), but these 
authors also recorded the failure of immune mouse serum alone to 
initiate trypanolysis, presumably as a result of a deficiency in 
the complement system* Once removed from the host, mouse complement 
is extremely labile (I* McConnell, personal communication), thus 
caution must be exercised when discussing the importance of trypano­
lysis in experimental and natural trypanosomiasis*
Many authors have described the activation of complement 
during infection (Nagle, Ward, Linds ley, Sadun, Johnson, Berkaw 
and Hildebrandt, 1974; Jarvinen and Dalmasso, 197 6; Nielsen and 
Sheppard, 1976; Musoke and Barbet, 1977) and hypocomplementaemia 
has also been recorded as a feature of the disease* If an intact
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complement system is essential for parasite removal, then hypo­
complementaemia induced by the parasite may be an important 
mechanism by which the parasite can avoid trypanolysis (Nielsen and 
Sheppard, 1976; Musoke and Barbet, 1977).
Alternatively, the humoral response may act in such a 
way that it does not directly destroy the parasite but enables its 
destruction to be initiated* Opsonisation of the parasite by anti­
body can occur in the absence or presence of complement, although 
C3 has an important opsonic role in many reactions (Pepys, 1976).
Opsonisation however requires additional cellular involve­
ment, usually in the form of phagocytic cells. The immune adherence 
reaction of antigen to cells was demonstrated when it was shown, that 
trypanosomes incubated in immune serum attached to platelets and 
monocytes (Nelson, 1953, 1963)*
The phagocytosis of trypanosomes by macrophages clearly 
must involve some method of attachment of the parasite to the cell 
surface* The demonstration of both C3 and Fc receptors on the 
surface of macrophages may facilitate this attachment (Berken and 
Benacerraf, 1966; Ma'ntovani, Rabinovitch and Nussenzweig, 1972; 
Bianco, Griffin and Silverstein, 1975; Hopf, Meyer zum Buschenfelde 
and Dierich, 1976)* Antibody need not be attached to the target 
cell but may be present on the surface of the effector cell*
Thus cytophilic antibodies (Boyden, 1963; ' Berken and Benacerraf,
1968) may be opsonic antibodies which act via attachment to the 
effector rather than the target cells, although Tizard (1969) has
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described in mice both cytophilic and opsonic antibodies which 
appear to be distinct* The temperature at which cytophilic anti­
bodies can be detected in mice is usually lower than normal body 
temperature so their biological importance is uncertain (Tizard,
1969)* Agglutination of the parasite is known to be mediated via 
the F (ab')^ fragment of IgG, while the attachment to macrophages 
occurs via the Fc region of IgG (Takayanagi and Nakatake, 1977),
It is therefore possible that agglutination plays a role in phago­
cytosis or attachment to phagocytes and thereby confers protection: 
Consequently, the agglutination titre may be a useful indicator of 
the protective power of the serum (Takayanagi, Nakatake and 
Enriques, 1974a).
The important relationship between the humoral response 
and the mononuclear phagocytic system (MPS) is well established 
and it has been known for many years that immune serum influences 
the phagocytic ability of macrophages (Laveran and Mesnil, 1901)* 
These workers observed that T* lewisi was phagocyosed in the peri- 
toneal cavity of rats which had been actively or passively 
immunised* This was subsequently confirmed ^  vitro (Lange and 
Lysenko, 1960; Patton, 1972)* A similar relationship has also 
been demonstrated in African trypanosomiasis (Lumsden and Herbert, 
1967) where peritoneal exudate cells exhibited better phagocytic 
ability against T* brucei in the presence of immune serum* This 
has since been confirmed on several occasions (Cook, 1975; 
Takayanagi et al, 1974a). '
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The dependency of phagocytosis on antibody was recently 
confirmed by Takayanagi, Na lea take and Kato (1977) who also 
suggested that optimal phagocytosis occurred in a situation of 
slight antibody excess* Furthermore, this attachment has been 
shown to be independent of complement (Takayanagi e_t al, 1974a) * 
Hypocomplementaemia (vide supra)/may not therefore be an important 
impediment to attachment and phagocytosis, at least in antibody 
excess c
Despite these studies, it is not knovm whether whole 
opsonised trypanosomes (Lange and Lysenko, 1960) or particulate 
debris resulting from intravascular lysis (MacNeal, 1904; Talliaferro, 
1924) are phagocytosed,
A further possibility is that non-specific phagocytosis 
of trypanosomes may contribute to the protective immune response* 
Several authors have described the successful use of non-specific 
MPS modulators to enhance phagocytosis of carbon and bacteria 
(Stiffel, Mouton and Biozzi, 1970)* Furthermore, activation 
of macrophages has been reported to increase protection against 
Plasmodium sp* and Babesia sp* (Clark, Allison and Cox, 1976;
Clark, Cox and Allison, 1977). Activation of macrophages may also 
be achieved in animals by products of activated T lymphocytes, iiTimune 
complexes, and complement cleavage product C3b (Allison and Clark, 
1977). Since all 3 are readily detectable in trypanosome infected 
animals, increased hepatic uptake of SRBC in such animals (Murray, 
Jennings, Murray and Urquhart, 1974a)could well be a result of 
macrophage activation*
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Evidence of resistance to trypanosomiasis in the field
Reports of several investigators showed no evidence of 
immunity developing in cattle maintained under chemotherapy in 
endemic areas over periods of time (Hornby, 1941; Wilson, Paris 
and Dar, 1975), Other workers, however, claim that drug therapy 
induced a degree of protective immunity in treated animals (Bevan, 
1928; van Saceghem, 1938; Fiennes, 1953, 1970; Soltys, 1955;
Smith, 1958; Wilson, Paris, Luckins, Dar and Gray, 1976; Bourn 
and Scott, 1978). These workers found that not only did the 
interval between infections increase as reflected by the frequency 
of chemotherapy, but also, when the decision to treat was made on 
the basis of detectable parasitaemia, animals were frequently 
parasitaemic without showing severe clinical effects.
Wilson reported a series of experiments which investig­
ated acquired immunity. Cattle maintained in a high tsetse chall­
enge area, treated on an individual basis either when clinically 
ill or when their PCV fell below 20%, produced an increase in 
live births and a decrease in the number of abortions. There was, 
however, no development of protective immunity, as continual 
regular drug therapy was required (Wilson, Paris and Dar, 1975) .
In contrast, when cattle were maintained in an area of medium 
tsetse challenge.(Wilson et al, 1976), the interval between drug 
treatments increased while control cattle introduced at regular 
intervals became infected and required regular chemotherapy, thus 
indicating that the level of tsetse challenge may play a crucial 
role in the acquisition of resistance.
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There are a number of possible explanations for the 
acquisition of resistance in the field* First, it is possible 
that cattle gradually develop specific immunity to all or most of 
the trypanosome serodemes in a particular location. Although each 
serodeme is capable of elaborating a large number of VATs during an 
infection, there is now evidence that the antigenic composition of 
the metacyclic trypanosomes extruded by the tsetse fly is always 
similar for a given serodeme (Jenni, 1977; Nantulya ad, 1979) 
and may be limited and consistent for each serodeme (Nantulya and 
Musoke, personal communication)* Complete neutralisation of a 
metacyclic population of T* congqlense can be achieved by serum 
taken from cattle 14-16 days after tsetse challenge (Morrison, 
unpublished data). Furthermore, animals treated with Berenil 
shortly after the establishment of infection are immune for up to 
6 months to rechallenge with tsetse infected with the same serodeme, 
but are still susceptible to other serodemes* This has been 
confirmed in cattle with T* congolense and goats with T* brucei 
(Emery, Akol, Murray, Morrison and Moloo, 1980), although goats 
similarly treated after tsetse transmitted T* vivax infection showed 
no evidence of immunity (DeCee, 1980)* Thus at least with 
T* congolense and T. brucei, if animals in endemic areas survive 
a primary infection with a particular serodeme, they should be 
able to resist subsequent tsetse challenge with that serodeme for 
at least 6 months* The possibility that the number of serodemes 
may be limited in some locations offers the hope that Immunisation 
with metacyclic trypanosomes may be feasible.
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Another factor which may contribute to acquired resistance 
in the field is antigenic cross-reactivity of VATs from different 
serodemes* Evidence of this has been obtained in studies with 
different repertoires of the sub-species Trypanozoon (Van Meirvenne, 
Janssens, Magnus, Lumsden and Herbert, 197 5; Van Meirvenne ^  al, 
1977)0 Some VATs derived from widely differing field isolates of 
T.b* brucei, T,b. rhodesiense, T*b, gambiense, T* evansi and 
T. equiperdum show strong cross-reactions in immunofluorescence 
and immune lysis tests with infection sera* These cross-reactive 
VATs have been termed iso-VATs, and although of similar molecular 
weight they have different isoelectric points* At present the 
frequency of these iso-VATs and their existence in T„ congolense 
and To vivax is uncertain, but if they are common, they might be 
expected to confer partial protection between different serodemes*
There is now evidence from serological studies that 
during a trypanosome infection certain VATs may recur within a few 
weeks of one another* This has been reported in cattle infected 
with a stabilate of T* congolense (Wilson and Cunningham, 1972) and 
a clone of T* brucei (Nantulya _ej; al, 1980), but whether these 
represent identical VATs or iso-VATs is not kno\-7n.
In addition to the cross-reactivity exhibited by iso-VATs, 
a glycopeptide at the C-terminal region of the variable surface 
glycoprotein (VSG) cross-reacts in all isolates and species of 
trypanosome. so far tested (Barbet and McGuire, 1978; Cross, 1979; 
Barbet, McGuire, Musoke and Hirumi, 1979), However, unlike iso-VAT 
determinants, this common region is not accessible on the surface
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of live trypanosomes and its role, if any, in acquired resistance 
is unknown*
The development of a significant resistance was observed 
in 3 adult Hereford cattle subjected to several needle challenges 
with unrelated stocks of T. congolense* Following successive 
challenges, each several months apart, the level of parasitaemia 
and the degree of anaemia which occurred were significantly less 
than in corresponding challenge controls* There was no evidence 
of serological cross-reactivity* An explanation for these findings, 
and possibly also a factor influencing acquired resistance in the 
field, came in further experiments investigating the effect of an 
established infection upon the susceptibility of the host to 
subsequent challenge* The results indicated that the initial 
infection interfered with the establishment of the second infection 
despite the absence of detectable antibodies against the trypanosome 
used for the second challenge (Murray, Morrison and Whitelaw, in 
press)* This interference required the presence of an active 
infection, since animals were completely susceptible to the second 
challenge following treatment with Berenil, and may reflect some form 
of competition between trypanosome populations or a non-specific 
response of the host that limits the growth of trypanosomes*
It has been postulated that age appears to play a 
significant role in resistance to trypanosomiasis, young animals 
being more resistant than adults (Fiennes, 1970)* This was thought 
by Whiteside (3.962 ) to be through transmission of an immune factor
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to calves born of immune or partially immune dams, but inter­
pretation of much of the field data is difficult because of the 
use of small numbers of animals of unkno^-m condition and the 
question of persisting trypanocides, However, one report showed 
significant age-related resistance in a large number of buffalo 
(Drager and Mehlitz, 1978), in which maternally derived immunity 
may have been an influencing factor.
There is at present a growing interest in the reduced 
susceptibility to trypanosome infection shown by some breeds of 
cattle and also some smaller ruminants. The majority of published 
information suggests that trypanotolerant livestock are confined to 
West and Central Africa, but while this is broadly the case, there 
is no obvious reason why they should not have evolved in other 
regions of Africa infe-sted by the tsetse fly. Indeed, Cunningham 
(1966) pointed out that thousands of Zebu cattle survive around 
the shores of Lake Victoria, even though they are continually 
exposed to tsetse, thus by definition they must be regarded as 
trypanotolerant* Similarly, certain breeds of sheep and goat 
in East Africa have a greater capacity to withstand the disease 
(Griffin and Allonby, 1979),
In one of the first accounts of West African livestock, 
Pierre (1906) recorded the ability of certain cattle to survive 
in tsetse-infes ted areas. Subsequently, the resistance of the 
taurine breeds was recognised increasingly in West Africa (reviewed 
by Godfrey, Leach and Killick-Kendrick, 1964 and ÏLCA, 1979), as
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well as in the Sudan (Archibald, 1927)* In 1951, Stewart described 
his experience with what he termed "West African Shorthorn Cattle" 
in Ghana (Gold Coast) over a period of 20 years from 1929 to 1948* 
These animals were genetically heterogeneous and comprised Hamitic 
longhorn, Shorthorns and Zebu* The contribution made by each ’breed 
appeared to depend on the level of tsetse challenge; the greater 
the tsetse risk, the smaller percentage Zebu in each animal. His 
overall conclusion was that these animals possessed very high 
resistance to the disease*
The major fact by which trypanotolerance may be defined 
is based on the field observation that certain breeds of cattle, 
sheep and goats, as well as some species of wild animals, can 
survive in endemic tsetse fly-infested areas without the aid of 
chemotherapy where other breeds cannot. Most studies have focused 
on the N'Dama which is the main descendent of the Hematic longhorn 
in Africa, and now the most common trypanotolerant breed in West 
Africa with an estimated population of 3,4 million head* Its 
popularity is probably related to the fact that it is the largest 
of the trypanotolerant breeds and is thought to be the most 
productive*
The superior resistance of the N'Dama to trypanosomiasis 
was consistently confirmed as judged by comparisons of weight loss, 
anaemia and survival. This was true regardless of the nature of 
the challenge. In some experiments, animals were exposed to 
natural field challenge of G, palpalis or G* morsitans (Chandler, 
1952; van Hoeve, 1972), in others the. animals were challenged with
30
Go palpalis infected in the laboratory with T* vivax (Chandler,
1958; Desowitz, 1959), while other investigabors involved the 
inoculation of bloodstream forms of T* congolense (Chandler, 1958)* 
These studies emphasised the potential of trypanotolerant livestock 
and presented evidence that trypanotolerance was an innate character­
istic (Chandler, 1952, 1958),
While there is no question of the general validity of the 
foregoing results, some of the conclusions might be criticised for 
the following reasons; the clinical history of many of the animals 
was not precisely known, the antigenic characteristics of the various 
trypanosomes to which the animals were exposed was not investigated 
and, lastly, only small numbers of cattle were available for study* 
Without these data, it is impossible to define the relative contri­
butions of innate and acquired resistance*
As a result, Stephen (1966) and Roberts and Gray (1972) 
evaluated the resistance to trypanosomiasis of N'Dama and Zebu which 
had been reared free from tsetse exposure* The Zebu dams had 
never been exposed to tsetse although the N'Dama dams had. Later, 
Roberts and Gray.(1973a) extended these investigations to include 
N'Dama born of dams which had never been exposed to tsetse. In 
all these experiments the animals were challenged under laboratory 
conditions with wild caught G*__morsitans submorsitans which were 
found to be infected with T, vivax, T* congolense and T, brucei*
While once again the number of animals available was small and in 
some experiments there was a considerable age range (Roberts and 
Gray, 1972), the greater resistance of the N'Dama was obvious.
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This result, assessed on the basis of weight loss, anaemia and 
survival, confirmed that the trait was an innate characteristic.
Susceptibility studies have also been done on the Muturu 
(a West African Shorthorn) breed of cattle, whose trypanotolerant 
characteristics were emphasised by Ferguson (1967), However, it 
was not until the studies of Roberts and Gray (1972, 1973a,b) that 
attempts were made to evaluate the extent of trypanotolerance in 
Muturu and compare it with N*Dama and Zebu* Their level of 
resistance was found to be intermediate between the N'Dama and 
Zebu, as judged by clinical condition, anaemia and survival*
This result was confirmed by van Hoeve (197 2) when animals of the 
same breeds were exposed to natural tsetse challenge in the field, 
and the superior resistance of the Muturu over the Zebu was 
demonstrated after needle challenge with T* vivax (Esuoroso, 1977),
The observation by Ssenyonga (1974) that C57B1 mice 
survived a T. congolense infection for a much longer period than 
CBA mice provided the opportunity for susceptibility studies to be 
done in the laboratory with animals of defined genetic background* 
This is the basis of the third chapter of this thesis (Chapter 3)*
Secondly, the influence of maternal immunity has been 
investigated, in particular its role on early post-natal resistance
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to trypanosomiasis and the effect on this of concomittant chemo­
therapy, This is the subject of Chapter 2,
The opening chapter describes studies on a feature of 
trypanosomiasis common to both animal and human infections, namely 
the problems associated with chemotherapy of chronic infections*
Chapter 4 details the development of a method for
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labelling trypanosomes with the amino acid analogue Selenometh­
ionine, and its use in studying the efficiency of the immune response 
in removing circulating trypanosomes. The relative importance of 
antibody, complement and the mononuclear phagocytic system in this 
removal is described.
Finally, parasite-induced immunosuppression has been 
suggested to be of practical importance in the response of animals 
to vaccination against other disease-causing agents. A collabor­
ative investigation with the ODM Veterinary Team in Ethiopia, was 
done in mice and cattle, into the effect of chemotherapy at the 
time of vaccination against louping-ill virus on the subsequent 
antibody response of infected animals to the louping-ill vaccine*
The results of this study are appended at the end of the
thesis.
CHAPTER I
CHEMOTHERAPY
Section 1
The relapse of infection after chemotherapy
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INTRODUCTION
The chemotherapy of trypanosomiasis in man and animals 
is at present dependent upon a relatively small number of synthetic 
drugs, against most of which drug resistance has been reported to 
occur. No new drugs have been introduced in recent years. In 
the absence of a vaccine against the parasite, and considering 
the expense and problems inherent in an effective vector control 
compaign, the use of chemotherapeutic and chemoprophylactic drugs 
remains the only alternative in combating the infection in 
susceptible humans and livestock. However, a necessary require- , 
ment in the successful treatment of the disease is early diagnosis 
and adequate surveillance of treated individuals after chemo­
therapy, and in the geographical areas where human and animal 
populations are at risk such conditions seldom prevail. Thus 
frequent use or mis-use of the compounds available has increased 
the dangers of drug resistance.
Strains of trypanosomes resistant to the commonly used 
trypanocidal drugs have been documented frequently in the 
literature (Williamson, 1970; MacLennan, 1970) and it has been 
shown that trypanosomes which are resistant to certain drugs may 
retain this property after transmission through the tsetse fly 
(van Hoeve & Grainge, 1966; Gray and Roberts, 1971). Although 
these reports have largely concerned strains of T.- vivax and 
T. congolense, resistant strains of T. brucei have been recorded 
(Walker & Watts, 1970), . Mwambu and Mayende (1975) reported that
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of 23 T. brucei sub-group stabilates (3 from game animals, 10 
isolated from cattle and 10 isolated from Glossina fuscipes)
, which were passaged in mice, only 1 stabilate was completely
susceptible to the drug Ethidium. With the other 22 stabilates, 
the infections in a proportion of the mice relapsed.
This chapter deals with a type of relapsing infection in 
mice treated with trypanocidal drugs which in some respects 
resembles drug resistance as outlined above, but is apparently 
due to another cause, since the infections were always completely 
susceptible to chemotherapy administered at an early stage of the 
infection. The second section of the chapter deals with 
investigations to localise the focus of the cryptic infection, 
and the implications of the phenomenon are discussed in relation 
to the use of drugs in the natural disease.
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MATERIALS & METHODS
Trypanosomes: Mouse passaged derivatives of stocks T. brucei
TREU 667 and LUMP IGOl were used in most experiments. The histories 
of these parasites are outlined in Appendix I. T. brucei LUMP 227, 
571, 612 and 962 were obtained through Professor W.H.R, Lumsden 
from the stabilate bank of the London School of Tropical Medicine 
and Hygiene, Winch's Farm, St. Albans, Herts., and were studied in 
one comparative experiment only. The T. congolense parasite used 
was designated GVR 1, and was derived in irradiated mice from 
T, congolense GUP 93. Its background is also outlined in Appendix 
I, The original stabilates were passaged in mice irradiated at 
500 rad the day before infection, the blood removed on the ascending 
parasitaemia prior to the first peak, and preserved in polythene 
tubing in liquid nitrogen (Taylor, 1972) ,
T . brucei TREU 667/56 was isolated from a mouse which had 
been treated with Berenil after it had been infected for a period 
of 56 days with the original TREU 667/1; the infection recurred 
30 days later, was transferred to irradiated mice and the frozen 
stabilate, TREU'667/56, was prepared after 4 days.
Clones of T. brucei TREU 667 were prepared by a modific­
ation of the method of Lumsden, Herbert and McNeillage (1973). The 
stock TREU 667 was gro;-m in irradiated mice until the parasitaemia 
reached a level of approximately 1 x 10^ per ml. The blood from 
the donor mice was diluted in phosphate saline glucose ( PSG,
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pH 7.2) containing 10% foetal calf serum (FCS) until a tiny drop 
on a glass covers lip could be expected to contain approximately 
1 trypanosome. A hanging drop preparation was made by inverting 
the coverslip over a cavity microscope slide, the edges sealed 
with Vaseline to prevent evaporation of the drop, and examined 
under the microscope. The presence of a single organism in the 
drop was confirmed by a colleague before being termed a clone.
The coverslip was then removed, the drop aspirated 3 or 4 times 
into a hypodermic syringe containing 0.2ml PSG with 10% FCS and 
injected intravenously into an irradiated mouse (500 rad). In 
this way, clones 667/lC, 667/2C and 667/3C were prepared.
Mice ; All experiments with T. brucei species parasites were
done in female CFLP mice (Anglia Laboratory Animals, England).
At the start of experiments, these were 6 to 8 weeks of age and 
weighed approximately -25 g. Experiments with T. congolense GVR 1 
were done in female inbred C57B1/6 mice (Laboratory Animal Centre, 
Edinburgh) of the same age. Mice were housed in either 5- or 8- 
capacity cages and were fed mouse diet pellets (Diet 41, Angus 
Milling Co., Perth) and water ad libitum.
Infection; Infections were initiated by intraperitoneal injection 
of 1 X  10^  ^ trypanosomes prepared from the frozen stabilates in 
phosphate saline glucose (PSG).
Monitoring of infection; Tail blood from the mice was examined 
for trypanosomes by the wet film technique prior t® treatment to 
ensure that all were infected. After treatment, they were 
examined every two days for six days and thereafter twice per
37
week* In some instances, tall blood was inoculated into control 
mice to detect parasites. Precautions were taken to prevent 
accidental transmission of infection by removing positive mice 
from a group as soon as they became detectably parasitaemic*
Permanent cure was considered to have occurred only if mice 
remained aparasitaemic for 200 days after treatment.
Drugs ; The following drugs were inoculated intraperitoneally: 
Berenil (diminazene aceturate, Hoechst, Germany), Ethidium 
(homidium bromide) and Prothidium (pyrithidium bromide, Boots 
Pure Drug Company, England), Samorin (isometamidium), and 
Melarsen (N“ (4,6 Diamino-5-triazin-2-yl)arsanilic acid monosodium 
salt heptahydrate (May and Baker Ltd., England). The doses 
selected for Berenil, Ethidium and Prothidium were several times 
greater than those recommended for cattle and were selected from 
experience to give maximum trypanocidal effect without evidence 
of toxicity in mice. Samorin was initially given at the dose 
level used for bovines, due to lack of previous experience of 
this drug in mice. Subsequently, the dose rate was increased to 
a level severa'hfold greater than its recommended dose. Melarsen 
was administered to reflect its use in the treatments of chronic 
infections in man. Accordingly, four doses were given on 
successive days, starting on day 21. ‘ The doses used for each 
drug are summarised in Table 1*1.
Immunosuppression of the host: This was done in 5 different
ways, i) The powerful alkylating agent cyclophosphamide (Koch, Light
38
Table 1.1 Recommended and Experimental Dosage of the Common 
Trypanocidal Drugs studied.
Drug* Recommended dose Experimental dose
mg/kS mg/kg
Berenil** 3.5 - 7.0 AP 40.0 AP
Ethidium 1.0 7,5
Prothidium 0.2 - 0,4 10.0
Samorin 0 . 2 5 - 1 . 0  1.0 - 4.0
Melarsen 15 25
*Drugs were administered to mice on the basis of their weights to
the nearest 5 g ie. a mouse weighing 23.5 g received a dose for a
25 g animal.
**The granule preparation of commercial Berenil is only 44.5% 
active principal. It was administered according to the following 
equation :
40 mg Active Principal/kg body wt.
= 90 mg granules / kg body wt,
= 2.25 mg granules/25 g mouse
22.5 rag granules is sufficient for 250 g body w t .
Dissolve 22.5 mg granules in 2.5 ml distilled water.
2.5 ml contains dose for 250 g body wt.
0.05 ml contains dose for 5 g body wt.
Thus, for a 20 g mouse, dose = 0.2 ml 
25 g " " = 0,25 ml
30 g '* " = 0.3 ml etc.
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given at a dose of 300 mg/kg body weight, has a profound effect 
on the immune system of the host (Poulter & Turk, 19.72; Lagrange, 
Mackaness & Miller, 1974), the effect being maximal 3 days after 
administration* Groups of mice were treated with cyclophospha­
mide (Cph) either 3 days before infection with T. brucei TREU 
667/1 or on the same day as infection.
ii) Similarly, perturbation of host responses and enhanced para­
sitaemia result from treatment with (3-methasone (Betsolan, Sigma, 
London). This was given on 5 consecutive days at a level of 
1.0 mg/kg, starting the day after infection and ending 2 days 
after treatment,
iii) Sub-lethal total body irradiation at a dose of 650 rad 
depresses immune responses (Taliaferro & Taliaferro, 1964;
Luckins, 1972). This was done the day before infection with 
trypanosomes, using a ^^Co irradiation source,
iv) Babesia microti infection. This piroplasm is a natural 
pathogen of mice, and is knox-m to severely depress host immune 
responses concurrent with peak bloodstream parasitosis (Phillips and 
Wakelin , 1976)* A stabilate of B* microti which had been 
cryopreserved in liquid nitrogen from an infected mouse was 
injected into splenectomised mice. Ifhen a 20% parasitosis was 
achieved the mouse was killed, and its blood used to initiate 
infection in three groups of eight CFLP mice. Patent para­
sitosis with Babesia occurred on day 5, reached a peak on day 10 
and thereafter subsided, Trypanosome infection was initiated on 
day 9 and treated with Berenil on day 12, A horse red blood
40
cell (HRBC) haeinagglutination assay was done in a control Babesia- 
infected group to assess the degree of immunosuppression induced
9
by the parasite. 1 x 10 HRBC were injected on day 8 and the 
mice killed and serum collected on day 13* No antibody to HRBC 
was detected in the haemagglutination assay (Materials and Methods,
Po128 )*
v) C57B1 mice were infected with T, congolense GVRl for 21 days, 
superinfected with T. brucei TREU 667/1 and treated 3 days later 
with Berenil. The degree of immunosuppression exerted by the 
To congolense infection was assessed as in iv) above.
The 5 different immunosuppressive protocols are summarised 
in Table 1.2.
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RESULTS
Horizontal spread of infection
The very nature of the experiments in this section 
necessitated mice being kept for long periods while being 
sampled for parasitaemia at regular intervals a Thus, the 
possibility existed that, despite meticulous cleaning of scissors 
with 70% alcohol after sampling each mouse in a cage, infection 
might be transmitted within a group through continued bleeding 
from the tail of an infected individual,, Thus, others in a 
group may become infected horizontally by contact of their own 
open tail wounds. To test this possibility, 4 mice were 
infected with T. brucei TREU 667/1, and housed in a cage with 4 
uninfected mice. All 8 mice -were checked twice weekly for 
parasites by tail blood wet film. After the 4th day of infection, 
parasites were regularly found in the infected mice until between 
days 60 and 86, when these mice died of the infection. At no 
time were parasites found in the 4 control mice.
Time of treatment: The effect of time of treatment on the
efficacy of eliminating T. brucei 667/1 in mice was tested by 
infecting a large group of 56 mice on day 0, and then removing 
from the original stock on days 3, 7, 14, 21, 28, 42 and 56, a 
group of 8 mice. These were isolated and treated with Berenil 
at 40 mg Active Principal/kg, and subsequently examined for a 
recurrence of parasitaemia as described.
The pattern of reappearance of parasites in the blood
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after treatment is illustrated in Figure 1,1. The earliest 
reappearance was 21 days after drug treatment and the latest 
was 63 days after treatment, with the majority of breakdowns 
occurring between 20 and 50 days. There were no relapses if the 
mice were treated at 3 and 7 days after infection, but at 14 days,-’
6 out of 7 mice eventually relapsed. If administration of the drug 
was delayed later than this then all of the mice relapsed.
Treatment of relapse infection. To test if the relapse of
the infection was due to the survival of drug resistant trypano­
somas, a stabilate TREU 667/56 from a relapsed mouse (Materials 
and Methods) was inoculated into 2 groups of mice. The patterns 
of recrudescence of parasitaemia in this relapsed strain when 
treated 3 and 21 days after infection, together with that of the 
original 667/1 are shown in Figure 1.2.
The relapse strain of ^  brucei 667/56, if treated 3 days 
after infection, was completely susceptible to Berenil treatment; 
however, if treatment was delayed until 21 days after infection 
then all of the mice showed a pattern of relapse similar to the 
original stabilate 667/1 ranging from 28 to 56 days after treatment.
Treatment of clones of T. brucei 667/1. To further substantiate 
that the survival of a few drug-res istant trypanosomes did not 
cause the relapse after Berenil treatment, three separate clones 
were prepared from the original 667/1, Each of these three cloned 
stabilates, 667/lC, 567/2C and 667/3C was used to infect 2 groups 
of mice which were treated with Berenil after 3 or 21 days. The
Fig 1.1
The reappearance of trypanosomes in the blood of 
individual mice given a single treatment with Berenil 
(40 rag/kg) on one occasion between 3 and 56 days after infection 
with Trypanosoma brucei 667/1.
(0 : Day on which trypanosomes first reappeared
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Fig 1.2
Tlie reappearance of trypanosomes in the blood of 
individual mice given Berenil (40 mg/kg) 3 or 21 days after 
infection with Trypanosoma brucei TREU 667/1, or TREU 667/56 
isolated from a relapsed infection.
: Day on which trypanosomes first reappeared.
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patterns of relapse shovm in Figure 1,3, are essentially similar 
to the original 667/1 or the relapsed stabilate 667/56,
Effects of size of initial infection. In an attempt to show 
that relapses were not simply associated with a larger number of 
parasites being present when treatment was initiated late in the 
infection, 3 groups of mice received initial infections of 1 x 10^,
1 X 10^ or 1 X 10^ T, brucei TREU 667/1, followed by treatment 
with Berenil at 3 or 21 days after infection. As before, all 
mice treated on day 3 were permanently cured regardless of infective 
dose. On visual appraisal most of the animals treated at 21 days 
had lower circulating parasitaemias than the 3-day infections, 
but the relapse patterns (Fig 1.4) showed no correlation with the 
size of the initial infections.
Effect of suppression of host responses. Immunosuppression of 
the host by cyclophosphamide or p-methasone treatment, total body 
irradiation, or B. microti or T . congoleiise infection did not 
influence the efficacy of chemotherapy. Treatment with 
Berenil after 3 days of a trypanosome infection resulted in 
permanent cure despite the immunosuppressive treatment.
Treatment of different stocks of T. brucei. In view of the
results obtained with T . brucei TREU 667/1, the efficacy of 
Berenil was tested against the other strains of T. bruce^ available 
in the laboratory. Two stabilates, T. brucei LUMP 612 and LUMP 962 
are particularly pathogenic for CFLP mice, and cause a high 
proportion of deaths by 3 weeks after infection. Treatment
The reappearance of trypanosomes in the blood of 
individual mice given a single treatment of Berenil (40 mg/kg) 
3 or 21 days after infection with 3 cloned stabilates prepared 
from Trypanosoma brucei TREU 667/1.
: Day on which trypanosomes first reappeared.
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Fig 1,4
The reappearance of trypanosomes in the blood of 
individual mice given a single treatment of Berenil (40 mg/kg) 
3 or 21 days after infection with doses of 10^, 10^, or 10^ 
Trypanosoma brucei TREU 667/1.
: Day on which trypanosomes first reappeared.
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was therefore initiated on the day of the first fatality with 
these parasites ie, on days 14 and 12 respectively.
Of these other stabilates of To brucei, only one,
T, brucei LUMP 571, showed any indication of a relapse if treat­
ment was at 3 days (1 of 8 mice); all the other mice treated at 
3 days exhibited 100% susceptibility to Berenil (Fig 1,5), thus 
it is likely that the one relapse with T, brucei LUMP 571 was the 
result of a faulty injection. If treatment was delayed from 
between 12 and 21 days after infection, a high incidence of 
relapses was encountered with all stabilates.
Treatment with different trypanocidal drugso The phenomenon of 
relapsing infections after chemotherapy was not confined to 
Berenil alone, but was also exhibited by Ethidium, Prothidium and 
Samorin (Fig 1,6). Ethidium and Prothidium were both 1007, 
effective against T. brucei TREU 667/1 when treated at 3 days; 
however, if therapy was delayed for 21 days after infection, then 
Ethidium-treated mice relapsed 9-24 days later. Prothidium had, 
in general, a much more prolonged effect when given 21 days after 
infection, many of the mice remaining aparasitaeraic until 60-120 
days after treatment»
Samorin behaved somewhat differently from the other drugs 
in that at 1 mg/kg body weight, it failed to cure mice permanently. 
Even if treated at 3 days, 6 out of 8 mice became parasitaeraic 
after approximately 30 days. However, this was probably due to 
drug underdosage, since in a subsequent experiment in which the
The reappearance of trypanosomes in the blood of 
individual mice given Berenil (40 mg/kg) 3 or 21 days (or at the 
time of first fatality) after infection with different 
stabilates of Trypanosoma brucei,
(2) : Day on which trypanosomes first reappeared in a mouse
treated 3 days after infection.
^  : Day on which trypanosomes first reappeared in a mouse
treated 21 days after infection.
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Fig 1.6
Tlie reappearance of trypanosomes in the blood of 
individual mice given a single treatment with one of 4 
trypanocidal drugs 3 or 21 days after infection with Trypanosoma 
brucei TREU 667/1.
(2) : Day on which trypanosomes first reappeared in a mouse
treated 3 days after infection,
^  : Day on which trypanosomes first reappeared in a mouse
treated 21 days after infection.
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dose was increased to 4 mg/kg, permanent cures were obtained with 
treatment at 3 days, with substantial relapses occurring after a 
21-day treatment even at this elevated dose (Table 1.3)»
Effect of different doses of Berenil» The recommended live­
stock dose for Berenil is 3.5 mg/kg for T. congolense and T. vivax, 
and 7ûO mg/kg for T. brucei. At these doses, the drug is curative, 
and there is very little prophylaxis afforded by the drug» The 
Berenil dose in mice of 40 mg/kg was an arbitrary choice, being 
below the toxic level of the drug for mice, but at a level which 
effected elimination of the parasite for a considerable period of 
time» This was demonstrated in a dose-response.experiment 
(Fig 1.7). Even at very high doses, permanent cures were not 
obtained in a large proportion of mice. At doses equivalent to 
the recommended livestock dose, permanent cure was obtained with 
treatment at 3 days, but such low doses were able to eliminate 
parasites from the bloodstream for only a short time when given 
on day 21 of an infection. 40 mg/kg was the dose at which
parasites remained undetectable in the bloodstream after treatment
for at least 4 weeks before recrudescence, and was below the
threshold of drug toxicity.
Multiple treatment with Berenil. The effect of repeated treat­
ments of Berenil on mice is shox-m in Table 1.4. Six groups of 
mice (groups A-F) xeere infected with T, brucei 667/1 on day 0 and 
all were treated with 40 mg/kg Berenil on day 21. Group A 
received only this one treatment, group B received this and a 
further treatment on day 42, group G was treated on days 21, 42
47
Table 1.3 The efficacy of Samorin and Melarsen on infections of
T . brucei 667/1 "
Drug - Day(s) of treatment No. cured/ Relapses occurred
(dosage after infection Total treated days after last
™g/kg) treatment
Samorin
(1.0) 3 10/10
(1.0) 21 0/8 18-42
(2.0) 3 10/10
(2.0) 21 0/10 35-71
(4,0) 3 . 10/10
(4.0) ■ 21 1/10 40-81
Melarsen
(25) 21, 22, 23,24 0/20 10-18
Fig 1.7
The reappearance of trypanosomes in the blood of 
individual mice given different doses of Berenil 21 days after 
infection with Trypanosoma brucei TREU 667/1.
^  ; Day on which trypanosomes first reappeared.
I 70
E
I
^ 40Im
E 30i
10
& Q
o
0^0
O Q
©
©
© © 
© 
©
o ©
o ©
o ©
©
7
©115
%  %  %  %  %  3X
mgy^kgi Berenil
No. Relapse^
/Total
48
c
o
• H
U
U
0)
m
c!
v£)
vO
"H
Q)
O
0M
,û
H
g
&c\5
UCD
Æ
4J
I
•S
û)
W
RJ
Q)
CL
(D
h
U-t
O
U
Q)
mM-t
Q)
0)
M
(ü
4->
CM U o
cd d r - î
d i-C
QJ 0 <*- CT\
co w 1—1 P'-
Pu cd r—C CO <J" r~4
cd eu CTi CT>
r-4 P 1 r-c :
CD 4J
H o \ Ln  00
■<J- en vo
M-l co
O  cd
i—H
%
cd
«
00
0)
4J
Cd
d
d
u
1—c o  o
cd CT\ ON t-H r-4
4J
O <J- VD ON m
4J
Td
CD
u
d
o
O
:a
4-1
C
Std
0)
w
4-1
m
o
O
o
r - i
•g
H
r— î
c
0}
U
Ü)FQ
tiO
.is!
00
e
O
vO
<N
m
o
co
en
vD
CN
N
\0
ol
vO
lO
as
as
vO
en
( ) I I I +
I I I I -î* +
t I I *1* +
I . +  +  +  "i* 'h
4" + + +
< ; pq ü  Q  W  Pu
P .
P
O
o
4J
ti
fl>
Bw
«!
0)
P
4J
•HS
h
(ü
pq
I- !
td
P
•H
m
CD
■6
00 
d
1  
r-i 
i~i
OIW
%
S'
ID
o
oCNl
d
Q)
>
O
Pf
(8
T )
©
£
<ü
co
■ë
Q)
U
§
co
pu
p
o
U
00
49
and 63, and so on» Thus, group F was treated on days 21, 42,
63, 84, 105, and 126, At no time were parasites detected in mice 
between treatments» With the exception of the group receiving 
5 treatments, in which no relapses occurred, relapse of infection 
occurred after the cessation of treatment in ail cases, and in 
some instances over 200 days had elapsed since the first treatment 
before parasites were detected in the bloodstream (Table 1,4)»
Relapse of T» congolense infection» Initial experiments with 
Tq congolense Infections in C57B1 mice did not show a similar 
outcome to those described for T» brucei. In these experiments 
Berenil chemotherapy at 40 mg/kg on day 21 elicited permanent 
cure.
To test if a longer period of time xvas required with 
T, congolense to create the conditions where relapse infections 
occurred, a group of 30 mice xfere infected with T, congolense 
OVr 1, By the 88th day of the infection, 10 mice still survived, 
and those were treated with 40 mg/kg Berenil, Four mice relapsed 
on days 14, 22, 22 and 25 after treatment, A  stabilate x-zas made 
from the blood of the mouse which relapsed on day 25, and 2 groups 
of mice were infected with this stabilate. One group xfas treated 
on day 3 and the other on day 21, Permanent cure was effected by 
treatment on day 3, whereas 4 out of 5 mice relapsed in the group 
treated on day 21, 2 on day 26 after chemotherapy and 2 on day 28 
(Fig 1.8), The success of the Berenil therapy in these mice x<ras 
confirmed by the inability to transmit infection with tail blood 
by inoculation into susceptible mice 7 days after treatment.
Fig 1.8
Tlie reappearance of trypanosomes in the blood of 
individual mice given a single treatment of Berenil (40 mg/kg)
88 days after infection with T. congobMse GVR 1, or 3 or 21 days 
after infection with a relapsed population.
: Day on x-zhich trypanosomes first reappeared.
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A further experiment was done with this, relapse population 
in which Berenil treatment was given at 20 mg/kg. Treatment on 
day 3 was completely successful, whereas trypanosomes reappeared 
in the bloodstream of 5 out of 7 mice on the 14th day following 
treatment on day 21„ The relapse infections in these mice were 
allowed to continue for a further 21 days, at which time they were 
treated with 40 mg/kg Berenil, One mouse relapsed.18 days later,
A stabilate was made of this population, and 3 groups of mice,
groups A, B and C, infected, groups A and C with 10^ parasites and
group B with 10^ parasites. Groups A and B were treated on day 
3 with 40 mg/kg Berenil, and were permanently cured, whereas of the
8 mice in group C which were treated on day 21, 3 relapsed 22, 27
and 34 days later,
A summary of this experiment is sho'im in Fig 1,9,
Fig 1.9
The reappearance of trypanosomes in the blood of
individual mice given a single treatment with Berenil.
a) Treatment at day 3 or day 21 of relapsed T. congolense
from Fig. 1.8 with 20ing/kg Berenil
b) 5 mice from a) which relapsed after 14 days were all­
owed to remain parasitaemic for a further 21 days and 
then treated with 40mg/kg Berenil
c) A stabilate was made from the one mouse which relapsed 
in b), and groups of mice were treated 3 or 21 days 
after infection with either 10*^  or 10^ parasites.
@  : day on which trypanosomas first reappeared.
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DISCUSSION
The experiments in this section have investigated the 
efficacy of chemotherapy in mice undergoing T o brucei and, to a 
lesser extent, T, congolense infections* From these studies, it 
is evident that relapses of infection after chemotherapy occur 
which can be ascribed neither to drug-underdosage nor drug 
resistance.
Extrapolation from a large animal system to- a rodent 
experimental system is an exercise that must be done with extreme 
caution* Thus, a therapeutic dose of Berenil (40 mg/kg) many 
times greater than that recommended for infections in livestock 
was chosen to investigate the effect of chemotherapy on mouse 
infections, A similar approach was adopted with the other drugs. 
The justification for this approach was obtained in the Berenil 
dose-response experiment (Fig 1,7) which showed that at doses 
therapeutic for livestock infections (3,5-7,0 mg/kg), there is a 
very transient aparasitaeraic period in mice after treatment before 
trypanosomes reappear in the blood. This experiment eliminated 
as a possible explanation for post-treatment relapse of infection 
the possibility of drug-underdosage, 40 mg/kg Berenil eliminated 
trypanosomes from the bloodstream for a considerable period of 
time during which they could be detected neither microscopically 
nor by subinoculation of blood into mice, and even at elevated 
doses which are toxic, relapse infections always occurred. For 
example, a dose of 160 mg/kg given as a single injection, or as 2
52
injections of 80 rng/kg given on successive days, or as 4 
injections of 40 mg/kg over 4 days, failed to give permanent 
cure.
The complete efficacy of Berenil on a variety of stabil-
ates of T, brucei if treatment was initiated 3 days after infection
compared to an almost 100% incidence of relapses if treatment was 
delayed, suggests that the inability of chemotherapy to produce 
permanent cure is not due to drug resistance of the parasite.
This is supported by the finding that a relapsed strain is 
completely susceptible to chemotherapy when treated at an early 
stage in a new host.
Further evidence against drug-resistance £er was the 
finding that 3 separateclones prepared from one of the original 
stabilates behaved in a similar manner after chemotherapy. 
Furthermore, no evidence was obtained that the incidence of 
relapses was influenced by the size of the initial infection*
The efficacy of early treatment raises the possibility
of another explanation* It has been clearly established that 
T. brucei infection has a profound immunosuppressive effect on 
mice (Murray e^ 1974a,b)
Studies in cattle (Maxie and 
Losos, 1977) suggested that Berenil acted by making trypanosomes 
available to host defences such as the macrophage system, which 
eliminated them from the host. However, it is possible that 
through immunosuppression due to an established trypanosome
infection, the host's immune .system cannot process drug-treated 
parasites, and as a result, subsequent relapse occurs* Thus 
treatment after only 3 days of infection is successful since the 
degree of immune impairment which is manifest by 21 days has not 
yet developed*
The results with irradiated, drug suppressed and Babesia 
microti-infected mice suggest that this is not the case* Thus, 
despite total body irradiation, treatment with cyclophosphamide 
or p-methazone, or a concurrent infection with another immuno­
suppressive parasite, permanent cure resulted in mice whose 
duration of trypanosome infection was only 3 days* While the 
interpretation of these results must be made with the proviso that 
the mechanism of immunosuppression induced by agents other than 
trypanosomes may be markedly different from that imposed by a 
trypanosome infection, the experiment in which a T* brucei infection 
was superimposed on a 21 day T, congolense infection supports the 
conclusion that immunosuppression is not involved in the relapsing 
phenomenon* Treatment on the 3rd day after challenge with 
To brucei resulted in permanent cure*
An interesting observation in this experiment was made in 
a control group of mice superinfected with T* brucei, which was not 
treated with Berenil* On the 7th day following infection with 
10^ To brucei 667/1 when peak parasitaemia would normally be 
attained in mice with a primary infection with this parasite, no 
T* brucei parasites were seen in Giemsa stained slides made from
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tail blood of 3 out of the 10 mice in the group. All parasites 
displayed the typical morphology of T* congolense. This suggests 
that in some way establishment of the superinfection was inhibited 
by the existing T* congolense infection* Presumably, in the 
group treated on day 3 when the T* brucei infection was not yet 
patent, a similar preparation may have also failed to become 
established* However, within the context of this experiment, 
the remaining mice were permanently cured by chemotherapy.
The phenomenon of relapse after chemotherapy appears not 
to be a result of drug underdosage or drug resistance* Rather, 
it would seem to be a result of the trypanosomes escaping the 
action of the chemical, either because they are in an inaccessible 
situation in the body, or in an insusceptible stage of development, 
Either of these stages apparently requires some time to develop 
during the course of a normal infection in view of the suscept­
ibility of early infections to drugs*
Furthermore, the evidence suggests that once either of 
the above states is reached, it can be maintained indefinitely, 
or the parasite can reattain such a state if required* Thus, 
the parasite can survive repeated treatments given over a pro­
longed period, yet still retain the.capability of causing a 
relapse infection when treatment ceases*
This is similar in some respects to the observations of 
Broiling and Calver (1943) and Calver (1945)* However, in these 
experiments, cure was ultimately obtained in mice which showed
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repeated relapses of a strain of T, congolense after repeated 
doses of a pbenanthridinium drug*
It is not possible to account for the different lengths 
of time which elapsed between drug treatment and the reappearance 
of infection* With Ethidiura and Berenil, the onset of relapse 
is relatively rapid and in the latter at least may be associated 
with the apparently rapid rate of excretion of the drug. Thus, 
Pink and Darnra (1974) have reported successful infections of mice 
with To congolense 5 hours after treatment with Berenil at 10 mg/ 
kg, and Fairclough (1963) found that cattle were susceptible to 
experimental infections with T. congolense 24 hours after treatment 
at 3*5 mg/kgo However, other workers (van Hoeve and Cunningham, 
1964; Lumsden, Herbert and Hardy, 1965; Raether, Hajdu,
Seidenath and Damm, 1972; Zahalsky and Weinberg, 1976; Williamson, 
1976) have shown that Berenil may have a prophylactic effect for 
up to 6 weeks after administration. These contradictory obser­
vations may be due to the use of different strains of brucei 
or depend on the numbers of trypanosomes used as the challenge 
inoculum; however, this will be further discussed in Chapter 2,
Most of the mice treated with Samorin or Prothidium 
(both of which are prophylactic drugs) did not show relapses until 
40-70 days after treatment, and in some cases mice remained 
negative until nearly 120 days after treatment* The result from 
the second Samorin experiment suggested that, despite being-used 
initially at the recommended livestock dose, such a level of 
Samorin is insufficient for the treatment of infections in mice*
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Thus, the relapses obtained after treatment on day 3 with 1 mg/kg 
were undoubtedly due to drug underdosage, since higher doses 
resulted in permanent cure*
The result with Melarsen was interesting since a course 
with this drug has proved effective against the later stages of 
the Gambian disease in man. However, a dose of 25 mg/kg given 
daily for 4 days failed to cure a three-week infection in mice.
The implications of this result will be discussed further in the 
2nd section of this chapter, A possible explanation for the 
type of relapse described in these experiments could be the 
persistence of the amastigote phase of T, brucei infection described 
by Ormerod and Venkatesan (1970, 197la,b), (The situation with
T, congolense appears to be different and will be discussed 
separately,) These forms, primarily present in the choroid 
plexus, may be unsusceptible to drug treatment and produce fresh 
waves of bloodstream forms. In this connection, these authors 
(1971a) stated that “it is probable that all current trypanocidal 
compounds are active against the occult visceral phase, but this 
problem needs to be investigated specifically". However, this 
would not correlate with the findings of Soltys, Woo and Gillick 
(1969) and Soltys and Woo (1969, 1970), that tissue forms which 
would pass through a filter pore size 0,8 pm diameter could be 
detected in a number of organs as early as 72 hours after the 
administration of blood-form trypanosomes. Obviously, these 
forms, if present with these stabilates must still be drug 
sensitive, since treatment at 3 days would not otherwise give a 
permanent cure. There are also several reports (Schwetz, 1928;
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Schwetz and Fornara, 1929; Fiennes, 1950a,b; MacLennan, 1973) in 
which the existence of an 'occult' or 'tissue' form of bovine 
trypanosomiasis caused by T. congolense and T* vivax was post­
ulated, and Goodwin and Rollo (1955) have suggested that such forms 
might be relatively unsusceptible to the action of drugs*
Thus, if one assumes that re-emergence of bloodstream 
trypanosomes from drug-unsusceptible tissue forms does occur as 
postulated above, perhaps, as suggested by MacLennan (1971), even 
trace amounts of Berenil in the plasma are sufficient to kill these 
forms for a certain number of weeks* Eventually, however, the drug 
level falls below the level of trypanocidal activity and, if tissue 
forms still persist, parasitaemia will recur.
An alternative explanation is that the trypanosomes may 
be sequestered in a site in the host where they are inaccessible to 
the action of drugs* With such a situation, the capability to 
adopt a stage of development of the parasite which is unsusceptible 
to drug action is not required, and the trypanosome may merely exist 
in a sheltered environment and continue replicating as a bloodstream 
form. Provided that the integrity of the isolation mechanism 
remains intact and excludes trypanocidal drugs, one can visualise 
a situation where there may be continual repopulation of the blood­
stream from this focus, which is eliminated as long as adequate 
drug-levels are maintained in the host* However, as soon as drug 
levels fall below that required for trypanocidal activity, the 
relapse infection is established*
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These observations have a three-fold significance. First, 
if cattle exhibit a similar type of relapse phenomenon after treat­
ment, much of the information on the epidemiology and iiamunity of 
the natural disease, which has been based on information obtained 
from the use of trypanocidal drugs, may require to be reassessed* ' 
This is particularly true if such relapses occur after treatment of 
T. vivax and T. congolense infections, and in this context, two 
reports from Nigeria are of interest. The first (MacLennan and 
Na'isa, 1970; MacLennan, 1971) reports experiments conducted in 
cattle with a strain of 2? vij^x regularly relapsed 10-25
days after treatment with Berenil at both normal and elevated 
doses* During the aparasitaemic periods no trypanosomes were 
detected in blood as tested by sub-inoculation into susceptible 
cattle and by the absorption elution technique of Lanham and 
Godfrey (1970)* The second, by Gray and Roberts (1971) describes 
2 strains of T, congolense and 2 strains of T* vivax which were 
resistant to therapeutic doses of trypanocidal drugs in that the 
infections generally relapsed 2-6 weeks after treatment* There 
was no loss of this drug resistance despite repeated transmission 
through tsetse flies., MacLennan (1971) administered Berenil on 
the 9th day after infection while Gray and Roberts, whenever 
possible, treated their cattle on the 5th to the 7th day of patent 
paras itaemia *
It is not possible to say whether or not these relapse 
infections in cattle are examples of true drug resistance or are 
due to the phenomenon recorded here in mice. However, it seems
59
desirable that the comparative incidence of relapse infections in 
cattle infected with T, congolense and T* vivax should be examined
in relation to drug treatment administered very early and late in 
the course of infection. In this connection, a Zebu ox, which 
had been treated on day 21 of a T. congolense infection with 7*0 
mg/kg Berenil, relapsed 69 days after chemotherapy (P*H* Holmes, 
personal communication). Since this experiment was done in a 
fly-free area of Ethiopia, there was no possibility of re-infection 
of the animal, and experiments in mice similar to those recorded 
have indicated that the relapse population was completely suscept­
ible to treatment on day 3, eliminating drug resistance of the 
parasite as a possible explanation*
The experiments reported here indicated that although 
relapses of T* congolense infections occurred with less frequency 
than T. brucei, they nevertheless did occur, thus indicating further 
the influence that the phenomenon might exert in a field situation.
Secondly, the experimental evidence, at least in mice,
that trypanosomes are more susceptible to drug treatment during the 
period of establishment in a new host is of importance in the 
evaluation of potential trypanocidal drugs, since it is very seldom 
that evidence for trypanocidal activity is sought in established 
infections (eg. Nathan, Soto, Moreira, Chunosoff, Hutner and 
Bacchi, 1979),
Finally, the chro^icity of infection in man despite treat­
ment, at least in T. gambiense infection (Apted, 1970) may be
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associated with a similar phenomenon to that described here in 
mice.
The importance of T* brucei as a pathogen for domestic 
livestock has largely been underestimated because of the proven 
impact of T. congolense and T* vivax* Indeed, the literature 
cites many occasions where T* brucei has been stated as not being 
a major pathogenic species (Fiennes, 1970; Killick-Kendrick,
1971), along with its related species T* rhodesiense and T, gambiense 
which are pathogenic for man* Moreover, recent studies have 
questioned the validity of separating T* brucei, T* rhodesiense 
and To gambiense into subspecies in view of the ability of clones 
to produce human-infective and non-infective populations sequent­
ially (N. Van Meirvenne, personal communication; DDW, unpublished). 
However, experimental studies (Murray _e_t ^1, 1979; Wellde £t al,
1980) have produced a fatal outcome in cattle with T* _brimei and 
T* rhodesiense, and dogs (Morrison, Murray, Sayer and Preston,
1981) and goats (Emery and Moloo, 1980) are also very susceptible*
The experiments recorded in this section, if reproducible 
in livestock, raise the possibility of an animal being "infected 
for life" with trypanosomes, despite chemotherapy. The "cryptic 
focus" of infection which has been under discussion forms the 
basis for the second part of this chapter*
Section 2
The Brain as the Source of Infection after Chemotherapy
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INTRODUCTION
Sequestration of a pathogenic organism in a site 
inaccessible to host defences and drugs, or in a stage- of develop­
ment such that normally effective drugs are unable to act, is a 
frequently observed phenomenon* Penicillin cannot eradicate 
tertiary syphilis in man, not because of the organisms becoming 
drug-resistant, but because of the presence of non-growing trepon- 
emes (Collart, Borel and Durel, 1962; Rice, Dunlop, Jones, Hare, 
King, Rodin, Mushin and Williamson, 1970). Furthermore, in 
experimental infection in rabbits, viable organisms persist for 
life and can be readily isolated from lymph nodes. It has been 
sho\<m that hypobiotic fourth-stage Ostertagia larvae lodged in the 
gastric glands of calves, are insusceptible to many of the common 
anthelmintics (Anderson, Armour, Jarrett, Jennings, Ritchie and 
Urquhart, 1965). Brucella abort_us may persist within mononuclear 
phagocytes (Karlstad, Kessel, de Pétris and Monaco, 1964) where 
it is inaccessible to the action of streptomycin and host antibody, 
and even with the tetracyclines, eradication of some Brucella spp
wurtiw ..a»*
only follows prolonged treatment (Spink and Bradley, 1960; 
Phillipson, Kazmierczak, Plommet, Marly and Nevot, 1976)*
Natural Leptospira infections in rats display chronic 
involvement of the kidneys, and similarly multiplicative infective 
parasites have been demonstrated in the kidney capillaries of mice 
which had apparently recovered from Trypanosoma musculi infection 
one year previously (Viens, Targett and Lumsden, 1975) by transfer
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of these tissues to normal recipients and subsequent examination 
of peripheral blood* Borrelia recurrentis, the causative 
organism of relapsing fever in man, undergoes a similar syndrome 
of waves of parasitaemia as is seen in trypanosome infection, and 
during the afebrile period between successive waves, infection 
cannot be detected in nor transmitted by blood*
The ability to evade host response and the action of 
drugs, and also to adopt an insusceptible form, is well illustrated 
in tuberculosis infections* The typical tubercle lesion, which 
is present in lung parenchyma and mediastinal lymph node, retains 
viable bacilli which even after many years can resume multipli­
cation* Such fibrous or calcified lesions protect the organism 
from host defences and also promote a metabolically Inactive 
state which prevents the action of bactericidal drugs.
The previous section of this chapter described a type of 
relapsing infection in mice after chemotherapy which can be 
ascribed neither to drug-underdosage nor drug-resistance* Rather, 
the results indicated that a situation similar to that described 
above may be operating, namely that the parasite may be present 
in a site inaccessible to the action of the drug or in a stage of 
development against which normally effective drugs are unable to 
act* The latter would suggest a stage in the life-cycle of the 
parasite akin to the amastigate form of T* brucei suggested by 
Ormerod and Venkatesan (1970, 1971a,b), or the "ocult" form 
(Goodwin and Rollo, 1955) which may be relatively unsusceptible 
to the action of drugs*
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This section records the outcome of a series of 
experiments to identify the location of the cryptic infection 
during the aparasitaemic period following chemotherapy and to 
determine the morphology of the parasite during this phase*
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l'ÎATERIALS AND METHODS
The mice and trypanosomes used in these experiments have 
been described in section one of this chapter*
Chemotherapy; This was done with Berenil (dirninazene aceturate,
I n 1 I |»li|iP»g|—ill IMUgnm*>i /iM ^
Hoechst, Germany)* The dose was 40 mg active principle/kg body 
weight, and was administered to mice as outlined on page
Preparation of tissue homogenatess Donor mice were exsanguinated 
by cardiac puncture under deep trichloroethylene anaesthesia 
(Trilene, 1*0*1*, England), and immediately dissected* Initially, 
all tissues were mechanically disrupted with a homogeniser 
(Silverson, London, England), but in later experiments, with the 
exception of brain, all tissues were teased apart through a fine 
wire sieve, using a rubber-tipped spatula, into sterile PSG*
Whole mouse brains were transferred from the cranial cavity using 
forceps into a 2 ml syringe containing a small quantity of sterile 
PSG, and forced sequentially through hypodermic needles of pro­
gressively narrower gauge* After passage through 16 gauge, 19 
gauge and 21 gauge needles, the tissue was of a consistency 
suitable for injection* Each cell suspension, derived from an 
entire organ, was then injected i*p* into 1 recipient, except in 
the case of liver whose size required that it be divided between 
2 recipients. Four lymph nodes per animal (right and left pop­
liteal and prefemoral) were pooled, disrupted and injected together 
into 1 recipient mouse* The volume of blood injected was 0*5 ml *
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Ion-exchange chromatography:. This was done by the miniature 
anion-exchange/centrifugation (AEG) technique of Lumsden, Kimber 
and Strange (1977)* Briefly, 70 [il of blood from a capillary 
tube was introduced on to the surface of a DEAE-cellulose gel 
(DE52, Wliatman, England) which had been prepared in a 2 ml syringe 
barrel* The blood sample was allowed to penetrate the surface 
of the cellulose bed, the buffer reservoir attached (PSG, pH 8*0) 
and 2 ml eluate collected in a pasteur pipette with a drawn-out, 
sealed end* This was centrifuged at 3000 x g for 15 minutes, and 
examined microscopically at the tip for trypanosomes.
Experimental design; The results from the first section of 
this chapter indicated that treatment with Berenil at 40 rng/kg 
resulted in an aparasitaemic period of at least 3 weeks duration 
following which recrudescence of parasitaemia occurred* Accord­
ingly, it was on the initial phase following treatment that most 
attention rvas paid*
Mice were inoculated with 1 x 10^ parasites i*p* and tail 
blood was examined, after 5 days to confirm that they were infected, 
Treatment was given on day 21, and the mice were monitored over 
the ensuing 3 days to confirm the diminution of the bloodstream 
parasitaemia* On either the 7th or 14th day after treatment, the 
mice were killed, the organs removed, and homogenates of these 
organs injected into clean recipients. The absence of trypano­
somes in the blood on the day of tissue transfer was confirmed by 
microscopic examination and the miniature AEG method. Tail blood
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from the mice which received inoculation of tissues was checked 
every 2 days for the presencd of parasites for the first 10 days 
after tissue transfer, and thereafter twice per week* Mice were 
judged to be uninfected only after 60 days had elapsed since 
tissue transfer without trypanosomes being detected in the blood­
stream* Mice with positive wet films were immediately killed 
to avoid possible cross-infection within a cage* Between 3 and 
6 donor mice in each experiment were not sacrificed after Berenil 
treatment and served as relapse controls*
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RESULTS
The focus of the cryptic infection* The experiments from
section 1 of this chapter established that a high incidence of 
relapse of infection occurred when a T* brucei infection in mice 
was treated after 3 weeks with Berenil, whereas no .relapses 
occurred after chemotherapy of a 3 day infection* The absence of 
viable trypanosomes in the host after treatment at this early 
stage was confirmed by a tissue transfer experiment, the results 
of which are shovm in Table 1*5* None of the tissues which were 
removed, 2 weeks after chemotherapy, from mice treated on the third 
day of a T* brucei TREU 667/1 infection were able- to transmit 
infection to recipient animals*
However, when this experiment was done in mice whose 
infection was of 3 weeks* duration at the time of chemotherapy, 
infection was successfully transmitted from a proportion of mice 
(Table 1*6)* The brains only from 3 of 8 mice established 
infection in recipient mice* Infection in these donors resided 
in no other location, since blood and other tissues failed to 
transmit infection* Mice from the donor group which were not killed 
developed parasitaemias 28-47 days after chemotherapy.
In both of these experiments, tissue disruption was done 
mechanically using a Silverson homogeniser, which produced easily 
injectable tissue homogenates* However it was possible that such 
treatment of tissues may also have disrupted trypanosomes, particu-
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Table 1.5 Transmission of infection with tissue from mice
14 days after chemotherapy of a 3-day infection with T. brucei 
TREU 667/1,
No. of Tissue
donors Blood Brain Liver Kidney Spleen
* 0/8 0/8 0/16 0/16 0/8
*No. of recipients parasitaemic/No. of recipients injected.
Six donor mice which were not sacrificed after Berenil treatment 
did not relapse after treatment.
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Table 1.6 Transmis s i-on o£ infection with tissue from mice
14 days after chemotherapy of a 3-week infection with 
T. brucei TREU 667
Donor
Brain Blood
Tissue
Liver Kidney Spleen
1 0/1* 0/1 0/1 0/1 0/1
2 0/1 0/1 0/2 0/1 0/1
3 0/1 0/1 0/2 0/1 0/1
4 0/1 0/1 0/2 0/1 0/1
5 0/1 ■ 0/1 0/2 0/1 0/1
6 1/1 (24) 0/1 0/2 0/1 0/1
7 1/1 (26) 0/1 0/1 0/1 0/1
8 1/1 (22) 0/1 0/2 0/1 0/1
( ) : day of patent parasitaemia after tissue transfer.
* No. of recipients parasitaemic/No, of recipients injected.
Six donor mice which were not sacrificed after Berenil treatment 
relapsed on days 28, 30, 30, 40, 40, 47.
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larly since there is no information on the fragility of tissue 
forms compared to trypomastigates* For this reason, these two 
experiments were repeated, including heart, lung and lymph node 
tissues, and a more gentle tissue disruption method employed.
The result of the experiment involving tissue transfer 
from mice 2 weeks after day 3 treatment with Berenil was unaltered,, 
Table 1*7 shows the outcome of transfer after a 3 week infection* 
Infection from 3 of 5 donors was successfully transmitted, again 
only from brain tissue* In those recipient mice which became 
parasitaemic, the prepatent periods were significantly shorter,
10, 12 and 14 days compared with 22, 24 and 26 days than in the 
previous experiments* However, whether the higher incidence of 
detection of infection in brain tissue and the apparently greater 
number of parasites present, as reflected by the prepatent 
periods in the recipient mice, is a direct consequence of more 
gentle handling of the material or merely between-experiment 
variation is unclear*
A higher incidence of transmission from brain was 
achieved from mice which had been infected with T* brucei 667/1 
for 7 weeks before treatment (Table 1.8): brain homogenate from
6 of 8 mice produced parasitaemias between 7 and 27 days after 
inoculation into recipient mice* Spleen, liver, heart, lymph 
node, kidney and lung tissue failed to transmit infection* The 
absence of circulating trypanosomes, indicated by blood films 
and miniature AEG on the day of transfer was substantiated, as in 
the previous experiments, by the non-infectivity of donor blood*
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Table 1.7 Transmission of infection with tissue from mice
14 days after chemotherapy of a 3-week infection with
T. brucei TREU 667
— — —
Tissue
— ------------------------------™
Donor Lymph
Brain Blood Spleen Lung Heart Kidney node
1 0/2 0/2 0/2 0/1 0/1 0/1 0/1
2 1/2 (14) 0/1 0/2 0/1 0/2 0/1 0/1
3 0/2 0/2 0/2 0/1 0/1 0/1 0/1
4 1/2 (12) 0/1 0/2 0/1 0/1 0/2 0/1
5 1/2 (10) 0/2 • 0/2 0/2 0/1 0/1 0/1
( ) : Day of patent parasitaemia after tissue transfer
No. of recipients parasitaemic/No . of recipients injected
Three donor mice which were not sacrificed after Berenil treatment
relapsed on days 59, 59, 68.
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7.3
Previous experiments in section 1 had revealed that the 
phenomenon of relapse after chemotherapy was a feature common to 
several stabilates of T* brucei, l\fo other stabilates, brucci 
LUMP 1001 and To brucei LUMP 571 were therefore examined to find 
if infection also resided in the brain tissue during the aparasit- 
aemic period after drug treatment* Since the previous experiments 
Involving these two stabilates, in particular LUMP 1001, indicated 
that relapses occurred in some cases as early as 3 weeks after 
chemotherapy, tissues were transferred on day 7 following Berenil 
treatment rather than day 14* This was done to eliminate the 
possibility of trypanosomes already being in the bloodstream at 
the time of tissue transfer*
With T* brucei LUMP 1001 blood transfer was negative, thus 
confirming the absence of circulating trypanosomes as indicated by 
wet film and miniature AEG examinations* All 24 recipient mice 
which received brain homogenate from the 12 donors developed parasit- 
aemias (Table 1*9)* All recipi*k&s were parasitaemic by day 24 
except for one which became patent after 43 days* That the donors 
themselves would ultimately have developed a relapsing parasitaemia 
was indicated by the recrudescence of infection in the controls 24 
to 30 days after Berenil treatment*
A similar pattern was observed with T* brucei LUMP 571*
The brains of 6 donor mice transmitted infection to recipients, 
while the blood from the same donors was non-infactive (Table 1*10)* 
Relapse in control mice occurred between 40 and 54 days following 
chemotherapy*
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Table 1.9 Transmission of infection with tissue from mice 
7 days after chemotherapy of a 3-week infection with 
T. brucei LUMP 1001
Tissue
No. of donors Blood Brain
12 0/24 24/24-
*23/24 recipients were parasitaemic by day 24 after tissue 
transfer. Last mouse became patent on day 43.
No. of mice parasitaemic/No. of recipients injected.
Four donor mice which were not sacrificed after Berenil 
treatment relapsed on days 24, 25, 27, 30.
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Table 1.10 Transmission of infection with tissue from mice
7 days after chemotherapy of a 3-week infection with 
T. brucei LUMP 571
Tissue
No. of donors
Blood Brain
0/12 12/ 12*
*A11 mice became patients by day 17 after tissue transfer
No. of mice parasitaemic/No. of recipients injected.
Three donor mice which were not sacrificed after Berenil 
treatment relapsed on days 40, 48, 54,
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The indications from these experiments was that it was 
only in brain tissue that infective trypanosomes could be found 
after chemotherapy* The stage of development of the parasite, or 
the particular location of the parasite within the brain, and the 
number present could not be ascertained from the above information*
The number of trypanosomes in the brain after chemotherapy
An approximation of the numbers of trypanosomes present 
in the brain could be made in the above experiments by considering 
the prepatent periods in the recipients of brain tissue, but in 
order to obtain a more accurate assessment of trypanosoma numbers, 
an infectivity titration of brain tissue was done* Seven days 
after Berenil treatment of a 21 day infection with T*„bjucei LUMP 
1001, the brains were removed from 6 mice, pooled and homogenised* 
Ten-fold dilutions were made of the brain tissue in PSG, and 
groups of mice (6 per group) were inoculated with the dilutions 
of tissue* The volume of tissue which was injected into the 6 
mice comprising the group receiving undiluted tissue homogenate 
was one-sixth of the total material, ie* the group as a whole 
received an equal share of "1 brain equivalent” * Similar volumes 
of material were accordingly inoculated at the other dilutions*
The results (Table 1*11) indicated that at this stage after chemo­
therapy of T, brucei LUMP 1001, the brain contained approximately 
25,000 infective trypanosomes*
Morphology of trypanosomes in the brain
Brain homogenate was also examined for trypanosomes by
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Table I.11 Infectivity titration of brain tissue seven
days after Berenil treatment of a twenty-one day infection 
with T. brucei LUMP 1001
Dilution of 
brain tissue
No. of recipients 
positive/Total
Neat 6/6
1:10^ 6/6
1:10^ 6/6
3
1:10 6/6
4
1:10 6/6
1:10^ 0/6
1:10^ 0/6
This corresponds to approximately 25,000 infective 
trypanosomes/brain, from the method of Lumsden, Herbert 
& McNeillage (1973)
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applying a slurry of homogenate to the surface of a DE52 column 
(Lanham and Godfrey, 1970) and examining the eluate after centri­
fugation for trypanosomes* Examination of a wet preparation of 
the hrain homogenate hy light microscopy failed to detect any 
trypanosomes, nor were parasites seen on a Giemsa-stained smear 
of this material* However, after chromatography and centrifugation 
parasites were detected* Morphologically, these were trypornast- 
igotes, and no amastigote forms were seen*
Location of trypanosomes in the brain
Using To brucei TREU 667/1 and T* brucei LUMP 1001, an 
experiment was done to investigate the location of trypanosomes 
within the brain. Seven days after chemotherapy of a 3 week 
infection with each of these parasites, the brains were removed and 
dissected (Fig lolO)* . Both cerebral hemispheres and the cerebellum 
were removed, the choroid plexuses were excised from both lateral 
ventricles, and the remainder of the brain was sectioned trans­
versely to yield fore-brain, mid-brain, hind“brain and the upper 
section of spinal cord* These were then injected separately 
into individual micei which were then monitored for infection*
The results (Table 1*12) indicated that in the case of T* brucei 
LUMP 1001, the ability to transmit infection was possessed by each 
portion of the brain, while with T. brucei TREU 667 there appeared 
to be a localisation of trypanosomes in the fore- and mid-brain, 
while the other portions were non-infective to mice*
Fig 1.10
After removal of the brain from the cranial cavity, 
the mouse brain was dissected as shown opposite. After 
removal of the cerebral hemispheres (ch) and the 
cerebellum (cer), the choroid plexuses were removed from 
the exposed lateral ventricles (TOP). The remainder of 
the brain was dissected transversely with 3 parallel 
incisions to yield forebrain (f ), midbrain (M), hindbrain 
(h ) and spinal cord (SC). (BOTTOM),
Figure compiled from Sissons (1975).
Bulbus o lfaclofius
Cerebrum
CôTpüs'(>îneaie
i ' ^
y / / ; '
v;^'—
;:,' ap- 
k'- /br%y ,
Seplum  
Stria m eduîlaris
.,.xl;fs -^*'-.>.i5-ïy|; ,^ y .." '”  Y/X' r^g
Colliculus posterior 
Cerebellum
Parafloccuius
Verm is
Pyraæis
Uvula
Sulc. m edianus dorsalis
N ervi spinales  
C, C , .
Radices dorsales
Bulbus olfactoriiis  
Cortex cerebri (neocortex) 
.C orpus  callosum
TïïâTami 
Stria term inalis
Corpus geniculatum latérale
Colliculus anterior
Colliculus posterior
Ped. cerebetlaris 
médius
fovea inferior
% ; : y "  A.
f M  ' ■'
> li^i^ / H r  r«A j
■ Thalam us
Corpus genicu la tum  m ediate
Fovea superior 
Ped. cerebetlaris sup.
red , cerebellari.s 
inferior
f
Nue. cochlearis 
• ventralis
■N. octavus 
Tuberculum  acusticum
Taenia ven lricu li quarti 
Clava
Fasc. cuneatus
M
SC
79
Table 1.12 Infectivity of different sections of mouse brain 
7 days after chemotherapy of a 3-week infection with either 
T. brucei TREU 667/1 or T. brucei LUMP 1001
Forebrain
Midbrain
Hindbrain
Cerebral
Hemispheres
Choroid Plexus
Cerebellum
Spinal Cord
T. brucei 
LUMP 1001 TREU 667/1
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The focus of infection after chemotherapy of T* congolense
infection
A tissue transfer experiment similar to those described 
above was done with a T* congolense population which had previously 
shown a high incidence of relapse after chemotherapy of a 3-week 
infection* This population had been stabilated from a mouse 
which relapsed 35 days after a 3 week treatment with 40 mg/kg 
Berenil (Fig 1*9c)* Brain, spleen, liver, lung, kidney, heart,
lymph node and blood were transferred to recipiaA^ mice on the 7th 
day after chemotherapy of a 3 week infection with this stabilate 
in C57B1 mice* This experiment was done on 3 separate occasions 
and the distribution of infective tissue was different in each 
case, with no obvious pattern being seen* However, taking the 
3 experiments together, infective parasites were transferred 
after chemotherapy from each tissue type*
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DISCUSSION
A significant problem in the chemotherapy of animal 
trypanosomiasis is .the occurrence of relapses after treatment.
When a trypanocidal drug fails to clear the circulating parasitaemia 
or if parasites reappear in the bloodstream after a very short 
aparasitaemic phase (8-10 days) the likely reason is either under- 
dosage of the drug or drug resistance of the parasite* In contrast, 
a prolonged aparasitaemic phase after chemotherapy followed by the 
eventual reappearance of the parasite has usually been attributed 
to reinfection*
The results from the first section of this chapter 
provided the basis for the experiments described in section 2, 
namely that after a 21 day infection in mice, T, brucei assumes a 
form of development or a location within the host in which it is 
insusceptible to chemotherapy and is thus capable of re-establishing 
a bloodstream infection*
A series of tissue transfer experiments with several 
different stocks of T* brucei provided consistent evidence that 
during the aparasitaemic phase following chemotherapy with Berenil, 
viable trypanosomes are present only in the brain* Thus, tissue 
forms (Soltys et al, 1969; Soltys and Woo, 1969, 1970) which are 
presumably present in spleen and liver and other tissues at the 
time of chemotherapy are as accessible and susceptible to the drug 
as the trypomastigotes in the bloodstream* Consequently, these 
tissues are unable to establish infection when injected into
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susceptible mice* With brain tissue, however, successful trans­
mission is possible, which suggests 2 possible explanations*
First, the environment in the brain promotes the formation of a 
drug-insusceptible form of the parasite, which in the absence of 
trypanocidal levels of drug reverts to a replicative form which 
re-emerges and initiates a bloodstream infection. Alternatively, 
and more probable, is that there exists a barrier through which 
the trypanosome may penetrate but the coirmonly-used trypanocidal 
drugs may not* Once beyond this barrier, the parasite may 
assume an amastigote-like form (Ormerod and Vehlcatesan, 1970,
197la,b) or remain as a trypomastigote, either in the neuropil 
or in the cerebrospinal fluid (CSF)*
Such a barrier exists in mammals, the blood brain barrier, 
and it is operative at 3 levels; first, at the endothelial lining 
of blood vessels within the brain and in the pia-mater, secondly, 
at the epithelial lining of the choroid plexuses, and thirdly, at 
the mésothélium which forms the outer lining of the sub-arachnoid 
spaces* At all 3 levels, complete tight junctions or zonula 
occludens are found between the cells, preventing leakage of large 
molecules (Brightman and Reese, 1969)* In addition, the endo­
thelial cells of blood vessels within the brain have a limited 
capacity to endocytose and do not contain contractile elements, 
thus rendering them insensitive to inflammatory mediators such 
as histamine, serotonin and noradrenalin* ' The level at which the 
trypanosomes cross the blood-brain barrier and whether their 
passage requires damage or increased permeability of the barrier
83
is unkno^vn* In acute infections with T* brucei in dogs and mice 
(Poltera ejb 1980), large numbers of trypanosomes are found
extravascularly in the choroid plexuses prior to invasion of the 
brain* In this site they are still outside the blood brain 
barrier, and presumably accessible to drugs* However, the early 
presence of organisms in the choroid plexus suggests that this 
may be the site where they initially cross the blood-brain barrier 
into the CSF* Once within the CSF in the ventricles, they can 
pass directly into the sub-arachnoid space and from there into the 
Virchow-Robin spaces: as there is no functional barrier either at
the level of the ependymal lining of the ventricles or at the pia- 
olial lining of the Virchow-Robin spaces (Rapoport, 1976), it is 
likely that trypanosomes in the CSF will have ready access to the 
neuropil *
Tv-70 experiments were done to obtain information on the 
location and numbers of parasites beyond the blood-brain barrier* 
An infectivity titration of brain tissue after chemotherapy 
indicated that T* brucei LUMP 1001 was present in very large 
numbers after chemotherapy, and from the dissection studies it 
appeared that the parasites were widely disseminated through the 
tissue* brucei TREU 667/1 was less widely dispersed, but
this may be a result of the timing of the experiment*
It is technically very difficult to obtain uncontaminated 
samples of CSF from mice* Central nervous system (CNS) involve­
ment in human patients is confirmed by examination of CSF after
84
lumbar puncture, and trypanosomes can often be detected micro­
scopically in the fluid. In view of the wide dissemination of 
trypanosomes in the brain of mice after chemotherapy and the fact 
that CSF was no doubt present in each brain tissue preparation, it 
is possible that parasites were present throughout the CSF*
However, in the absence of a sample of CSF this possibility remains 
unconfirmed„
Also unconfirmed is the morphology of the parasite within 
the CNSt Chromatographic studies revealed only the presence of 
trypomastigotes, but the existence of other forms, which may for 
example, possess a different surface charge, and thus be retarded 
in a DE52 column, cannot be eliminated. This is particularly 
relevant if one considers the prepatent periods of the mice which 
received brain tissue* In some cases, the prepatent period was 
6 days, in others 6 weeks elapsed before circulating parasites 
were detectable* Such a difference may be due to the status of 
the parasite in the brain, a rapid establishment of parasitaemia 
in the recipient arising from trypomastigotes, whereas a delayed 
infection may be due to amastigote-like forms which require time 
to revert to blood forms„ However, stained smears from brain 
tissue did not reveal the presence of morphological types 
resembling those described previously (Ormerod and Venkatesan, 
1971b; Mattern and Felici, 1972)*
Furthermore, a result from section one of this chapter 
may be interpreted as evidence of a drug insensitive form of the 
parasite existing within the CNS* Most of the commonly used
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trypanocidal drugs do not efficiently cross the blood-brain barrier 
(Gutteridge and Coombs, 1977), but the ionic character of Melarsen 
enables it to pass from the bloodstream to the CSF and for this 
reason it has been used in the treatment of human cases of the 
Gambian disease (Butler, Duggan and Hutchinson, 1957)* In view 
of the inability of Melarsen to produce permanent cure in mice 
(Table 1*3), the possibility of there existing a less susceptible 
form of the parasite beyond the blood-brain barrier, while perhaps 
unlikely, cannot be eliminated*
The results of the experiments with T* congolense are less 
easy to interpret, and it is likely that the mechanism of relapse 
is different than that described above for T, brucei* T* congolense 
is considered to be strictly a plasma parasite confined to the 
circulatory system (van de Ingh ^  a^, 1976; I.osos ^  1973),
but it has recently been demonstrated that T* congolense can 
multiply and persist in connective tissues (Luckins and Gray, 1978)* 
If the parasite has the capability of populating the tissues of a 
host during an infection, its persistence in such a location may 
influence the efficiency of chemotherapy, particularly since as 
discussed earlier, it has been suggested that such forms may be 
relatively unsusceptible to the action of drugs (Goodwin and Rollo, 
1955)* However, there is no evidence for there being specific 
localisation within the CNS of the host as appears to be occurring 
with T * brucei*
Recent studies have provided information on the lesions
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resulting from CNS involvement wi th T* brucei species parasites in 
mice, and are in accord in concluding that T.b.gambiense (Van Marck 
et al, 1981a,b), Tcb.rhodesiense (Fink and Schmidt, 1979) and 
Tpb.brucei (Poltera 1980) produce a meningo-encephalitis,
with inflammation and parasitism of the choroid plexus* In all 
reports, histological or electron microscopic evidence eliminated 
the occurrence of amastigote forms of the parasite*
The sequential involvement of brain structures described 
by Polkera et aj^  (1980'), provides an explanation for both the 
invasion of the CNS in chronic trypanosome infections and the 
consequent efficacy of chemotherapy* Trypomastigotes may first 
migrate from the vascular compartment into the interstitium of 
the choroid plexus, possibly favoured by an increase in -vascular 
permeability involving circulating immune complexes and complement 
activation* At this stage they are accessible to chemothera­
peutic drugs* Trypanosomes localised in the tissues may then 
trigger a local immunologically mediated inflammatory reaction 
favouring their migration into the CSF and further invasion of 
other cerebral structures where they are inaccessible to drug 
action*
CHAPTER II
MATERNALLY-DERIVED IMMUNITY TO TRYPANOSOMIASIS
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INTRODUCTION
It has long been recognised that diseases such as mumps, 
measles, diphtheria, scarlet fever and some other infections of man 
and of animals rarely affect the very young* This is the result 
of inheritance from the mother of resistance to a specific infective 
agent to which she has previously been exposed or against which she 
has been vaccinated. Thus the mother has an active immunity 
against the agent which is passively transmitted to her offspring, 
a sequence of events which has been knovm for many years. Young 
mamjTials are unable to produce antibodies themselves for some time 
after birth, and they acquire these ..antibodies, which are assoc­
iated with their immunity, from the mother, either whilst in the 
uterus before birth, or through the colostrum after birth* The 
relative importance of the route of transfer varies from species 
to species (Table 2*1).
The concept of the transmission of immunity from a mother 
to her offspring is by no- means a new one * Ehrlich (1892) 
administered the toxalbumins recin, robin and abrin to pregnant 
mice which subsequently became immune to them. Wlien the young 
were born, they were also immune, and this immunity was considered 
to be passive, the specific antibodies being transferred to the 
foetus in utero across the placenta and also through the milk 
immediately after birth* \^hen the young from normal mothers 
were allowed to suckle from immune mice, they too became immune, 
showing that immunity could be transferred via the milk* When,
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however, the young of immune mice were allowed to suckle with 
non**immune mice, they displayed some immunity, though to a much 
less degree than in the previous group. He concluded that while 
immunity appeared to be obtained by the young to a very small 
extent whilst still within the uterus, most was being transmitted 
through the milk*
The importance of colostrum to the new-born calf was 
investigated almost sixty years ago by Smith and Little (1922a) 
who described its protective effect against white scours in a 
small group of experimental animals* Of twelve newborn calves 
deprived of colostrum, eight died and a ninth was destroyed in 
extremis, All of the ten calves that were allowed to receive 
colostrum survived, and the authors coiTimented that "the calf 
deprived of colostrum lacks something which permits intestinal 
bacteria to invade the body and multiply in the various organs"* 
ïfhatever this something may have been, they were able to show that 
cow's serum might under some circumstances be a more or less 
successful replacement for it (Smith and Little, 1922b)*
In many mammals, the cornerstone of early postnatal 
survival of infection is the acquisition of passive immunity from 
the mother through suckling* Such passive immunity in rats or 
mice-‘has been demonstrated to many infectious agents or toxins: 
Plasmodium berghei (Bruce*-Chwatt and Gibson, 1956; Terry, 1956); 
Rickettsia (Jo, 1953); Toxoplasma (Lewis and Markell, 1958); 
Cysticercus fasciolaris (Miller, 1935); Salmonella (Halliday, 1955); 
Brucella abortus (Halliday and Kekwick, 1960); Trichinella spiralis
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(Ma^ss, 1940); tetanus toxin (Kosunen and Halonen, 1963); and 
many viruses eg blue tongue virus (Svehag and Gorman, 1963)*
Although the development of immunity to trypanosomiasis 
in domestic animals is only occasionally a sequel to natural 
infection, protective immunity against a particular antigenic 
variant can be readily induced by a variety of vaccination pro­
cedures (reviewed by Terry, 1976; Clarkson, 1976; Murray and 
Urquhart, 1977 ; Holmes, 1980)* Such immunity depends largely on 
serum antibody, and protection can be achieved by passive transfer 
of homologous antibody, as has been sho\m with T* gambleuse (Seed 
and Gam, 1966a,b; Takayanagi, -Kainbara and Enriquez, 1973),
T„ brucei (Watkins, 1964), and T* rhodesiense (Seed, 1963)* While 
both specific XgG and IgM are protective (Seed, 1972; Takayanagi 
2b ad, 1973; Zaha 1 sky and Weinberg, 1976), Takayanagi ejr^ (1973) 
found that IgM was more effective at neutralising T* gambiense, 
smaller quantities being required to neutralise a given number of 
trypanosomes, whereas Zaha1sky and Weinberg (1976) suggested that 
IgG was more effective in producing protection to T* brucei in mice,
The experiments which form the basis of this chapter were 
stimulated by studies reported over 40 years ago* Following the 
failure by Minning (1936) to demonstrate the transmission of 
immunity to Trypanosoma lewisi from mother rats to their offspring, 
and a similar failure by Collier (1931) with mice infected with 
To cruzi, Culbertson (1933) showed that the young of mother ratsr  --r*--T-i m-r—Im-imnmami '  ■/
recently recovered from a T. lewisi infection were immune for the 
first few weeks of life to infection with this parasitCo This
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immunity was transmitted both by milk and colostrum, and partial 
immunity could be transmitted by specific antiserum per 02 
(Culbertson, 1939)* A similar result was observed in suckling 
mice whose mothers had recovered from a T. duttoni infection or 
been given passive injections of immune serum (Culbertson, 1940), 
and also in T* cruzi infections, where a normally fatal consequence 
to infection in young rats was modified to a mild abortive infection 
by suckling recovered or passively immunised mothers (Kolodny, 1939),
In the present study, the effectiveness of maternally- 
derived Immunity to T* brucei and T* congolense, and the inter­
relationship of passively-acquired immunity and trypanocidal 
therapy, have been investigated)
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MATERIALS AND METHODS
Miceo These were CFLP and C57B1/6 mice from Anglia Laboratory 
Animals (Cambridgeshire, England) and the Animal Breed$f%#^ Research 
Organisation (AJBRO, Edinburgh, Scotland) respectively* All 
pregnant mothers had been synchronously mated before despatch from 
the suppliers*
Trypanosomes* T* brucei TREU 667, and T* congolense GVRI have 
have been described in Chapter 1 (page 36 )* The T* brucei stock 
produced infections in CFLP mice of over 6 weeks duration*
Similarly, T* congolense GVRI results in a chronic syndrome in 
C57B1/6 mice (see Chapter 3)*
Infections * Mothers were infected on the 14th day of pregnancy
5
by intraperitoneal (i*p*) injection of 1 x 10 trypanosomes, 
prepared from frozen stabilates, in phosphate-buffered saline 
glucose (PSG), pH 8*0* Since the gestation period of mice is 
19-21 days (Bronson, Dagg and Snell, 1975), this infection ensured 
that mothers were at or around peak parasitaemia at parturition, and 
unless otherwise -stated, such mothers remained infected throughout 
the experiment* Offspring were challenged (i*p*) with 1 x 10^ 
trypanosomes *
Chemotherapy* Diminazene aceturate (Berenil, Hoechst, Germany)
was used at a dose of 40 mg active principle/kg body weight* In 
newborn mice (whose weight at birth is approximately 1*5 to 2*0 g), 
this was given on the day of birth as a single subcutaneous (s*c*)
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injection in the scruff, using a micro-syringe (Hamilton Instru- 
ments, England ) in a volume of 25 pi. Where required,
pregnant mothers were treated i*p* with a single dose of Berenil 
the day before parturition*
Estimation of parasitaemia. Tail blood from tlie mice was examined 
for trypanosomes by the wet film technique* Mothers were 
monitored every 2 days until one week after parturition, and 
thereafter once per week* Similarly, challenged offspring were 
examined every 2 days until 2 weeks after infection, and subsequently 
twice per week* Such mice were judged to be immune if by 40 days 
after challenge they remained negative for trypanosomes*
Vertical transmission of infection* As part of the culling
procedure of litters born of infected mothers, one or two newborn 
were killed and bled out at birth to screen for the possible 
presence of congenital infection: this was done by examination of 
blood by the wet film technique and mouse sub-inoculation* New­
born were judged to be negative for trypanosomes if, by 40 days 
after sub-inoculation, recipients of their blood remained aparasit- 
aemic*
Fostering procedure* In each experiment, the groups were set up 
in duplicate* This was done to ensure that a mother was available 
as foster parent as soon as a litter was born, since there was no 
guarantee that despite synchronous mating, the mothers would reach 
full term on the same day* Thus, for each paired group, the
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first litter born was destroyed to enable its mother to accept a 
foster litter. In order to optimise the chances of a mother 
accepting its foster litter, newborn were transferred to the cage 
of a mother, never vice-versa, and the young mice were handled 
with gloves dusted with the bedding of the recipient cage. The 
nest prepared by the mother for its own litter was retained.
Thus it was hoped that by reducing stress to the mother and 
"camouflaging" the foster litter, she would be encouraged not to 
reject her new family. As a result of this procedure, the 
incidence of abandoned or devoured litters was kept below 25%,
Once the litter had been accepted by its foster parent,
it was culled to comprise a maximum of 10 neonates (in some 
instances mothers gave birth to as many as 16 infants). Litters 
were weaned to 21 days of age.
In vitro neutralisation of trypanosomes with Berenil, Doubling
dilutions of Berenil were done in distilled water from 256 pg active
principle per ml to 2 pg per ml. To 0,6 ml of each dilution was
added 0,6 ml of trypanosome suspension in 10% foetal calf serum in
PSG, containing 2,5 x 10^ organisms/ml. After incubation at 37°C
for 2 hours, the contents of each tube were inoculated into a group
5
of 6 mice. Thus each mouse received 2,5 x 10 trypanosomes which 
had been incubated in Berenil at a final concentration of between
1 and 128 pg/ml. These were then examined over the following
thirty days for the presence of trypanosomes,
Trypanosome clearance assay. The development of this assay forms
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the basis of chapter IV. Briefly, trypanosomes were harvested by
ion-exchange chromatography (Lanham and Godfrey, 1970) from mice
with fulminating parasitaemias which had been injected (i,v.) 24
75
hours previously with 5 mCi of the radioisotope Selenomethionine*
The parasite suspension was diluted such that a volume of 0„2 ml
contained approximately 6,000 counts per minute (cpm)* This
7
corresponded to 5 x -10 trypanosomas* Test mice were injected 
ieVo with this labelled trypanosome suspension and sacrificed 60 
min later* A terminal blood sample was collected, the liver and 
spleen excised and each was assayed for radioactivity in a gamma- 
counter (Packard • tri-'carb'-3330,'-FVS.Ac) . The percentage distribution 
of radioactivity was then calculated*
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RESULTS
Vertical transmission of infection* No offspring born of 
infected mothers were found to be infected themselves at birth*
Over 100 neonates were screened by microscopic examination of 
blood or subinoculation of blood into susceptible recipients, both 
methods failing to reveal the presence of trypanosomes*
Transmission of immunity to young mice* To investigate if 
immunity to trypanosome infection was transmissible from a mother to 
newborn mice, and in order to determine if this immunity was 
transferred to offspring before or after birth, an experiment was 
done involving 6 series of mice* In Series I, mothers infected 
with To brucei TREU 667/1 were allowed to keep their own litters*
A group of uninfected mothers and their o^m litters comprised 
Series II* Series III consisted of a group of normal mothers on 
which were fostered the litters of infected mothers, and Series IV 
was the reciprocal of Series III, namely a group of infected 
mothers which received litters from non-infected mothers * Series 
V and VI resembled I and II, except foster litters were used*
Thus Series V comprised infected mothers with a foster litter from 
an infected mother, and Series VI was made up of normal mothers and 
the offspring of normal mothers* Series II and VI also served as 
challenge controls for the experiment* In each Series, there were 
3 groups of mice, which were challenged 16, 23 and 31 days after 
birth respectively.
Litters which were born of uninfected mothers, or were
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fostered after birth to an uninfected mother regardless of whether 
or not the true parent was infected (Series II, III and VI), all 
became infected after challenge (Table 2*2)* On the other hand, 
litters which suckled after birth an infected mother, irrespective 
of whether or not they themselves were born of an infected or 
normal parent, were totally immune when challenged 16 days after 
birth, approximately 55-60% were immune if challenged 23 days 
after birth, with the remainder exhibiting an extended prepatent 
period, whereas all mice were completely susceptible to challenge 
by 31 days of age*
A  s i m i l a r  e x p e r i m e n t  w a s  d o n e  i n  C57BI/6 m i c e  w i t h  
To C o n g o l e n s G  GVRl* F r o m  a p i l o t  s t u d y  ( r e s u l t s  n o t  s h o w n ) ,  the  
p r o t e c t i o n  a f f o r d e d  y o u n g  m i c e  a p p e a r e d  to b e  o f  a s h o r t e r  d u r a t i o n  
w i t h  th i s  p a r a s i t e  c o m p a r e d  to T* b r u c e i  T R E U  667/1* A c c o r d i n g l y ,  
t h e  c h a l l e n g e  d a t e s  w e r e  b r o u g h t  f o r w a r d  i n  t h i s  e x p e r i m e n t *
The results (Table 2*3) were similar to those described above for 
T* brucei* All mothers infected with T* congolense GVR 1 
conferred immunity on their sucklings which waned to a non- 
protective level between 14 and 19 days after birth* This was 
the case irrespective of whether or not the young mice were the 
natural offspring of the parent* In contrast, suckling a normal 
mother resulted in complete susceptibility to challenge, even in 
mice which were the progeny of an infected mother*
Clearance of ^^Se~labelled Trypanosoma brucei TREU 667/1 in mice
r e c e i v i n g  a n t i b o d y  f r o m  t h e  m o t h e r *  T h e  a b i l i t y  o f  m i c e  r e c e i v i n g
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colostrum/milk from an infected mother was measured by a clearance
75
assay using homologous trypanosomes labelled with Selenomethionine, 
This was done in mice aged 16, and 31 days of age which had been 
suckling withv their o;m mother or a foster mother. The result 
is shown in Table 2.4, and correlates . exactly with the results 
obtained with live challenge (Table 2*2). High liver uptake was 
achieved with mice of 16 days of age suckling an infected mother, 
but this activity had waned by 31 days of age. Hepatic clearance 
was absent in all mice suckling an uninfected mother.
Antigenic priming. From the first experiment, the duration of 
immunity to T. brucei TREU 667/1 conferred by suckling an infected 
mother, was in the region of 25 days. Termination of the capacity 
to transmit immunoglobulin from the intestine to the circulation 
occurs comparatively suddenly in the mouse between 14 and 16 days 
of age, there being no detectable transmission in a normal 17 day 
old mouse (Halliday, 1955, 1959). To determine if it is possible 
to prime an infant during the time it is passively acquiring its 
immunity from the mother, offspring were challenged on day 16, 
when intestinal transmission is ceasing but the young mouse is 
still protected, and subsequently rechallenged when maternally- 
derived immunity has normally waned. The results are sho^-m in 
Table 2.5. As in the previous experiment, young mice challenged 
at 16 days of age were completely resistant to infection (Group A), 
whereas by 33 days of age they were completely susceptible (Group 
B)o However, rechallenge of Group A on day 33 (17 days after the 
priming challenge) failed to establish infection, indicating that
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Table 2.5 Antigenic priming
Day of
16
challenge
33 44
Group A 9/9* 8/9 -
It g - 0/8 -
C 9/9 - 0/9
It D - - 0/8
Challenge controls 5/5 5/5 5/5
*^All four groups were offspring of infected mothers, from which
they suckled until weaning at 21 days of age.
*Number of offspring which fail to develop parasitaeraia/total in 
litter.
gis 2.1
Transmission of immunity in mice to T, brucei 
TREU 667/1 infection. This figure summarises the result of 
the first experiment, which showed that offspring were immune 
to a homologous T* brucei challenge for over 3 weeks after 
birth, providing that they suckled a mother infected with the 
parasite. This occured even if the young mice were them­
selves born of an uninfected parent. In contrast, a mouse 
which was suckled by an uninfected mother was completely 
susceptible to challenge, even if its natural parent was 
itself infected.
An identical situation occurred with T. congolense 
GVRl infection, with a slightly different time scale.
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priming of the host, despite the presence of passively acquired 
antibody, had occurred* The priming challenge had lost its 
effectiveness by 44 days of age (28 days after priming), showing 
that the active immunisation was no longer lasting than passively 
acquired immunity (Groups B and C) and was probably eliciting a 
primary response in the host,
Berenil prophylaxis in mice. The trypanocidal drug Berenil is 
used extensively in the treatment of trypanosomiasis in Africa, 
There are very few reports of drug resistance developing against 
it, which has been ascribed to its rapid rate of excretion which 
also accounts for its lack of prophylactic activity. However, 
pronounced prophylactic activity has been reported on several 
occasions (see p* 55 , Chapter 1), and consequently its effect 
on neonatal and adult mice was investigated in the present study* 
First, groups of neonatal mice which were the offspring of normal 
mothers were injected s.c* with 40 mg/kg Berenil on the day of 
birth, and challenged with 1 x 10^ T* brucei TREtJ 667/1 either at 
16, 23, 31, or 41 days of age. All infants were suckled normally 
by the mother until being weaned at 21 days of age* The results 
are shown in Fig 2*2* All 11 mice challenged on the 23rd day of 
age were protected, but by 31 days of age, despite there being a 
slight residual effect of the Berenil as reflected by an extended 
prepatent period in 6 out of 7 mice (6 days compared with 4 days), 
all mice became infected*
This experiment was also done in adult mice. Female
Berenil prophylaxis in neonatal mice,
The appearance of trypanosomes in individual mice 
challenged with T, brucei TREU 667/1 on different 
days after prophylactive treatment with 40 mg/kg 
Berenil at birth.
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CFLP mice aged between 6 and 8 weeks were injected s.c, with either 
4 mg/kg or 40 mg/kg Berenil, and challenged with To brucei TREU 
667/1 either 3, 7, 14, or 21 days later (Fig 2*3). At the lower 
dose, trypanocidal levels of Berenil were present 7 days after 
treatment, 5 of 8 mice being completely protected against the 
challenge with the remaining 3 exhibiting a markedly prolonged 
prepatent period (14 days compared to 4 days in controls), but by 
14 days the trypanocidal activity had virtually disappeared. As 
might be expected, 40 mg/kg Berenil afforded a greater degree of 
protection, with 2 of 5 mice completely eliminating the challenge 
and residual activity being evident in the remaining 3 mice.
In contrast, when adult C57B1/6 mice were challenged 
with T, congolense GVR 1 after treatment with 40 mg/kg Berenil, 
very little prophylactic activity was evident (Fig 2.4). A small 
level of activity was seen in 2 of 8 mice challenged on day 7 
after treatment as reflected by prepatent period, but even in mice 
challenged only 3 days after treatment, complete protection was 
not seen. All animals had prolonged prepatent periods (13 to 17 
days compared to 4 days in controls)'but in all cases the parasite 
became established» The possibility that this was the result of 
the presence of a drug resistant population of trypanosomes was 
discounted, since this same stock is permanently eliminated from 
mice if treated with Berenil 3 days after infection in mice (see 
Chapter 1)»
Combined immune- and chemo-prophylaxis against T, ^brucei TREU 667/1» 
From the above experiments, protection against trypanosome challenge
Fig 2.3
Berenil prophylaxis in adult mice.
The appearance of trypanosomes in individual adult mice 
challenged with T, brucei TREU 667/1 on different days after 
prophylactic treatment with either 4 mg/kg or 40 mg/kg Berenil,
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Fig 2.4
Berenil prophylaxis in adult mice»
The appearance of trypanosomes in individual adult mice 
challenged with T. congolense GVRl on different days after 
prophylactic treatment with 40 mg/kg Berenilo
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can be afforded newborn mice which either receive antibody via 
the colostrum/milk of an infected mother or are given chemoprophylaxis 
on the day of birth* The protection given by each is of similar 
duration* To investigate the response of young mice which receive 
both antibody and drug, an experiment was done involving 3 series of 
mice. Series I comprised a group of mothers infected with T* brucei 
TREU 667/1 whose offspring were left to suckle undisturbed, Series II 
was a group of normal mothers whose offspring were treated with 
40 mg/kg Berenil on the day of birth, and Series III consisted of a 
group of infected mothers whose offspring also received Berenil 
prophylaxis on the day of birth* Groups of young mice were then 
challenged with the homologous parasite at either 16, 23, 31, or 41 
days of age (each group comprised a complete litter)* A result 
representative of the numerous occasions this experiment was done is 
shown in Fig 2*5. As before, young mice which suckle an infected 
mother are themselves immune for approximately 25 days (5 of 9 mice 
immune to challenge on day 23, Fig 2*5a), and young mice treated 
at birth with Berenil resist infection for a similar period (all 
resistant at 23 days of age, all susceptible at 31 days of age,
Fig 2.5b)* However, young mice which receive colostrum/milk from 
an infected mother and also receive Berenil prophylaxis at birth, 
are able to resist homologous trypanosome challenge for considerably 
longer* Only 1 of 8 mice was susceptible to challenge on day 31, 
and on day 41, 3 of 8 mice were completely resistant to challenge, 
the remaining 5 mice showing prolonged prepatent periods (7-9 days 
compared with 4 days in controls. Fig 2*5c).
Fig 2*5 Combined immune- and chemo-prophylaxis in
newborn mice.
The appearance of trypanosomes in individual young mice 
challenged with T* brucei TRE 667/1 on different days after 
birth.
a* Young mice suckling an infected mother,
b. Young mice treated at birth with Berenil suckling an 
uninfected mother*
c. Young mice treated at birth with Berenil suckling an 
infected mother*
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A more extensive experiment was done to investigate 
further the conditions under which the observed enhanced protection 
afforded by Berenil and antibody could be reproduced, A series 
of 7 groups of mothers and litters were set up as outlined below,
I, A pool of normal mothers with their own litters; 5
offspring to be challenged every 5 days as infection controls*
II, Three groups of normal mothers with foster litters; 
mothers given Berenil the day before receiving their foster litters. 
This series investigated the possibility of protective levels of 
Berenil being transferred to young mice in colostrum/milk,
IIXo Three groups of normal mothers with foster litters;
the offspring were born of mothers which had been treated with 
Berenil before parturition. This series investigated the possib­
ility of Berenil crossing the placenta into the young mice whilst 
in utero thus providing subsequent protection after birth*
IV, Four groups of infected mothers with foster litters; 
maternal antibody controls,
V, Four groups of infected mothers with foster litters; 
mothers treated with Berenil the day before receiving their foster 
litters. This series investigated whether or not treatment of the 
mother's infection affected the degree of immunity transmitted to 
the newborn suckling her,
VI, Four groups of normal mothers with their o^ra litters; 
offspring treated with Berenil on the day of birth. This series
106
constitutes the Berenil prophylaxis controls,
VII, Eight groups of infected mothers with foster litters;
offspring treated with Berenil on the day of birth. This is the 
combined immune-/chemo-prophylaxis series.
The protocol for the experiment and the results are 
shown in Table 2,6,
As in the first experiment, young mice which had suckled 
a mother which was infected were immune to challenge for up to 25 
days of age (Series IV), whereas normal mice suckling uninfected 
mothers had no resistance to challenge (Series I), Litters 
fostered to mothers which had been cured of their infection the 
day before fostering had a similar, if slightly less resistance to 
challenge (Series V), 5/9 mice being immune to challenge on day 25 
compared to 7/7 in the untreated group (Series IV), Berenil 
treatment of normal mothers affords no protection to their litters 
(Series II), indicating that trypanocidal levels of Berenil are 
not transmitted to suckling infants via colostrum/milk. Similarly, 
the offspring of mothers treated with Berenil before parturition 
were unprotected, which eliminates the possibility of drug residue 
in foetal tissue (Series III), Chemoprophylaxis of between 20 and 
25 days was evident in offspring treated at birth with Berenil 
(Series VI), However, prolonged prophylaxis was seen in mice 
treated at birth with Berenil which were fostered to an infected 
mother, therefore acquiring in addition passive immunity via 
colostrum/milk (Series VII), Over 50% of such mice were resistant
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Combined immune-/chemo-prophyIaxis in mice to T. brucei 
TREU 667/1 infectioHo This figure summarises the findings 
of numerous experiments, and shows that it is only in a 
situation in which a neonate receives antibody from a mother, 
or chemoprophylactic therapy at birth, or both, that there is 
subsequent resistance to homologous infectiono It is only 
in a situation where both antibody and drug have been 
received that enhanced resistance resultso
Mothers A, B, and C are uninfected<,
" D, E, and F are infected*
All litters are fostered*
CL'CJ
Ç 2
>
iw
§
y
I
O
a
■gS’
c 2
m
" n
108
to challenge at 40 days of age, and complete susceptibility to 
infection was not achieved until 55 days of age. This compares 
with the 25 days protection afforded by Berenil treatment alone or 
maternal antibody alone (Series VI and IV) o
Effect of Berenil ijn vitro on infectivity of T. brucei TREU 667/1. 
The effect of vitro incubation with Berenil on the infectivity 
of To brucei TREU 667/1 was studied. After incubation for 30 min, 
trypanosomas were injected into susceptible mice, and monitored for 
subsequent infection. The result is sho\-ra in Table 2.7 o At a 
level in excess of 64 pg/ml, 2.5 x 10^ trypanosomes were completely 
neutralised by Berenilo At 16 and 32 pg/ml Berenil, a proportion 
of recipient mice became positive, but the prepatent period in these 
mice indicated that the infectivity of the trypanosome suspension 
was much less than controls. As the concentration of Berenil 
decreased further, thus the difference from the control group also 
decreased.
109
Table 2.7 The effect of in vitro incubation with Berenil on 
the infectivity of T. brucei TKEH 667/1
Berenil concentration 
pg/ml
No. positive/ 
Noo in group
Prepatent period in 
positive mice (days)
128 0/6 -
64 0/6
32 3/6 12,13,14
16 4/6 9,11,13,13
8 6/6 6,6,5,6,8,11
4 6/6 5,5,5,5,5,6
2 6/6 3,4,4,5,5,6
1 6/6 3,3,3,3,4,4
Controls 6/6 3)3)4,4,4,4
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DISCUSSION
Early postnatal life in many mammals relies on maternally 
derived immune protection to combat infection, but the role that 
this may have in influencing the survival of animals exposed in 
early infancy to trypanosomiasis, has been the subject of much 
conjecture. Experimental studies, however (Culbertson, 1938, 1940), 
had shown that the young of mother rats recently recovered from a 
T . 1ewisi infection, or mice whose mothers had recovered from a 
T, duttoni infection, were themselves immune for the first few 
weeks of life. Similarly, a normally fatal consequence of T. cruzi 
in young rats was modified to a mild abortive infection by suckling 
recovered or passively immunised mothers (Kolodny, 1939).
The findings presented in this chapter demonstrated that 
immunity to the salivarian trypanosomes T. brucei and T. congolense 
can be conferred on young mice by suckling mothers which were 
experiencing an active trypanosome infection. Moreover, the 
experiments with T, brucei showed that mothers cured of their 
infection prior to parturition transmitted to their sucklings a 
similar level of protection as those which were not given trypano­
cidal therapy.
This immunity is by way of colostrum/milk after birth; 
effective placental transmission appears not to occur since off­
spring of infected mothers are susceptible to challenge if suckled 
with non-immune colostrum. Litters of non-immune mothers, however, 
are protected if after birth they are suckled by an infected mother 
(Fig 2.1).
Ill
Talcayanagi, Takayanagi, Yabu and Kato (1978) reported 
maternal protection in neonatal rats to T. gambiense infection, 
but only if the offspring had received colostrum from their o^ m. 
mothers. Rats fostered from control mothers to immune mothers 
were susceptible to challenge, implicating an essential utero 
component of subsequent immunity in neonates, and they concluded 
that transplacental IgG was more effective than colostrum-derived 
IgA in protecting offspring against trypanosome infection. How­
ever, experimental studies in young rodents have shown that IgM 
and IgA of maternal origin are not transmitted across the neonatal 
gut to the circulation (Jones, Hammings and Williams, 1973; 
Hammings, Jones and Williams, 1973). Furthermore, placentation 
in rodents is of the haemoendothelial type, and while antibody 
transmission is thought to occur to a small extent before birth, 
the majority of immune transfer from mother to offspring occurs 
after birth (McGirr, 1947; Brambell, 1970). In this respect, 
the mouse or rat is a particularly good model for bovines and 
ovines, whose syndesmochorial placentation allows materno-foetal 
transfer of immunoglobulin only after birth by way of colostrum.
Transmission of immunity after birth by way of the 
neonatal gut involves transport of the immune globulin across the 
gut wall from the lumen to the circulation without loss of its 
immunological activity. In young rodents, which receive most of 
their passive immunity from the mother after birth, milk proteins 
are taken into the absorptive cells of the gut non-selectively by 
pinocytosis (Clark, 1959; Vacek, 1964). Only a small proportion
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of the absorbed protein is then transmitted into the circulation 
intact, and most of this is y-globulin. It is thought that y-G 
globulins are transmitted across the gut of suckling rodents by- 
virtue of transmission sites on the Fc regions of the molecules 
(Brambell, 1966) and the markedly different modes of transmission 
of homologous IgG^ and IgG2 may reflect the operation of distinct 
receptors for these immunoglobulins. Jones (1974) showed that 
different regions of the small intestine transported different 
chromatographic fractions of IgG differently and with varying 
efficiency, an observation consistent with an uneven distribution 
of distinct receptors in the gut. Homologous y-globulins are 
transmitted more easily than heterologous globulins (Bangham and 
Terry, 1957), and the efficiency of transmission of heterologous 
y-G-globulin observed in neonatal feeding experiments, presumably 
reflects the degree of resemblance of its Fc regions to those of 
the homologous protein (Morris, 1969, 1976; Jones, 1976).
The main site of transport in rat and mice is the small 
intestine. Evidence of transmission has been shown in the ileum 
(Bamford, 1966) and cytological evidence supports this and also 
suggests that the jejunum is also involved (Clark, 1959; Kraehenbuhl, 
Gloor and Blanc, 1967). More recent evidence suggests that the 
proximal rather than the distal half of the small intestine is the 
principal site, where entry into the cells occurs by selective 
surface endocytosis (Rodewald, 1970, 1973; Morris and Morris, 1976). 
There is no evidence that transport occurs in the duodenum or the 
stomach. However, there can be no doubt as to the efficiency of 
intestinal transmission of immunoglobulin, since significant
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quantities of maternal IgG pass into the circulation of suckling 
mice during the first 15 days of life despite the low concentration 
of IgG in the mother's milk (less than 5% of the maternal serum 
concentration, Stechschulte and Austen, 1970).
The termination of the capacity to transmit immunoglobulin 
from the intestine to the circulation occurs comparatively suddenly 
in the mouse between 14 and 16 days of age and in the rat between 
18 and 20 days (Halliday, 1955 ., 1959). In a normal 17 day old 
mouse and the normal 21 day old rat there is no detectable trans­
mission. The means by which this change in the permeability of 
the gut occurs is still unclear, but it has been shown that 
replacement of the vacuolated cells of the distal intestine which 
take up polyvinylpyrrolidine (PVP) by a new cell type which is PVP 
impermeable, a clearly defined feature of the maturation of the 
small intestine which occurs in rodents at this time, can be 
induced by certain steroids (Daniels, Hardy, Malinowska and 
Nathanielz, 1973). Treatment with certain steroids will also 
induce precocious closure to antibody and labelled globulin
(Halliday, 1959; Jones, 1972; Morris and Morris, 1974) and it is
thought that such treatment must also affect those proximal and
middle regions of the intestine which are actively engaged in immuno­
globulin transmission and whose maturation is thought to be under 
natural control by secretions from the adrenal cortex (Daniels 
et al, 1972).
The development of immune competence in rodents suckling 
immune mothers is complicated by interference of the induction of
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active immunity through the presence of antibody of maternal origin 
(Solomon, 1971). Halliday (1968) showed that anti-B. abortus 
agglutinins of maternal origin, even at very low concentrations, 
can significantly inhibit the active production of agglutinins 
in young rats, but the effect is transient because of the decline 
in the passive immunity and the increasing potential for active 
immunity. This interference is due to competition for antigen 
between specific receptors on lymphocytes and antigen-combining 
sites on molecules of circulating antibody derived from the mother 
(helper and Solomon, 1976). If maternal antibodies are present 
in sufficient concentration, they complex with antigen which is 
then removed so rapidly from the circulation by phagocytes that no 
antigenic stimulation occurs. The amount of opsonic activity is 
finite, and provided the antigen can remain in the circulation 
long enough to combine with specific receptors on the lymphocytes 
of reactive clones, successful induction of the immune response may 
occur (helper and Solomon, 1976).
The result of the antigenic priming experiment showed 
that while maternally-derived antibody is no longer protective by 
33 days of age (Table 2,5, Group B) animals primed at 16 days of 
age, when gastrointestinal transmission of immunoglobulin is 
ceasing (Halliday, 1955, 1959) but maternally derived antibody is 
still protective, can successfully respond to a subsequent 
challenge 17 days later (group A). Thus it appears that while a 
challenge infection at day 16.is eliminated, presumably by hepatic 
phagocytosis (Table 2.4), induction of the immune response occurs.
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Since maternal IgM and IgA are not transmitted across 
the neonatal gut (Jones et al, 1973; Hemmings e_t 1973), the 
newborn mouse relies on colostrum-derived IgG for immunity, and 
within the IgG class, IgG^ is transmitted more readily than IgG^ 
(Morris, 1969, 1976). Assuming a half-life of 4 days in mice for 
maternally-derived IgG (Fahey and Sell, 1965) very low levels 
exist in sera by 24 days of age (Brambell, 1970), which is around 
the time that young mice become susceptible to infection with 
To brucei (Fig 2.1)o Thus, in the absence of antigenic stimulus, 
mice of this age will no longer have protective levels of maternally- 
derived anti-trypanosome antibody, and succumb to- challenge with 
To brucei. Presumably, the shorter period of protection afforded 
against T. congolense is a reflection of a lower level of antibody 
having been transmitted to the offspring at the time of termination 
of absorption.
It is interesting to note that congenital infections of 
trypanosomiasis have been reported on a number of occasions (Olowe, 
1975; Burke, Bengosi and Diantete, 1974; Buyst, 1976), and it has 
been claimed (Lanfranchi, 1915) that infection can be transmitted 
from mother to offspring in the milk, though this has been disputed 
(Werner, 1954). No evidence of vertical transmission of infection 
from mother to offspring was found in the present study.
The observations on the prophylactic activity of Berenil 
against T, brucei confirm those of previous studies that "biologically* 
active" Berenil, which is presumably retained in the tissues, has a 
protective.effect lasting several weeks (van Hoeve. and Cunningham,
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1964; Lumsden, Herbert and Hardy, 1965; Raether, Hajdu, Seidenath 
and Damra, 1972; Zahalsky and Weinberg, 1976; Williamson, 1976).
Diamidines related to Berenil (eg pentamidine and stilbamidine)
!■
have been shown to bind to nucleoproteins (Kopac, 1947; Makulu 
and Waalkes, 1975), which may facilitate tissue retention. However, 
no prophylactic activity was seen against T. congolense, an obser­
vation in agreement with that of Fairclough (1963) and Fink and Dann 
(1974).
Newborn and adult mice are resistant to infection for 
approximately 25 days after treatment with 40 mg/kg Berenil (Fig 
2,2, 2.3). Furthermore, it is of interest to consider that between 
birth and 25 days of age, a mouse increases its bodyweight by 10-fold, 
thus reducing, in absolute terms, a dose of 40 mg/kg Berenil at 
birth to 4 mg/kg. Such a dose is prophylactic in adult mice for a 
period of only 7-14 days.
Immunity in calves exposed to natural tsetse challenge has 
been reported on several occasions. Chandler (1952) noted a calf 
alive and uninfected at 8 weeks of age, despite its mother being 
infected and there being a constant exposure to tsetse. Calves of 
cows newly introduced into an endemic area developed trypanosomiasis 
within 5 weeks of birth (Whiteside, 1962). Those born 8 months 
later took an average time of 14 weeks, and calves born 12 months 
later did not become infected until 30 weeks of age. Furthermore, 
it is kno^-m that offspring of game animals 'of species which thrive 
in tsetse country succumb to trypanosomiasis if exposed to infection 
for the first time when they are adult (Fiennes, 1970) which
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strongly suggests a situation in which maternally-derived immunity 
has waned and antigenic priming has been absent (vide supra). The 
same author also reported a situation in Kenya which illustrated 
the ability of calves, born of dams with experience of trypanoso­
miasis resulting from light exposure to tsetse, to resist or 
tolerate infection with pathogenic trypanosomes.
Drager and Mehlitz (1978) noted significant age-related 
resistance in 416 buffalo in Botswana. In calves of less than one 
year of age, trypanosomes were found in only 1 of 74 animals, whereas 
the prevalence of parasites in adult animals was much higher (31 of 
90 animals aged between 1 and 3 years were positive for trypanosomes), 
They concluded that maternally-derived immunity may have been an 
influencing factor in these findings.
Fiennes (1953) investigated calf infections in the course 
of experiments on the maintenance of cattle protected with Antrycide 
prosalt. All of the treated cows produced normal healthy calves, 
and the bull calves which received no treatment remained "more or 
less refractory to infection". In the same context, commenting on 
the observations of Whiteside (1962), Murray and Urquhart (1977) 
stated that since the dams received trypanocidal therapy inter­
mittently, the resistance of the newborn may have been through 
drug residues in foetal tissue or milk, rather than a genuine 
maternally-derived immunity. The current study, however (Table 
2.6, Fig 2.6), indicates that newborn mice acquire no or insufficient 
drug either whilst fa utero (Series III) or in the milk (Series II) 
to resist infection.
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Attempts to produce immunity in animals against African 
trypanosomiasis have been undertaken by several investigators 
with varying degrees of success. As early as 1904, Ehrlich and 
Shiga demonstrated a high level of immunity by infecting an animal 
with a given strain of trypanosomes and then curing it with a 
trypanocidal drug. These animals proved extremely resistant to 
challenge with the homologous trypanosome strain.
Mice have been successfully immunised against homologous 
challenge using Berenil-treated trypanosomes (James, 1976), and 
the results of Kinnaraon and Rane (1978) confirmed the reports of 
others (Soltys, 1955; Fulton, 1944; Fiennes, 1950b; Wilson, 
Cunningham and Harley, 1969) that prophylactic protection may be 
enhanced by frequent test challenges with trypanosomes, although 
they did not support the contention that neither drug therapy nor 
immunization alone could be as effective a means of protection as 
when they are given in combination (Fiennes, 1950).
Such a situation, however, seems to be the case in the 
present study. A combination of chemoprophylaxis at birth and 
ingestion of anti-trypanosome antibody from the mother, markedly 
extends the period that young mice are refractory to infection 
beyond that which is afforded by chemoprophylaxis or immuno- 
prophylaxis alone (Table 2,6, Fig 2,6).
The explanation for this is unclear. Berenil acts by 
combining with and preventing the replication of DNA. It resembles 
certain phenanthridine and acridine drugs in being able to select­
ively block kinetoplast DNA replication, but its trypanocidal
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activity is more likely due to its action on nuclear DNA. It has 
been shoi-m to bind rapidly and irreversibly to trypanosomes (Bauer, 
1958), and at low doses of Berenil, the kinetoplast alone seems to 
form Berenil/DNA complexes (Newton and Le Page, 1967). Fink and 
Dann (1974) showed that diamidines concentrated at higher levels 
in the tissues than in plasma, perhaps through their facility of 
binding to nucleoproteins (Makulu and Waalkes, 1975) and were slowly 
eliminated.
Thus one may envisage a situation which in mice occurs 
around 25 days of age (vide supra) in which levels of Berenil and 
maternal antibody per se have fallen below that which affords 
protection to challenge, but in concert can act in a trypanocidal 
manner. Trace amounts of Berenil may be able to interfere 
sufficiently with the parasite to slow or even stop replication, 
or alternatively allow replication but prevent antigenic variation. 
However transient such an effect may be, it may enable a small 
amount of antibody, which alone could not cope with a challenge 
infection, to eliminate the parasite. In vitro incubation of 
Berenil and trypanosomes, with subsequent injection into suscept­
ible mice (Table 2.7), showed that at low levels of drug, the 
infectivity of the trypanosomes was markedly reduced, but not 
abolished. The occurrence of a similar effect in vivo with 
tissue residues of Berenil would support the argument forwarded 
above of a transient deleterious effect of the drug on the challenge 
inoculum. This may be compared with the conclusion of Fiennes 
(1953) that the effectiveness of a drug depended mainly on its
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ability to suppress infection to a point where the animal's ovm 
defence mechanisms were able to gain control.
A similar effect was recorded by Goodwin and Tierney 
(1977) who observed higher trypanocidal titres in the plasma of 
rabbits which had been infected and treated with drug than in 
those receiving drug alone, and ascribed this to a boost in the 
antibody response of the host through the release of additional 
antigenic protein by chemotherapy. Such a mechanism cannot be 
operable here, however, since the young mice have no experience 
of trypanosome antigen until the day of challenge.
The results of the experiments in this chapter offer a 
possible approach to augmenting immunity in the field. If it
transpires that within particular locations the number of sero- 
denes is limited and that the antigenic nature of metacyclic 
trypanosomes is a stable characteristic (vide supra),production of ' 
immunity in dams by "cocktail" vaccination may be possible. This 
has been done with a mixture of VATs in mice (Herbert and Lumsden, 
1968) and cattle (Scott, Holmes, Jennings and Urquhart, 1978) though 
broke down when there was present in the challenge inoculum a VAT not 
represented in the vaccine. Prophylactic therapy in newborn 
in conjunction with the acquisition of passive immunity through 
immune colostrum may be of practical value in field situations in 
the generation of resistance to the disease.
CHAPTER III
Genetic resistance of mice to 
T. congolense infection
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INTRODUCTION
The exploitation of genetic resistance to disease is 
becoming an increasingly important consideration in livestock 
development programmes, particularly where conventional disease 
control measures are not effective or are too costly, and conse­
quently the application of such an approach to African animal 
trypanosomiasis has provoked much interest in recent years.
Despite the use of many control strategies in the past, 
there has been little effect on the disease at the continental 
level. There are several factors responsible for this. First, 
there are 22 species of tsetse capable of transmitting infection; 
these are adapted to a wide range of habitats, thereby contributing 
to the widespread nature of the disease. Secondly, the 3 trypano­
some species pathogenic for domestic livestock, Trypanosoma 
congolense, T. vivax and T. brucei exhibit a wide host range for 
both domestic and wild animals. Thirdly, the phenomenon of 
antigenic variation which leads to persistent parasitaemia 
provides an excellent opportunity for transmission of infection 
by tsetse. At the same time, the implementation of current 
control measures poses several problems. The use of drugs, both 
therapeutically and prophylactically, can be costly because 
repeated treatments are required and diagnostic facilities are 
necessary if the drugs are to be used properly. Furthermore, 
frequent use or misuse can lead to the development of chemo- 
resis tance, a risk compounded by the fact that the number of
I'll
drugs commercially available at present is extremely limited.
Tsetse control followed by eradication has been successful in 
certain regions, but as with drug strategies, the cost is high 
and it is essential that the eradicated area is kept under rigorous 
surveillance for several years and protected by man-made tsetse 
barriers to prevent reinvasion. In addition, the emotive question 
of environmental hazards created by the use of the insecticides 
arises.
In the face of these problems, increasing attention has 
been focused on the potential use of genetically resistant or 
trypanotolerant livestock. There is no clear definition of 
trypanotolerance. At one extreme, Pagot (1974) has defined try­
pano tolerance as a "racial aptitude (of cattle) to maintain them­
selves in good condition and to reproduce while harbouring trypano­
somes without showing clinical signs of the disease". He 
recommended that they be introduced widely in high tsetse challenge 
areas throughout Africa. At the other end of the scale, Stephen 
(1966) stated that "tolerance is far from absolute" and concluded 
that propagation of trypanotolerant breeds was not to be recommended 
as a satisfactory means of improving the supply of protein in the 
densely populated areas of West Africa. These conflicting views 
reflect the complexity of the problem, since both statements are 
true for the circumstances under which each author made his 
observations.
With regard to the economic potential of trypanotolerance, 
more information is required on several aspects of the trait before
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widespread exploitation of trypanotolerant breeds can be recomra- 
ended (Stewart, 1951; Chandler, 1952). It is important to know 
the extent of the differences in resistance between different 
breeds and also within the same breed living under different 
levels of trypanosomiasis risk, under different management systems 
in different ecological zones. At the same time, an understanding 
is required of the mechanism(s) underlying trypanotolerance, the 
genetics of heritability, and the stability of the trait, ie, how 
it is affected by environmental factors.
The lack of suitable herds for study and the genetic 
heterogeneity of domestic livestock have made i t ‘difficult to 
analyse the mechanisms and inheritance of trypanotolerance. 
Accordingly, this chapter describes a series of experiments to 
investigate the susceptibility of different strains of mice to 
T. congolense infection, and attempts to establish whether trypano- 
tolerance is related to a modification of the pathophysiological 
changes characteristic to infection or can be explained in terms 
of differences in the efficacy of the immune response to the 
parasite.
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MATERIALS AND METHODS
Mice. These were GFLP and G57 Bl/6 female mice, aged 6-8 weeks 
unless otherwise stated. The supplier of these mice has been 
detailed previously (p.36). BALB/C, CBA, G3H/He, Porton and NZB 
mouse strains were also supplied by Anglia Laboratory Animals, 
G57B1/B.10D2 came from MRG (Carshalton), C57B1/ lOSc.Sn from Olac, 
1976 Ltd, and C57B1/ B from the breeding colony of the Zoology 
Department, Glasgow University. All mice, as soon as infected, 
were given oxytetracycline (Terramycin Soluble Powder, Pfizer Ltd) 
in their drinking water for the duration of the experiment. All 
experiments were conducted with a minimum of 5 mice of each strain,
Parasites. The histories of T. congolense GVRl and T. brucei 
TR^U 667 are outlined in Appendix I. T. congolense GUP 93 was a 
gift from Professor K. Vickerman, Department of Zoology, Glasgow 
University; LUMP 52, 79, 89 and 588 (all T. congolense) were 
supplied by Professor W.HoR. Lumsden, London School of Tropical 
Medicine and Hygiene, and T. congolense LRl was provided by 
Professor M.Jo Clarks.on, University of Liverpool Veterinary School. 
These stabilates were passaged in mice irradiated at 650 Rad one 
day before infection, the blood removed at peak parasitaemia, and 
preserved in liquid nitrogen. Unless stated otherwise, each 
mouse was infected by (i.p.) injection with 1 x 10^ trypanosomes, 
prepared from the frozen stabilates in PSG, pH 8.0.
Estimation of parasitaemia and haematological values. Tail blood
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from the mice was examined for trypanosomes by the wet film 
technique, and approximate parasite counts were done by a matching 
method (Herbert and Lumsden, 1976). Parasite numbers were 
checked at critical points of the parasitaemia profile by perform­
ing counts in an Improved Neubauer Haemocytometer chamber (Hawks ley 
and Sons Ltd., Lancing, Sussex). For packed red cell volumes (PCV), 
mice were bled from the tail vein into microhaematocrit tubes 
containing heparin as anticoagulant, and centrifuged (Hawksley). 
Plasma samples, when required, were obtained either a) by cutting 
such capillaries with a diamond cutter just above the huffy coat, 
giving 25-40 pi of plasma, or b) by killing mice under deep tri- 
chloroethylene anaesthesia, resulting in terminal plasma samples of 
approximately 0.5 ml volume. These were stored at -20°C in the 
sealed capillary or plasma vial until required.
Radioisotopic techniques.
a) Labelling methods. Radiolabelled parasites were prepared by
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the vivo method using Selenomethionine described in Chapter 4, 
and the tissue distribution of radiolabelled parasites determined 
as described (p. 166).
Red blood cells were labelled with ^^Cr by incubating 
blood from uninfected mice of the same strain with ^^Cr as sodium 
chromate (Radiochemical Centre, Amersham) and heparin as anticoagulant 
for 30 rain at 37^C. After washing twice with PBS, pH 7.4, the 
cells were prepared for injection by reconstitution in a suitable 
volume of PBS. Each mouse received approximately 20 (iCi of ^^Cr- 
labelled cells (Jennings, Murray, Murray and Urquhart, 1974).
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Mouse albumin (Sigma Chemical Co. Ltd., London) was 
125
labelled with I (Radiochemical Centre, Amersham) by a modifi­
cation of the iodine monochloride method (McFarlane, 1958).
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b) Trypanolysis of Se-T. congolense. Sc-labelled
T. congolense, 1 x 10 organisms in 0.1 ml, were incubated with 
serum or plasma (0.2 ml) from C57B1 or CFLP mice together with
0.2 ml guinea pig serum (0.2 ml) for 2 hours at 37°C. To achieve
75
maximum release of Se-activity, 0.2 ml of MP.40 (10%) or deoxy-
cholate (20%) was used in the place of test serum. Minimum
75 75
Se-release was assessed from Se-labelled parasites incubated
in PSG or normal mouse serum. Each test was carried out in
triplicate.
After incubation, 1 ml PSG was added to each tube
thoroughly mixed, spun,for 30 min (650 g) at 4°C, and 0.5 ml
supernatant pipetted into a separate tube. The percentage lysis
was calculated as
c/ 1 _ Supernatant c.p.m. x 3
Total c.p.m. of pellet + supernatant
c) Red cell survival. This was measured in groups of 10 infected
51
and 10 control mice using Cr red cells over a period of 10-13 
days following infection in i) both strains (ie C57B1/6 and CFLP) 
from the day of infection, and ii) G57B1/6 mice 9 weeks post- 
infection. After injection of the radiolabelled erythrocytes, 
blood samples were taken at 5 min post-injection and then at 2 day 
Intervals, using a 25 pi microcapillary tube (Drummond Scientific 
Co., U.S.A.). Each tube and contents was inserted into a counting
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vial containing 5 ml 0.02N NaOH, and the sample counted on a 
multichannel gamma scintillation counter (Packard Tri-Carb, 
Chicago) for enough time to give sufficient counts for analysis. 
The radioactivity of the samples was expressed as counts/min/ml 
packed red cells and plotted as a percentage of the 5 rain sample 
against time on semi-logarithmic paper. Plotted values are 
the means of 10 animals in each group on any given day, and 
disappearance curves are "best fit",lines calculated by regression 
analysis on the group results.
d) Plasma and red cell volumes. These were determined in
groups of mice of both strains by application of the dilution
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principle at 8 days post-infection using Cr red cells and ' I
albumin. The two were injected together into a tail vein and
blood samples were taken at 5, 15, 30, 40 and 60 min post-injectioiic
The radioactivity of the red cells and plasma as counts/ 
min/ml were plotted on semi-logarithmic graph paper and the zero 
time values obtained by regression analysis. The red cell and 
plasma volumes were determined by dividing the respective total 
injected activities by these values.
Blood biochemistry determinations. These were carried out on 
fresh, unfrozen samples of serum within 3 hours of collection from 
mice on the eighth day of infection and at suitable intervals 
thereafter. Lactate dehydrogenase, creatine phosphokinase, 
aspartate transaminase and alanine transaminase were measured on 
a reaction rate analyser (L.K.B. Products, Bromma, Sweden), using 
commercial test kits (Boehringer, Mannheim, Germany).
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Total protein, albumin, creatinine, alkaline phosphatase,
urea, glucose, bilirubin and phosphate were measured on an Auto-
analyser IX (Technicon Instrument Corporation, New York). Ca 
++
and Mg were estimated by atomic absorption (Pye Unicam, Cambridge,
- j -  - |—
England)j Na and K using a flame photometer and chloride on a 
chloride meter (Evans Electroselenium Ltd., Essex, England).
Immunoglobulin estimation. Serum levels of IgG-,, IgG^ and IgM
were quantified by radial immunodiffusion (Mancini, Carbonara and 
Heremans, 1965) using antisera against mouse IgM and IgG prepared 
in rabbits (Nordic Immunochemicals, Berkshire).
Humoral response to horse red blood cells. At 7, 14, 21, 42, 84
9
and 120 days after infection mice were injected i.p. with 1 x 10 
horse red blood cells (HRBC) which had been washed three times 
with PBS, Five days later the mice were killed and serum collected, 
This was inactivated at 56°C for 30 min and duplicate doubling 
dilutions were prepared with 25 jil of PBS in microtitre plates 
(Gibco Biocult Laboratories Ltd., Paisley, Scotland). To each 
well was added 25 pi of a 2% suspension of washed horse red blood 
cells (HRBC). The plates were then covered and left overnight 
at room temperature after which the haemagglutination titres were 
read as being the highest dilution of serum giving complete 
agglutination,
Trypanosome infectivity neutralization test. This test for 
antibody is based on the incubation of serum from infected mice
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with homologous trypanosomes and the subsequent inoculation of the 
mixture into normal mice* Absence of a subsequent parasitaemia 
in these mice is taken as evidence of antibody (Lumsden, Herbert 
and McNeillage, 1973)o Tïvo pools of serum were obtained 10 days 
post-infection from groups of mice of both strains and tested for 
their infectivity neutralization capacity* Each test well 
contained 200 pi serum, 50 pi guinea pig serum (complement) and 
5 X 10^ trypanosomes in 250 pi PBSG* After 30 min at 4°C the 
contents of the test wells were taken up in a syringe and 12 normal 
CFLP mice were each inoculated with an aliquot estimated to 
contain 1 x lO"^  trypanosomes* The mice were the'n monitored 
regularly for the appearance of parasites by wet blood film 
examination for 30 days*
Irradiation of mice. Where required, mice were subjected to total 
body irradiation (650 rad) in a ^^Co source one day prior to 
infection.
Drug suppression of mice* This was done using the agent cyclo­
phosphamide (Koch-Light) at a dose of 300 mg/kg body weight 3 days 
prior to infection*
Splenectomy* Mice were splenectomised under trichlorethylene
anaesthesia 14 days before being used in experiments. After the 
fur had been removed by shaving and disinfection of the skin with 
Savlon (i c i ) followed by 70% ethanol, a small incision was made 
over the clearly visible spleen. The peritoneal wall was cut
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and opened by blunt dissection, and the spleen externalised with 
blunt forceps* The Spleen's venous and arterial blood supply vras 
cut off with a tight suture tied around the pedicle, and the organ 
was excised* The peritoneal wall was closed with 2 silk sutures 
and the abdominal skin closed using 2 suture d a m p s ,
Activation of the Mononuclear Phagocytic System* The following
immunostimulants were used:
i) Escherichia coli lipopolysaccharide (phenol extract. Sigma 
Chemical C o * L o n d o n ) * Mice were given 10 pg LPS i*Vo
ii) Bordetella pertussis* This was a gift from Professor A*Cc
Ward law, Microbiology Department, Glasgow University, and each
9
mouse received an i*v* injection of 5 x 10 organisms*
iii) Bacillus Calmette-Guerin (BCG vaccine, Glaxo, Greenford)*
7
Mice received an i*v* injection of 1*5 x 10 organisms per mouse*
iv) Corynebacterium parvum (Coparvax, Wellcome Ltd*, Kent)*
0*2 ml was injected either i.v* or s*c. This corresponds to 
1.4 mg dry weight of organisms*
v) Freunds complete adjuvant (Difco Laboratories, USA)* 0*2 ml 
was injected i.p* into each mouse*
vi) Levaraisole hydrochloride (Nemicide, ICI, Cheshire) was 
injected i*v. or s*c. at a level of 75 pg/mouse*
E* coli LPS, B* pertussis, CFA and levamisole were all 
given on the day of infection,, BCG was given either on the day
131
of infection or on days -28, -14, -11, -7, or -1* One group of 
mice received two doses on day -11 and day -1* C* parvum was 
injected on the day of infection or 14 days previously*
Irradiation of trypanosomes* Trypanosomes were exposed to
gamma-irradiation to destroy their infectivity* This was done 
in a ^^Co source at a dose of 50,000 rad, Trypanosomes were 
maintained in ice in PSG containing 10% Foetal Calf Serum during 
irradiation*
J-.
Statistical analysis. Group results are presented as mean -
standard error (S*E*)*
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RESULTS
Susceptibility of different strains of mice* Ssenyonga (1974)
reported that C57B1 mice survived a T * congolense infection for 
longer than CBA mice. The results of a survival study on a 
variety of inbred and outbred mouse strains is shown in Table 3*1* 
After infection with 1 x 10^ T* brucei TREU 667, there was a 
marked similarity in survival time between C57B1, CFLP, CBA and 
Porton strains, and although more susceptible, C3H and NZB mice 
withstood the effects of infection for up to 5 weeks* However, 
after infection with T* congolense, apart from the NZB which 
survived for approximately 5 weeks, no strain was able to approach 
the tolerance to infection shown by the C57B1 strain which lived 
for over 10 weeks* All other strains succumbed to infection 
within 3 weeks*
Survival of C57B1 and CFLP mice to different T* congolense strains^ 
In order to confirm that the marked difference in susceptibility 
of C57B1 and CFLP mice, from above, was not merely a property of 
this particular parasite in these mouse strains, 3 derivatives of 
the same stock, GUP 93, GVR 1 and G\HR 2 and 5 unrelated stocks 
LUMP 52, 79, 89, 588 and LR 1 were compared for their effect on 
C57B1 and CFLP mice* The results (Table 3,2) show a clear trend, 
despite the necessarily small experimental* numbers (5 per group)* 
The extreme virulence of T* congolense LR 1 and LUMP 52 resulted 
in virtually 100% mortality in both strains of mouse by day 10^
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Table 3 e^* Survive1 
strains
of CFLP and C57B1 
of T* congolense
mice infected with varie
— —  '
To tal survivors by day :
— —
CFLP 10 15 20 30 50 70
GVR 1 0/5 - “ " -
GVR 2 3/5 0/5 - - "
GUP 93 5/5 2/5 1/5 1/5 0/5
LUMP 52 0/5 - - ~ - -
LUMP 79 5/5 2/5 0/5 - " -
LUMP 89 5/5 3/5 0/5 - - -
LUMP 588 5/5 3/5 2/5 2/5 2/5 0/5
LR 1- 0/5 " - - -
G57B1
— — --
GVR 1 5/5 5/5 5/5 4/5 3/5 3/5
G\/R 2 5/5 5/5 4/5 4/5 4/5 4/5
GUP 93 5/5 5/5 4/5 3/5 3/5 3/5
LUMP 52 0/5 ■ - - “ - -
LUMP 79 5/5 5/5 5/5 5/5 5/5 5/5
LUMP 89 5/5 5/5 5/5 5/5 5/5 5/5
LUMP 588 5/5 5/5 5/5 ■ 5/5 5/5 5/5
LR 1 1/5 0/5 - - -
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whereas a marked superior resistance to infection was shown by 
C57B1 with each of the other stabilates. It is of interest to 
note the varying survival in CFLP mice infected with GUP 93, GVR 1 
and GVR 2, the latter 2 being derivatives of GUP 93, which during 
passage appear to have increased in virulence.
Susceptibility of different sub-strains of C57B1 mice to infection. 
This was done to investigate the influence of genotype within the 
C57B1 strain on the susceptibility to infection. C57B1/6 (used 
above) was compared with C57B1/TB, C57B1/B-10/D 2. and C57BI/10ScoSn. 
Ten CFLP mice served as susceptible controls. No difference was 
found in survival with T. congolense GVR 1 infection (Table 3.3).
These initial experiments confirmed and extended the previous 
observation of the tolerance of C57B1 mice (Ssenyonga, 1974). All 
subsequent experiments•were done with T. congolense GVR 1, using 
CFLP and G57B1/6 mice as models of susceptible and trypanotolerant 
strains respectively to investigate possible mechanisms of resist­
ance*
Pattern and course of T. congolense infection in C57B1 and CFLP micCc
Groups of C57B1 and CFLP mice (30 of each strain) were infected with 
T, congolense G\^ 1* Ten of each group were monitored daily for 
PCV and parasitaemia, and the remainder monitored for survival.
The results presented in Fig 3.1 show that_there is a similar 
development of parasitaemia and anaemia in both strains during the 
first'5 days after infection. By 7 to S days, however, the C57B1 
are able to control and reduce the peripheral parasitaemia and
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Tab le 3.3 Effect of genotype on the susceptibility of C57BI mice
Mouse strain No. of Mean survival time
mice (Days)
C57B1/6 15 84 8.1
C57 Bl/TB 12 91 - 7.6
C57B1/B10.D2 10 95 4.3
C57B1/10 SCoSn 10 77 13.5
CFLP 8 8.7 ~ 0.,
The development of anaemia and parasitaemia 
in C57B1 and CFLP mice after infection with 
T, congolense GVR 1*
45
35'
30
25 6-3
20
50
45
7 8
40
35
30
j-6-0
25
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arrest the drop in PCVo CFLP mice, on the other hand, fail to 
reduce the high peripheral parasitaemia, suffer a progressive 
anaemia and die by day 10^ In addition, the peak parasitaemia 
is slightly lower in C57BI mice and although the initial increase 
in peripheral parasitaemia is similar in the two strains, from 
day 5 onwards the rate of growth is apparently slower in C57B1 
mice. The infection progresses in C57B1 mice and displays the 
typical remissions and peaks of parasitaemia found in trypanosome 
infection (Fig 3o2), With passing time, the general trend is 
towards an overall decrease in peripheral parasitaemia with 
very gradual recovery of PCV, The survival profile of both 
strains is shown in Fig 3,3,
51
Red cell'survivalc Examination of the Cr red cell survival
curves (Fig 3,4) showed that although there was a shortened survival 
of labelled cells between day 6 and day 10 in parasitized CFLP 
mice, these mice died before this difference became statistically 
significant from controls. In C57B1 mice the initial disappear­
ance rate was the same in both control and infected mice, but from 
day 10 onwards the half-life in the infected animals was dramatic­
ally reduced (Table 3,4) and continued throughout the chronic 
infection, (Fig 3,4c and unpublished observations).
Plasma and red cell volumes. The results of these estimations 
show that plasma volumes in mice of both strains were elevated by 
the 8th day of infection and that the circulating red cell volumes 
were lower than the corresponding control values (Fig 3,5), Since
Fig 3 q2 Packed cell volume (PCV) and
parasitaemia in C57BI mice infected with 
T, congolense GVR 1,
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Fig 3,3 Survival of C57B1 and CFLP mice
after infection with To congolense G\T1 lo
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Table 3*4
Infected
Day Intercept Slope Correlation
a-log
10 coefficient
Half-life ( )  
days
a) Control 0-10 - 104o4
- 2.06
0-6 101.0 
- 1.39
0.023 
+
0.0016
0.021 
-f
0.0018
0.9713
0.9959
13.2 - 0.93
14.4 - 1.02
6-10 139.9
15.86
0.046 
+
0.0046
0.9999 6.7 - 0.75
b) Control 0-20 100.5 0.021
t  3.64
Infected 0-10 101.5
- 2.63
13-20 1464
- 542.6
c) Control 0-10 100.5
-f
Infected 0-10 97.9
+
^ 0.0009
0.019 
'i' 0.0014
0.122 
- 0.0074
0.021 
-1
3.64 - 0.0009
6.41
0.125 
- 0.0149
0,9963
0.9950
0.9903
0.9963
0.9980
14.2 - 0.57
15.9 - 1.26
3.08 - 0.22
14.2 - 0.57
2.7 - 0.37
Labelled cells were injected into a) CFLP and b) C57 Bl mice on the 
day of infection and into c) C57 Bl mice 9 weeks after infection.
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Fig. 3.4. Cr red cell disappearance curves in
CFLP and C57B1 mice: labelled cells were
injected into a) CFLP and b) C57B1 mice on the 
day of infection and into c) C57B1 mice 9 weeks 
after infection.
C = control, I = infected.
Fig. 3o5. Plasma and red cell volumes of mice
infected with T, congolense GVR 1: group A -
CFLP mice, group B and C - C57B1 mice.
I - infected, C - control. Plasma volumes 
were measured on the 8th day of infection in 
groups A and B, and after a 9-week infection 
in group C.
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in both strains there was an increase in the total blood volume, 
it is apparent that the anaemia which develops in both strains by 
the 8th day of infection is essentially caused by a combination of 
haemodilution and accelerating red cell loss.
In the chronic infection of C57B1 mice the plasma volumes 
were markedly elevated, but circulating red cell volumes were 
comparable to control values despite a greatly decreased red cell 
survival ratCo This suggests that erythropoiesis must be greatly 
increased in such animals and that the depressed haematocrits are 
largely brought about by haemodilutioiio
Blood biochemical determinationso By the eighth day of Infection
striking and similar changes were evident in the biochemical indices 
of both strains (Table 3c5)o Lactate dehydrogenase, aspartate 
transaminase and alanine transaminase were markedly increased 
although whether the increased transaminase activities were due to 
specific organ damage or derived from the parasites is not knovm 
(Moon, Williams and Witherspoon, 1968)„ Glucose and albumin levels 
were decreased; as a consequence of the latter the albumin/globulin 
ratios in both strains were reduced by the eighth day, although in 
C57B1 mice the total protein levels were unaltered due to an 
increase in globulin* Electrolytes and other blood indices 
remained essentially unchanged, or were equally altered in both 
strains. In addition, in CFLP mice, moribund prior to death 
between 8 and 10 days post-infection, glucose levels were greatly 
reduced, urea levels increased four-fold and serum phosphate two- 
f oldo
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In chronic infections of C57BI mice all of these indices return­
ed to near normal , with the exception of albumin, which remained 
slightly depressed and globulin and lactate dehydrogenase which 
remained elevated.
Immunoglobulin levels. Levels of IgG, were essentially
unchanged but by the tenth day of infection IgM levels were 
elevated in both strains, the increase being more pronounced in 
C57B1 mice. At this time IgG^ levels were also increased in the 
C57B1 mice but remained unaltered in the CFLP mice (Table 3,5),
Humoral response to horse red blood cells, Haemagglutinating 
antibody responses to HRBC were totally suppressed in both strains 
of mice if antigen was administered after 7 days post-infection (Fig 
3,6), and they remained suppressed in the surviving C57B1 mice.
In the above experiments, no major difference was found in 
the two strains of mice in the degree of physiological aberration, 
as a consequence of trypanosome infection, which would account for 
the reduced susceptibility of C57B1 mice and their ability to 
survive an infection which kills CFLP mice on the 8th to 10th day. 
Consequently, further experiments were done on the basis that 
differences in susceptibility were a reflection of differences in 
the immune response to the trypanosome.
Fig 3o6o Haemagglutination titres against horse red
blood cells in mice infected with T, congolense GVR 1,
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The course of T« congolense infection in the absence of antibody* 
To investigate the role of the immune response in the control of 
parasitaemia in C57B1 mice, 2 groups of C57BI mice were irnmuno- 
suppressed either by total body irradiation (650 rad) the day 
before infection, or with a single dose (300 mg/kg) of cyclo­
phosphamide 3 days before infection* The response of these mice 
was compared to a cùntrol group by monitoring tail blood for 
parasites* Fig 3*7 shows the result of cyclophosphamide pre­
treatment, the effect of which was exactly the same as total body 
irradiation (result not shovm)» As a consequence of cither 
treatment, mice are unable to reduce and control the initial 
parasitaemia, thus suggesting that the ability of C57B1 mice to 
control and survive infection is influenced by the presence of an 
intact iiTimune response*
Clearance of ^'^Se-'labelled T* congolense by infected C57B1 and
7 5
CFLP mice* The use of Se-labelled T* brucei in assessing the
immune response in mice is the subject of chapter 4, and the
technique works equally well with T, congolense* Consequently,
75
Se-labelled T* congolense were used to compare the immune response 
of CFLP and C57B1 mice which had been infected 9 days previously*
C57B1 mice have a higher hepatic uptake than both uninfected 
mice of the same strain and infected CFLP mice (Table 3*6)( The 
higher uptake of the latter over its uninfected counterpart can 
be explained by the increase in liver weight as a consequence of 
infection, but the same cannot account for the marked elevation in 
infected C57B1 mice*
Fj.g 3.7. Parasitaemc profiles and survival of C57B1
mice infected with T. congolense following treatment 
3 days previously with cyclophosphamide compared with 
untreated controls.
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Table 3,6 Tissue distribution of 'Se-labelled T\ congolense 
in C57B1 and CFLP mice infected 9 days previously
Group
Infected C57B1 
Infected CFLP 
Control C57B1 
Control CFLP
Tissue distribution {% of the injected activity)
Spleen
9.4 ~ 0,7 (I7oO~lo9)*
8.0 1.4 (12,0-1.6) 
<3.0 (23.2-2.2)
<3.0 (29.4-3.8)
Liver
45.2 1.9 (22.5-2.5)
20.7 1.2 (8.6-0.5)
7.5 - 0.1 (5.2-0.3)
9.5 - 0.6 (7.6-0.4)
Table 3.7 75Tissue distribution of Se-labelled T. congolense
by infected CFLP mice and following chemotherapy
Group
Infected treated
Infected
Control
Immune
Tissue distribution (7. injected activity)
Spleen
6.8 - 1.3 (IO.stl.6)* 
7.2 - 1.3 (11.3^1.0) 
3.6 0.3 (25.6-2.5)
3.9 - 0.2 (16.8-2.0)
Liver
57.5 6.8 (25.8-1.5)
18.3 1.3 (9.0-0.9)
9.9 ■- 0.6 (8.6-1.3)
61.5 - 2.3 (34.8-0.7)
*Values in parentheses are the tissue distribution of radiolabelled 
parasites calculated from the c.p.m./g of tissue expressed as a % 
of the injected activity.
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Furthermore, the inability of CFLP mice to remove radio labelled 
parasites from the circulation is overcome by prior chemotherapy. 
Eight days after infection with T. congolense GVh 1, a group of CFLP 
mice were treated with Berenil and injected 24 hr later with radio­
labelled trypanosomesa The results (Table 3.7) show that chemo­
therapy increases the ability of CFLP mice to remove parasites by 
hepatic uptake, approximately 57% in mice receiving Berenil compared 
to 18% in infected mice not receiving Berenil. This hepatic uptake 
compares well with that of immune mice of approximately 61%,
The effect of splenectomy on survival of C57B1 mice. The 
importance of an intact immune system on the outcome of infection in 
C57BI mice was further illustrated in animals which had undergone 
surgical removal of the spleen two weeks prior to infection. 80% 
mortality occurred in such mice over the first 3 weeks compared 
with no deaths in the intact group (Pig 3.8). The involvement of 
antibody in the inability of splenectomised C57B1 mice to overcome 
the effect of infection was shown in 3 ways :
a) Infectivity neutralisation test. The tests conducted with 
sera collected 10 days post-infection from the 2 strains showed 
that trypanocidal activity was present only in serum collected 
from C57B1 mice, and prior splenectomy removed this capability 
(Table 3.8).
b) A hepatic uptake assay, similar to those described above, was 
done on intact and splenectomised C57BI and CFLP mice on the ninth 
day after infection with T . congolense G\Tl 1, The results (Fig 3.9)
Figo 3,8 Survival of C57B1 mice after surgical
removal of the spleen 2 weeks prior to infection
with T, congolense GVR 1
"O
"O
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Table 3.8 Infectivity neutralisation test on sera
and CFLP mice infected with To congolense GVR. 1
Day 10 serum from : Survival of susceptibl
Splenectomised CFLP 0/12
Intact CFLP 1/12
Splenectomised C57B1 0/11
Intact C57B1 9/13
Normal serum from CFLP 0/6
Normal serum from C57B1 0/6
Table^ 3^9 Trypanolysis of ^“^ Se-labelled To 'congo^L
Group % ly:sis
Splenectomised CFLP* 21.1 + 1.6
Intact CFLP 25.5
+
2.3
Splenectomised C57B1 22.4 1.2
Intact C57B1 58.1
+
1.8
Normal mouse s*erum 18.4
-h
2.0
PSG 15.0
+
1.8
MP40 85.2 t 1.4
'Pooled serum from mice killed on days 9 and 10 of infection
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show that only in the case of intact C57B1 mice was there the 
capability to remove radiolabelled parasites from the circulation. 
75
c) Se-labelled T. congolense trypanolysis. The superior
immune response of intact C57B1 mice V7as evident in a trypanolysis 
75
assay in which Se-labelled trypanosomes were incubated with day
10 sera from infected mice, in the presence of guinea pig serum
75as a source of complement. The release of Se~activity into 
the supernatant was used as a measure of the trypanolytic ability 
of the respective sera. The results (Table 3.9) confirmed the 
findings of the infectivity neutralisation and hepatic uptake 
assays. Marked trypanolytic activity was present only in the 
serum from intact C57BI mice.
Thus, the ability of C57BI mice to survive infection while 
CFLP mice succumb presumably reflects the difference in the 
effectiveness of the immune response, either in quantity or 
quality of antibody formation, or the rate at which antibody is 
formed. Presumably, the ability to maintain effective levels of 
antibody, possibly IgM (vide supra), accounts for the capability of 
the C57B1 strain, and consequently experiments were designed which 
attempted to enhance the iiTunune response of CFLP mice, thus 
decreasing their susceptibility to T. congolense infection.
Passive immunisation of CFLP mice. The above experiments con­
sistently indicated, by a variety of methods, that serum from
Hepatic and splenic uptake of T. congolense
75
labelled with Selenomethionine in intact and splen­
ectomised C5 7B1 and CFLP mice. The assay was per­
formed on the 9th day after infection.
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infected C57B1 mice is highly active against t r y p a n o s o m e s C o n ­
sequently, serum from C57B1 mice was injected into CFLP mice, 
following a range of regimens, in an attempt to confer protection 
against To congolense GVR 1 infection. The results are shown in 
Table 3, 10, Serum collected at various times from C57B1 mice, 
and injected into CFLP mice at various stages of infection, made 
no appreciable differences in survival, all recipients dying by 
day 12 of infectioiio Similarly, normal C57B1 was completely 
ineffectivGo
Passive immunisation was also attempted using hyperimmune 
serum from CFLP micep This had been raised in CFLP mice by Berenil 
chemotherapy of a 7 day To congolense infection, followed by two 
challenges on days 7 and 21 days after treatment, to which the mice 
were resistant* The hyperimmune serum (HIS) was collected 5 days 
after the second challenge. These mice were assumed to be immune 
because they resisted challenge, but confirmation was sought in an 
infectivity neutralisation test using 1/5 and 1/10 dilutions of 
the serum. These doses were selected to eliminate the possibility 
of the serum being diluted to below protective levels when subse­
quently injected into susceptible hosts. At both dilutions, 100% 
protection against infection was afforded to recipient mice.
The possibility of residual Berenil influencing the viability of 
the challenge inocula was discounted, since under these conditions 
Berenil is not prophylactic against T, congolense (see Chapter 2), 
HIS was unable to produce protection in mice which received it, 
and even when given at the time of infection produced only partial 
protection, as indicated by a delay in patency (Table 3*10 )«
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Effect on subsequent parasitaemia of different Infection doseo
To investigate if CFLP mice require a longer time to mount an
effective immune response to control the parasitaemia> time which
4
they may not be allowed with an inoculum of 10 organismsj groups 
of mice were infected with 10^, 10^, 10“’ and 10^ T . congolense 
GVll 1, and monitored for the appearance of parasites. As might 
be expected, a reduction in infective dose was accompanied by a 
lengthening of the prepatent period (Fig 3,10), However, despite 
an indication that with lower dose the time from detection of 
parasites to death was slightly longer, in none of the groups was 
initial parasitaemia controlled, and all mice died with fulminating 
parasitaemias„
Effect of simultaneous inoculation with irradiated trypanosomes.
An attempt was made to enhance the antigenic priming of CFLP
mice by inoculating a dose of 1 x 10^ trypanosomes rendered
incapable of replication by gamma irradiation at the time of
2
infection with 5 x 10 normal trypanosomes. The results (Fig 3,11) 
showT that mice given such a combination of trypanosomes had a 
prolonged prepatent period but, following patency, the parasitaemic 
profile was essentially similar to that of mice which received 
only normal infective trypanosomes. Those mice given only 
irradiated trypanosomes failed to develop patent infections,
Immunopotentiation of the mononuclear phagocytic system (MPS)
The basis of this approach is that various bacterial and chemical 
compounds cause hypertrophy and hyperplasia of the MPS, Some have
Fig 3.10. Parasitaemic profiles of CFLP mice infected
with different doses ( 10^, 10^, 10^, 10^) of T . congo- 
lense GVR 1.
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been reported to confer a degree of non-specific immunity against 
protozoan infections (Nussenzweig, 1967; Clark, Allison and Cox,
1976; Clark, Cox and Allison, 1977), thus the injection of various 
substances V7as carried out in an endeavour to enhance the activity 
of the MPS and thereby facilitate a reduction in the peripheral 
parasitaemia.
The results are presented in Fig 3,12. Neither levamisole, 
CFA, Cç^_par^yum (s.c.) nor any of the regimens using BCG produced any 
prolongation of the infection in CFLP mice. However, with C. jjarrnim 
(ioVe), B. pertussis and E , coli there was some evidence of a 
regulatory effect on the infection, although some animals in each group 
died within the normal period. Thus, with both C. painnim (i.v.) and 
Bo pertussis, one mouse from each group survived the first peak by 
successfully modulating the parasitaemia, only to die during the 
second peak. A similar outcome was observed in 3 mice treated with 
Eo coli LPS, none surviving beyond 23 days. In conclusion, there­
fore, hyperplasia and hypertrophy of the MPS alone does not confer 
any marked degree of protection in the absence of an effective 
antibody response.
Fig. 3,12. Parasitaemic profiles and survival of CFLP
mice following treatment with immunostimulants.
The result presented for BCG pretreatment is 
representative of that achieved with all of the 
treatment schedules described in the text.
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DISCUSSION
Field observations in Africa have long since indicated 
that certain species of animal are able to live in tsetse areas in 
which it is impossible for other species to exist, since they 
rapidly succumb to trypanosomiasis* Thus the concept of trypano- 
tolerance was realised, and it has been shown to occur in cattle 
(Stewart, 1951; Desowitz, 1959; Roberts and Gray, 1972; Toure, 
1977; Murray, Morrison, Murray, Clifford and Trail , 1979), in 
sheep and goats (Toure, 1977; Griffin and Allonby, 1979) and in 
certain species of wildlife (Ashcroft, Burtt and Fairbairn, 1959)*
The demonstration that certain inbred strains of mice
possess an inherent increased resistance to trypanosorae infection
(Ssenyonga, 1974) made it possible to conduct experiments to 
investigate the mechanisms of trypanotolerance in a host with a 
defined genetic background, such studies being very difficult in 
domestic livestock through their genetic heterogeneity*
The findings presented in this chapter confirmed the 
superior resistance of the C57B1 strain to T* congolense infection, 
but showed that the resistance was related to the virulence of the 
parasite. Thus, infection with T* congolense LUI4P 52 and LR 1 
results in a rapidly fulminating parasitaemia and death within
10 days in all strains of mice. Such an'influence has been
reported wi th T, brucei infections in mice (Clayton, 1978;
Sacks, Selkirk, Ogilvie and Askonas, 1980), and indicates that
1.5;
susceptibility may be influenced by a variety of factors* With 
the parasite selected for the remainder of the study, T, congolense 
GVR 1, significant resistance was shown only by C57B1 mice, and 
there was no difference in susceptibility of different sub-strains 
of this line* It has also been sho;vn that three resistant 
strains of C57B1 mice, congenic at the H-2 locus, have similar 
resistance to T* congolense infection, showing that susceptibility 
is not associated with the H-2 haplotype (Morrison, Roelants, Mayor- 
Withey and Murray, 1978)*
It is interesting to note that despite the marked 
difference in susceptibility between C57B1 and CFLP mice to infection 
with To congolense GVR 1, these 2 strains and indeed all strains of 
mice tested, responded remarkably similarly to T* brucei TREU 667*
Why this should be was not investigated further, but may be assoc­
iated with the additional extravascular component of T. brucei 
infection*
It was considered initially that the difference in mortal­
ity with To congolense GVR 1 infection between C57B1 and CFLP mice 
might be associated with one or more of the following factors:- 
first, the degree of anaemia, secondly a difference in the patho­
physiological changes associated with tissue damage and biochemical 
derangement: thirdly, the immunosuppressive effects characteristic
of trypanosomiasis may be more severe in susceptible strains of 
mice : finally, the degree and duration of the parasitaemia in the
t\TO strains may differ*
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With regard to the anaemia, the fall in PGV during the 
first 8 days post^infection was similar in both strains* Subse­
quently, it became stabilized in the resistant strain but continued 
to decline in the CFLP mice to very low levels* While, therefore 
anaemia may be significant as a final cause of death, its presence 
is entirely a consequence of the level and duration of the parasit­
aemia (Holmes and Jennings, 1976)* Furthermore, in both strains 
the pathogenesis of the anaemia at this stage of the infection was 
similar, ie an accelerating rate of red cell destruction compli­
cated by haemodilution, a situation similar to that reported in 
infected cattle (Holmes and Mamo, 1975)*
Although biochemical analysis of the blood showed gross 
alterations in the levels of some indices by the eighth day of 
infection, these were similar in both strains* The only exception 
was in the case of moribund CFLP mice which had elevated urea and 
serum phosphate levels and severe hypoglycaemia, all of which are 
knoTvn to be associated with high parasitaemias (Goodwin and Guy,
1973; Herbert, Mucklow and Lennox, 1975)* Elevated serum 
aspartate transaminase (AST) and alanine transaminase (ALT) values 
are indicative of diseases involving myocardial, hepatic and muscle 
damage, and have been reported in T* evansi infections in camels 
(Boid, Malimoud and Gray, 1979)* Changes in yVST levels have also 
been recorded with T* vivax (Gray, 1963) and T* congolense (Wellde, 
Lotzsch, Deindl, Sadun, Williams and Warui, 1974) infections in 
cattle, and rabbits infected with T* brucei (Goodwin and Guy, 1973), 
but comparative estimations have not been done in breeds of different
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susceptibility* Thus, in the absence of gross differences between 
the 2 strains of mice reported here, the pathophysiological changes 
over the first 8 days of infection must be regarded as being similar*
C57B1 mice were sho-î-m to be able to control the initial 
parasitaemia, and there was an indication that the rate of growth 
of peripheral parasitaemia may be an important factor in determining 
the outcome of infection. Thus, in C57B1 mice the rate of growth 
in peripheral parasitaemia slows from day 5 onwards, compared to an 
almost continual growth in CFLP mice, until parasite remission occurs 
in the resistant strain around day 8* In the meantime, death occurs
in the susceptible CFLP strain* It has been suggested (Clarkson, 
1980) that C57B1 mice modulate the virulence of the successive VATs 
wdiich appear with passing time, and ultimately the bloodstream para­
sitaemia is represented by VATs of low pathogenicity, which accounts 
for the ability of the C57B1 strain to survive so long* However, 
this is not the case in the host/parasite systern described here, 
since a population isolated from a C57B1 mouse on the 120th day of 
infection, when injected into CFLP mice, resulted in death within 
10 days, associated with a fulminating parasitaemia (results not 
presented). Thus the virulence of the parasite was unaltered*
A major feature of both animal and human trypanosomiasis 
is hypergammaglobulinaemia, particularly IgM (Mattern, Masseyeff, 
Michel and Peretti, 1961; Luckins, 1972a), a large proportion of 
which would appear not to be specific for the trypanosome (Freeman,: 
Smithers, Targett and Walker, 1970; Cors ini, Clayton, Askonas and 
Ogilvie, 1977)* At the same time the host becomes immunosuppressed*
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The agglutination response of both strains to heterologous 
red cell antigen (Murray, Jennings, Murray and Urquhart, 1974a) was 
suppressed to the same degree in both strains by 7 days after 
infection which suggests that the degree of immunosuppression was 
not a contributary factor to death* It is known that chronically 
infected mice are able to limit relapsing parasitaemias and it has 
been suggested that this is achieved by a smiall residual production 
of anti-parasite IgM (Hudson and Terry, 1979; Selkirk and Sacks, 
1980)0 A marked increase in IgM production occurs in C57B1 mice 
(Clarkson, 1976b), whereas there is virtually no increase in the 
highly susceptible C3H/mg strain* While the difference was not so 
marked in the system described here, CFLP mice did not produce as 
efficient a total IgM response as the resistant strain* These 
findings indicate that a more effective anti-trypanosoma response 
may be produced in the resistant strain even when the response to 
HRBG and SRBC is suppressed* The nature of the antigen is 
important and the dependency upon T cell regulation, which is 
thought to govern the response to SRBC (Claman and Chaperon, 1969; 
Katz and Benacerraf, 1972), may influence the efficiency of the 
immune response during trypanosoma infection, suggesting that 
trypanosome antigen elicits mainly aft IgM response which may not 
be under such rigorous T cell control as are SRBC responses*
Indeed it has been showm that the immune response to trypanosomiasis 
is relatively independent of T lymphocytes (Campbell, Esser and 
Phillips, 1978; Clayton, Ogilvie and Askonas, 1979), as judged by 
the ability of athymic mice to mount an effective immune response 
to trypanosome infection*
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Using Se-labelled trypanosornes to assess the inimune 
response in CFLP and C57B1 mice to T. congolense infection, it was 
shown that CFLP mice were unable to remove a large percentage of the 
injected activity by hepatic uptake» These differences were 
confirmed by infectivity neutralisation and trypanolysis of radio­
labelled parasites» Such results indicate that the ability of 
C57B1 mice to control the initial parasitaemia may be dependent on 
the levels of effective circulating antitrypanosome antibody»
\'jl'iether trypanolysis is an important mechanism of parasite removal 
in vivo is uncertain» It has been shown that mouse complement is
only poorly activated by IgM, while guinea pig serum is readily 
activated by IgM (Klaus, Pepys, Kitajima and Askonas, 1979)» Thus 
the high trypanolytic activity of serum from Infected C57B1 mice, 
in the presence of guinea pig serum iji vitro, may not necessarily 
reflect a similar situation ^  v ivo. However, it may indicate that 
a more effective antibody response is occurring in C57B1 mice.
Cyclophosphamide has been reported to enhance infections 
in mice (Luckins, 1969; Vickerman ^t a_i, 1977)» It was found in 
this study that total.body irradiation, splenectomy and pretreatment 
with cyclophosphamide all abolished the ability of C57B1 mice to 
control the peripheral parasitaemia and death occurred with a 
fulminating parasitaemia» The integrity of the hostds immune 
response appeared, therefore, to be important in resistance to 
infection, and this was supported by infectivity neutralisation, 
trypanolysis and immune clearance assays»
In view of the evidence that antibody is essential in
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controlling parasitaemia, it is difficult to explain the failure 
of passive immunisation using serum which had been showm to be 
protective using a variety of in vitro techniques (vide supra)»
It is possible that b y  injecting immune serum, which may contain 
antibody/antigen complexes, the B cells responsible for anti­
trypanosome responses may be blocked (Oberbarnscheidt and Kolsch, 
1978) or that levels of IgG, in the case of hyperimmune serum, 
inhibited the production of IgM and thus reduced the effectiveness 
of the immune response (Finkelstein and Uhr, 1964)» Furthermore, 
in vitro assessment of protective ability does not take into account 
the possibility that antigenic variation may rapidly circumvent 
the protective ability of the serum given in vivo a few days after 
infection- (Balber, Bangs, James and Proia, 1979)» On the other 
hand, the experiments in Chapter 2 demonstrated that passive 
immunisation against the same parasite could be achieved with 
maternal antibody, which is of the same class (IgG) as that in 
hyperimmune serum» It may be therefore that the explanation for
the failure to achieve passive immunisation with serum was that 
insufficient was used» Little information is available on this 
aspect, as most reports on passive immunisation have been concerned 
with Te brucei rhodesiense and T, brucei gambiense and the immune 
serum was always administered around the time of infection (Seed and 
Gam, 1966; Takayanagi, Kambara and Enriques, 1973a; Campbell and 
Phillips, 1976).
The susceptibility of CFLP mice could not be overcome by 
decreasing the number of infecting organisms, indicating that the
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ability to mount an effective immune response is dependent upon an 
intrinsic mechanism, rather than the speed of the immune response» 
This was supported by the finding that a massive primary dose of 
non-replicative trypanosorn.es given simultaneously with a small viable 
infection was an insufficient stimulus to the immune system. It 
is possible, however, that a minor variant, not represented in the 
priming population, was responsible for the parasitaemia which 
eventually killed the host»
It has been proposed that non-specific stimulation of the 
MPS can alter the susceptibility of mice to T» congolense and 
T. brucei infections (Singer, Kimble and Ritts, 1964; Murray and 
Morrison, 1979). However, in the current study, only minimal 
benefit was conferred by E . coll EPS, in that 3 of 5 mice survived 
the initial peak of parasitaemia, only to succumb to a fulminating 
relapse parasitaemia. Thus, an increase of the activity of the 
MPS in the absence of effective levels of antibody did not reduce 
susceptibility to the particular parasite used in this study, 
although it is possible that with a trypanosome of less virulence 
the effect of non-specific stimulation may be more pronounced, 
which may account for the success of the previous study (Murray and 
Morrison, 1979)»
The ability of immunostimulants to increase resistance 
to a number of other parasitic infections has now been extensively 
examined. In several instances they stimulated a dramatic increase 
in host resistance which in some cases was complete. In mice,
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pre-inoculation with G» parvum has been shown to increase host 
resistance to Plasmodium spp. (Nussenzweig, 1967; Clark et al, 
1977a; Cottrell, Playfair and de Sousa, 1977), Babesia spp»
(Clark et al, 1977a) and Trypanosoma crusi (Kierszenbaum, 1975; 
Brener and Cardoso, 1976). Similarly, BCG has also been used to 
stimulate increased resistance to Plasmodium spp. and Babes ia spp. 
in mice (Clark, Allison and Cox, 1976; Clark, Wills, Richmond and 
Allison, 1977b), T. cruzi in mice (Ortiz-Ortiz, Gonzalez-Mendoza 
and Larnoyi, 1975), Leishrnania donovani in mice (Smrkovski and 
Larson, 1977; Weintraub and Weinbaum, 1977), Schistosoma mansoni 
in hamsters and in mice (Capron and Lesoin, 1969; Fauve and Dodin, 
1976; Bout yt aA, 1977; Civil, Warren and Mahmoud, 1978), 
Ecchinococcus rnultilocularis in cotton rats (Rau and Tanner, 1975), 
Ecchinococcus granulosus in the gerbil (Thompson, 1976), the 
systemic larval phase of Trichinella spiralis in mice (Grove and 
Civil, 1978) and Toxoplasma gondii in the rabbit (Tabbara, O'Connor 
and Nozik, 1975). On the other hand, Brocklesby and Purnell 
(1977) reported the failure of BCG to protect both splenectomized 
and intact calves- against challenge with Babesia divergens»
Despite the failure to increase resistance in the current 
study with immunostimulants, this is an approach which deserves 
further investigation, particularly in the bovine, since if success­
ful, the high productive qualities of certain susceptible breeds 
may be exploited if increased resistance can be stimulated.
In conclusion, the results in this chapter indicate that
160
the C57B1 mouse strain is inherently more resistant to T„ congolense 
infection, through its ability to limit and reduce peripheral para­
sitaemia, Strains incapable of achieving this die from an 
uncontrolled fulminating parasitaemia» Several studies in labor­
atory animals have indicated that IgM is the important Ig class in 
controlling the parasitaemia and in protection (Campbell ^t a 1, 
1978), there is evidence that this is the case in cattle (Luckins, 
1976; Musolce, Nantulya, Barbet, Kironde and McGuire, in press), 
and the same is likely to be the explanation for the resistance of 
the C57B1 mouse»
CHAPTER IV
f75 ÎRadiolabelling of trypanosoraes with I Sei-methi
use in studies on immunological clearance
 onine and their
161
INTRODUCTION
The immune response to pathogenic trypanosomes has been 
the subject of much investigation, but is still poorly understood. 
Considerable attention has been paid to the antibody response to 
infection and the apparent failure of this response to control 
infections because of the parasite's notable ability to undergo 
antigenic variation. There is evidence that macrophages and cell- 
mediated responses also play an active role in combating the 
infection (see review by Murray and Urquhart, 1977), thus quantit­
ative evaluation of these responses in, vivo would be aided by the 
availability of a suitable method for measuring the removal of 
circulating trypanosomes.
This chapter outlines the development of such a technique
T75 1
utilising the incorporation of the amino-acid analogue Sei -meth-
75
ionine to produce Se -labelled Trypanosoma brucei. Much work
has been done in the use of radioactive isotopes for the labelling 
of cells for use in cell mediated immune reactions Jn vitro, and 
from this work have emerged the disadvantages of the various radio­
labels in particular assay systems. Long term assays involving 
cytostatic and cytotoxic influences (Takasugi and Klein, 1970) or 
only cytotoxic effects (Bean, Pees, Rosen and Oettgen, 197 3;
Oldham and Herberman, 1973) are normally not suitable for short 
term reactions. Short term assays able to monitor close, cell to 
cell contact (Henney, 197 6) or immediate cytotoxic effects (Brunner, 
Maud, Cerottini and Chapins, 1968) are usually not suitable for
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long term assays, due to the high spontaneous release of radio­
active material. The use of radioisotope-labelled target cells 
as an evaluation technique for various types of cell mediated 
immune reactions in v i t ^  has become well established. Labelling 
with p-isotopes, such as , or ^^Ca (reviewed by
Rooijen, 1977) has two major disadvantages: P~particles are
usually more efficient in cell-killing than y-rays (Bedford,
Mitchell, Griggs and Bender, 1975) and their preparation for 
counting is more laborious and expensive than that of y-isotopes. 
Moreover, p-isotopes suffer from quench problems, particularly 
when dissolved in coloured media. More easily-detectable y-iso-
ri7 5topes can be incorporated into cells in different ways; 1 " I-
125
iododeoxyuridine ( “ lUdR) is selectively taken up by DMA-synthes­
ising cells ( Nak and Till, 1963). Resting as well as prolifer­
ating cells can be labelled with various free y-isotopes such as 
^^Cr (Sanderson, 1964; Wigzell, 1965), ^^Ga (Burleson, Johnson, 
and Head, 1974), ^^Rb (Walker and Lucas, 1972), ^^^Tc (Gillespie, 
Barth and Gobuty, 1973) and ^^^Hg (Saha, Schell and Farrer, 1977)»
Several attempts to label trypanosomes with radioisotopes 
have been reported, but so far these methods, using in vi tro 
techniques, have been only partially successful»
The most common method used has been the incorporation of 
radiolabelled pyrimidines during parasite biosynthesis, primarily
(tritiated)-thymidine or adenine. It has been sho\'7n that
these pyrimidines are incorporated into kinetoplast and nuclear DNA 
(Leninger, 1975; Viens and Targett, 1972; Sanderson, Bunn and
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Lopez, 1978). ~thymidine has been used successfully to
label To rnega (Steinert and Steinert, 1962): T. evansi and
To gambiense (Inoki and Tadasuke, 1969); T» brucei (Balber,
1971) and T. musculi (Viens and Targett, 1972) although it is 
apparently not incorporated into T» vivax (Isoun and Isoun, 1974) 
presumably due to the parasite's ability to synthesise thymidine 
de novo*
  h i 1The gamma emitting isotope I Cr -chromium has been 
used successfully in cytotoxicity tests (Batchelor, 1973), and 
not surprisingly attempts have been made to label parasitic 
organisms with this radio isotopeo Schistosoma mansoni schisto­
somal a have been successfully labelled (Butterworth, Sturrock,
51
Houba and Rees, 1974) and Cr -labelled Litomosoides carinii 
microfilaria have found successful use in a cytotoxicity assay 
(Subrahmayan, Rao, Mehta and Nelson,' 1976). In contrast,
Tsi 1attempts to label trypanosomes with \ Crj -chromium have been less 
successful. The labelling efficiency of To_cruzi was low even 
when beta particle emissions were measured by liquid scintillation 
in preference to gamma emissions (Kuhn, Vaughn and lanuzzi, 1974)»
(Mkwanazi, Franks and Baker, 1976) was limited by the isotope's 
short half-life of 6 hours and difficulties in its manufacture 
from \ Mol-molybdenum» Two major criticisms arise when using 
in vitro cultivation to label trypanosomes. First, the 
incubation may result in a possible alteration to the parasite's 
surface antigen profile and secondly the incubation may adversely
The use of cl - technetium to label T. dionisii
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affect the parasite's subsequent infectivity and replication in 
the host (Dahlin, Hungerer and Zxvischer, 1976). A further limit­
ation is on the use to which labelled parasites may be subsequently
put, since a reagent synthesised from \ Sl-methionine (Cross, 1975),
] 25 3
and the procedure using ' I or H described by Rovis, Barbet 
and Williams (1978) label only the surface coats of T » brucei and 
To congolense respectively, the reagents being unable to penetrate 
the cell membrane.
The problems associated with in yi^t^ incubation may be 
overcome if the labelling is carried out in vivo, particularly if 
the isotope is metabolically incorporated into the trypanosome.
3
Thus, while H pyrimidihes have been used in the' past, a radio­
labelled gamma-emitting amino acid analogue was used, to overcome 
the problem of sample preparation for liquid scintillation yet 
benefit from the isotope's metabolic incorporation.
This chapter describes a series of experiments designed 
to investigate the possibility of labelling trypanosomes with
T75 nI Se|-methionine and the suitability of such radiolabelled 
parasites for use in immunological clearance studies.
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'MATERIALS AND METHODS
Parasite. The stabilate of Trypanosoma brucei used in these
experiments was originally derived from the stock TREU 226 
(Appendix I)»
Experimental Animals. These were female Hooded Lister rats (Olac 
1976 Ltd., Bicester), female CFLP mice (Anglia Laboratory Animals, 
Huntingdon), and AKR strain mice genetically deficient in the 5th 
component of complement (C5) (kindly donated by Dr. I. McConnell, 
MRC, Cambridge. Prior to their use the absence of C5 in AKR mice 
was confirmed by haemolytic radial diffusion (Lachman and Hobart, 
1978). Animals which were 8-10 weeks of age at the beginning of 
each experiment were used throughout.
Radiolabelling technique. Radiolabelled trypanosomes were
prepared in rats with fulminating parasitaemias, normally 4 or 5 
days after infection. The rats were sublethally irradiated 1 day 
prior to infection with 650 rad in a *^^ Co source (Nuclear Engin-
r*75 1eering Ltd., Berkshire). 50 pCi | Sej-methionine (Radiochemical 
Centre, Amersham : 100 pCi/ral containing 10-50 pg methionine/ml) 
was injected i.v, the infected blood collected 20 hours later, 
and the trypanosomes separated from blood cells by DEAE cellulose 
chromatography (Lanham and Godfrey, 1970).
Injection of radiolabelled trypanosomes and sampling. Washed
radiolabelled trypanosomes were diluted in PSG to give a final
9
concentration of 10 trypanosomes per ml. Each mouse then
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received 0.1 ml by injection into a tail vein after sedation with 
0o03 ml i.p. of a neuraleptanalgesic. mixture comprising Fentanyl 
base (Oo2 mg/ml) and Fluarisone (10.0 mg/ml) (Hypnorrn, Janssen 
Pharmaceuticals, Belgium). After 1 hour, unless otherwise 
stated, the animals were given an over-dose of trichloroethylcne 
and a blood sample taken by cardiac puncture. The spleen and 
liver were carefully excised, washed in PSG, blotted dry and 
weighed. Spleen, liver and an aliquot of blood (0.5 ml) were 
placed in individual counting vials, the remainder of the carcase 
was divided into a further 3 counting vials, and the radioactivity 
determined using an automatic gamma scintillation counter (Packard 
tri-carb 3330, Illinois, USA).
The injected activity for each animal was calculated as
the sum of the counts per minute (cop.m.) recorded for each sample.
The result for each organ is expressed as a percentage of the total
7 5
injected activity. The percentage of Se -activity remaining 
in the blood was obtained from the calculated total blood volume 
of each individual animal. The latter was estimated by multiplying 
the weight of each animal, expressed in grams, by 0.067 ml blood 
per gram of body weight. This factor for blood volume was 
obtained from earlier studies by application of the dilution 
principle using ^^Cr -labelled red cells.
Immunisation procedure. Mice were immunised by infection and 
trypanocidal therapy using diminazene aceturate (Berenil, Hoechst, 
Germany; 40 mg Active Principle/kg body weight). The drug was
16:
administered i^p, in distilled water on the fourth day of
infection, and 4 weeks later the mice were challenged with the
homologous strain of parasite,, Failure to detect parasites over
the ensuing 30 days was taken as evidence of immunity* Passive
immunisation vjas done by i*v* injection of 0*2 ml undiluted hyper-
75immune serum 15 minutes after the injection of Se -labelled 
trypanosomes*
Preparation of Hyperimmune scrum* Hyperimmune serum (HIS) was
obtained from rats infected with T, brucei 22.6 and subsequent drug 
cure with Berenil (40 mg/kg) on day 4 of infection; then 4 and 24 
days later the rats received two challenges of 1 x 10' organisms 
i.p* The serum was then collected 9 days later and pooled* This 
method consistently produced HIS with a trypanosome agglutination 
titre of at least 1/64*
75
Homogenization and Protein Separation of Se -labelled Trypanosomesc
75
A 5 ml sample of Se -labelled trypanosomes containing approximately 
5 X 10^ trypanosomes/ml PSG was disintegrated by 5 cycles of freezing 
in liquid nitrogen and thawing to 37°C in a temperature-controlled 
water bath* A sample of freshly prepared homogenate was fraction­
ated on a DEAE cellulose column (Lanham and Taylor, 1972) and its 
protein content and radioactivity quantified. The eluant gradient 
used was 0*4M phosphate buffer and 0.04M phosphate buffer with 0*8M 
KaCl added, pH 8*0.
75Location of Se -methionine in serum proteins on the surface of
trypanosomes* (a) Serum albumin and globulin were separated by
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paper electrophoresis as follows:- a 35 cm length of Whatman's 
No* 1 filter paper was placed in an electrophoresis tank* The 
ends of the paper were allowed to dip into 0*09M barbiturate 
buffer, pH 8*6 and soaked for 1 hr* 0*01 ml of serum was then 
applied using a wire applicator across the paper, approximately 
15 cm from the cathode, leaving about 5 mm on either side* The 
sample was then run for 16 hours at 100 volts* The strip was 
removed, dried and stained in 0*1% bromophenol blue (George T*
Gurr, London), dissolved in methanol for 20 min* It was then 
washed with dilute acetic acid to remove superficial stain, and 
the final wash was carried out using methanol*
The paper strip was then prepared for radioactivity 
determination by cutting it into equal segments and placing them 
into counting vials* The quantities of albumin and globulin 
were estimated by eluting the protein-bound activity with barbiturate 
buffer and measuring the protein content spectrophotometrically 
(Pye Unicam, Sp6-500 U*V* Spectrophotometer, Cambridge)*
75
(b) The location of Se activity in radiolabelled 
T* brucei was compared to labelled serum proteins by electrophoresis 
on cellulose acetate strips (Cellogram, Shandon Southern, Surrey)*
The procedure was as follows:- cellulose acetate strips were 
placed on the surface of 0*09M barbiturate buffer, pH 8*6* The 
buffer was allowed to soak up through the strip, thus preventing 
air bubbles being trapped in the pores* When thoroughly soaked 
the strips were immersed in the buffer*
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The strips were lightly blotted to remove excess buffer 
and laid across the supports of an electrophoresis tank* These 
supports were linked to the buffer by "wicks" made from filter 
paper* The edges of the cellulose acetate strips were sandwiched 
between these pieces of filter paper and held in position by 
perspex rods*
The samples were applied using an 0*03 ml applicator 
(Shandon Southern, Surrey) 4 cm from the cathode* Each sample 
was then run for 1 hr at 150 volts* Following electrophoresis, 
the strips were dried in a hot oven to fix the proteins, and 
stained with 2% Ponceu a in 207* TCA* Excess stain was removed by 
washing in 57* acetic acid* The radioactivity determinations were 
as above* The different plasma protein fractions were estimated 
on a chromoscan (Joyce-Loebl & Co* Ltd*, Gateshead) and expressed 
as a fraction of the total protein*
Total protein estimations* Total protein was measured either
by the Folin phenol method of Lowry, Rosebrough, Farr and Randall 
(1951) or by measuring the solution at 260 nm and 280 nm on a 
spectrophotometer and estimating the protein content from the 
following equation:-
Total protein = 1,45 x - 0*74 x OD^^q mg/ml*
Protein bound radioactivity of radiolabelled trypanosomes* The 
protein bound activity was measured after 107* trichloroacetic 
acid (TCA) precipitation of a homogenised sample. The resultant 
precipitate was sedimented in a temperature controlled centrifuge
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at 1500 g for 20 min at 4^0* The percentage protein-bound radio­
activity was calculated as follows;
CoP*mo of supernate x 100
Total counts of pellet plus supernate 
75
Maintenance of Se -labelled trypanosomes in vitro* Freshly
separated radiolabelled trypanosomes were maintained in commercial 
culture medium RPMl 1640 (Gibco-biocult, Paisley) (100 ml RPMl 
1640 with 15 imM Hepes and L-glutamine) to which had been added 
20 ml foetal calf serum, 1 ml, Molar Hepes buffer (Gibco-biocult, 
Paisley), 10,000 units Penicillin and 10,000 pg streptomycin 
(Glaxo Laboratories Ltd*, Greenford)*
5 ml aliquots of the culture medium were then dispensed 
into sterile universal bottles and each bottle seeded witli 1 x 10^ 
trypanosomes* They were then maintained at 37°C*
Decomplementation of mice* Mice were decomplemented by 3 i*v* 
injections of purified cobra venom factor (CVF) over a period of 
24 hours* Each mouse received a total of 25 pi CVF* The ability 
of these mice to remove radiolabelled trypanosomes was determined 
24 hours after the final injection of CVF* Serum C3 levels were 
quantified by rocket immunoelectrophoresis (Laurel, 1966) using 
rabbit anti-mouse C3 (Nordic Immunological Reagents Ltd*, Berkshire)*
Stimulation of the mononuclear phagocytic system (MPS)* Non-specific
stimulation of the MPS was achieved by i*v* injection of either
7
Mycobacterium bovis (BCG vaccine, Glaxo), 1*5 x 10 organisms per 
mouse or Corynebacterium parvum (Coparvax, Wellcome) 1*4 mg per
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mouse, 10 days prior to clearance studies*
In vitro treatment of trypanosomes with serum* (a) Neutralising 
antibody infectivity tests were performed on sera as described by 
bums den ej: a^ l (1973) with the following minor alterations* The 
test was performed in 1 ml plastic tubes* Each tube contained 
200 1-lI test serum or PBS, 50 pi fresh guinea pig serum (GPS), as 
a source of complement and 5 x 10^ trypanosomes suspended in 250 pi 
PBGSo After incubation at 4°C for 30 min the contents of each 
test well were taken up into a syringe and divided equally between 
5 mice* These mice were then monitored daily for the appearance 
of blood parasites* Failure to detect parasites over a 2 week 
period was taken as evidence for the presence of neutralising 
antibody*
(b) Agglutination titres of fresh HIS were determined 
in microtitre plates (Cooke Laboratory Products, Virginia, USA)* 
Serial doubling dilutions of the test serum were carried out in 
PBS* To each test well was added 5 x 10^ trypanosomes in 25 pi 
PEGS* The microtitre plates were incubated at 37°C for 30 min 
and then read on an inverted microscope (Leitz, Germany) at X 400 
magnification*
(c) Clearance studies using labelled trypanosomes were 
conducted following their yitro treatment w^ith serum* This 
consisted of a modified infectivity neutralisation test in which
^"^Se "labelled trypanosomes were incubated at 4^C for 30 min in 
HIS or normal rat serum (NRS) without guinea pig complement*
172
Some of the trypanosomes were then washed 3 times with PSG*
Groups of mice were inoculated i*v* with a suspension 
containing 1 x 10^ trypanosomes as described above*
Statis tics. Variation around the mean is expressed as the 
standard error* Unless otherwise stated, groups of mice comprised 
5 to 8 individuals*
17:
RESULTS
f75 *1Labelling of trypanosomes with L 'Sel-methionine. To investigate
P/bthe incorporation of Sc -methionine into trypanosomes the 
following two experiments were undertaken:-
(a) Time course of label incorporation;
The labelling efficiency was investigated in an experiment 
in which two groups of 3 irradiated rats received 50 pCi -
methionine on the day of infection or 4 days after infection*
The trypanosomes were collected 5 days and 20 hr later, respectively*
The results presented in Table 4*1 show that the shorter 
the exposure of the parasite to the isotope the greater the labelling 
efficiency, i*e* 0*04% after 20 hr compared to 0*004% after 5 days*
To investigate the dependence of the specific activity 
of labelled trypanosomes on the plasma concentration of the iso­
tope, the following experiment was done:
(b) The relationship between specific activity of labelled
f75 ntrypanosomes and injected dose of L SeJ-methionine :
1 75
If ^  -methionine is incorporated into the parasite
at the same rate as naturally occurring methionine, then by raising 
p75 1
the quantity of \ Set-methionine in the circulation, the ratio of 
^^Se -methionine to cold (non-labelled) methionine molecules 
entering the parasite should also rise* This may lead to an 
increase in the specific activity*
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Table 4.1 The relationship between specific activity
and labelling time
Period of c.p.m. % labelling
incubation g per efficiency*
10 trypanosomes
20 hr 4053 - 259 0.04
5 days 450 - 89 0.004
*The labelling efficiency was determined from the c.p.m, 
per 10^ trypanosomes expressed as a percentage of the 
total injected activity.
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To investigate this, a group of 6 irradiated rats with 
fulminating infections were given an i.Vo injection of either
Ç75 \
100 jiCi, 50 pCi or 30 pCi of \ SeJ-methionine* The populations 
of radio labelled parasites were then collected 20 hr later* The 
specific activity of these parasites is presented in Table 4*2*
The results show that there is a direct relationship
[75 I
between the injected dose of  ^ Set-methionine and the specific 
activity of the labelled trypanosomes* This would suggest that
1 75 1
Y Set-methionine was readily incorporated into the trypanosomes, 
probably at the expense of the unlabelled methionine*
[75 n
Incorporation of L Sej-methionine into trypanosomas: The uptake
f 7 5 1of I Sej-methionine into schistosomal protein (Christensen, 1977) 
and the rapid appearance of ^^Se-labelled host plasma proteins 
shortly after i*v* injection of -methionine into normal rats
(Awa-zad, Potchen, Adelstein and Dealy, 1966) suggests that it is a 
metabolic incorporation*
75
To ensure that the Se activity associated with the
f75 1trypanosomes was the result of | Sej-methionine incorporation
into trypanosome protein rather than the adsorption of labelled
host plasma proteins on to the parasites' surface, the distribution 
75
of Se-activity in host and parasite protein was investigated*
(a) Trichloroacetic acid insoluble activity* Separated and 
washed radiolabelled trypanosomes were homogenised by repeated 
freezing and thawing* The newly synthesised protein in the 
resultant supernate was precipitated with 10% Trichloroacetic
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Table 4.2 Relationship between specific activity and
the injected dose of isotope
Quantity of Specific activity per
isotope 10 trypanosomes
100 pCi 9000 ± 420
50 yCi 5027 ± 301
30 yCi 2359 ± 326
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acid (TCA)* The resultant precipitate retained 95-977* of the 
total radioactivity.
(b) DEAE Cellulose chromatography of trypanosome homogenate* The
particulate debris from the trypanosome homogenate prepared by
freezing and thawing was removed by high speed centrifugation
(1 hr at 30,000 g)* The resultant supernate contained 8*8 mg
75
protein/mlo A sample of this Se-trypanosome supernate was 
applied to a DEAE cellulose column (1*5 cm x 25 cm) and the elute 
collected at a flow rate of 48 ml/hr*
Figure 4*1 illustrates that the radioactivity of the 
sample was closely associated with several protein rich fractions*
75
Location of Se -methionine activity in proteins attached to the
surface of trypanosomes
It has been reported previously that adsorption of plasma
proteins on to the surface of trypanosomes may occur (Ketteridge,
1970; Diffley, 1977)* Hence the accumulation of labelled
plasma proteins (Awwad e^ t aj^ , 1966) on to trypanosomes could be a
possible mechanism by which the parasites become labelled with 
75
Se-activity* To investigate this possibility the distribution
75
of radioactivity of a homogenate of Se-labelled trypanosomes and
labelled plasma proteins was compared by paper and cellulose 
acetate electrophoresis*
The results presented in Table 4*3 show that the majority
75 7 5
of the Se-activity in the serum from normal rats given "Se -
Chromatographic separation on DEAE-ceXlulose of a
75 . .homogenate of Se-raethionine-labelled T. brucei.
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Table 4 .3 Paper electrophoresis of serum proteins from a normal
\ 75 ”\
rat given 30 pCi of SeJ-methionine 20 hr previously
cpm cpm/mg protein % total cpm % total protein
Albumin
Globulin
4
58 446
6
94
80
20
7 5
Table 4,4 Cellulose acetate electrophoresis of Se “labelled
serum and trypanosome proteins
Serum 
Protein faction
Albumin
a-globulin
8-globulin
y-globulin
S e r u m  T r y p a n o s o m e
% t o t a l  c p m  % t o t a l  c p m
18,3
64.8
13.8 
3.1
65.9
14.8
14.8 
4.4
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methionine 20 hr previously can be located in the globulin compon­
ent* In addition, when label led proteins from a horaogenate of
washed trypanosomas and host plasma proteins were run in parallel on
cellulose acetate, the results showed (Table 4*4) that the majority 
75
of trypanosome Se-activity was associated with a band correspond­
ing to the serum albumin of host plasma proteins. In contrast,
75the majority of plasma protein Se-activity is against found in 
the globulin component, and in particular with the a and |3 globulins<
75
Spontaneous release of ; Se-activity from radiolabelled trypanosornes!
The following experiments were undertaken to ensure that
75
Se-activity was firmly bound to trypanosome protein and not 
readily elutedî-
7 5
(a) ^  vitro release of Se-activity. In this experiment 5 ml
aliquots of culture medium in 20 ml universal bottles were seeded 
with a known number of radiolabelled parasites, approximately 1 x 10^  
organismso These bottles were then incubated at 37*^C for between 
1 hr and 4 hr* Each sample was set up in quadruplicate* After 
incubation the trypanosomas in each sample were pelleted in a tem­
perature controlled centrifuge (4^C at 1000 g for 20 min)* After 
this 1 ml of supernate was removed and transferred to a separate 
counting vial* The radioactivity of both supernate and pellet 
was then determined * The release of activity is expressed as a 
percentage of the total. CoPom* of the sample, calculated thus:
5 X supernate c*po!n„ in 1 ml x. 100 
total c*p,m* of pellet and supernate
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The results presented in Table 4.5 show that in yd.trjo 
75
leakage of Se-activity is approximately 10% after 4 hr*
75 75
(b) I n  v i v o  r e l e a s e  o f  S e - a c t i v i t y *  T h e  r e l e a s e  o f  S e-
activity into the supernate during fn vitro incubation was found to
be acceptable* To investigate the rn viyo^ release of activity
the following experiment was undertaken:- A group of normal mice
received approximately I x 10^ radiolabelled trypanosornes* These
animals were then killed 1 hr or 4 hr later and the radioactivity
o f  a b l o o d  s a m p l e  d e t e r m i n e d  * T h e  s p e c i f i c  a c t i v i t y  o f  r a d i o -
labelled trypanosornes was determined from washed separated trypano-’
somes obtained by DEAE cellulose chromatography*
The results presented in Table 4.6 show that the total 
blood CoPom* based on an estimated blood volume did not fall 
significantly over the 4 hr period* Thus the majority of the try­
panosomas would appear to remain in the circulation over this 
period* There is however a fall in the specific activity of 
labelled trypanosomas over this period* Table 4*7 shows that the 
specific activity falls to 67*4% of the original activity of the 
trypanosomas injected* This fall is not associated with trypano­
some removal from the circulation as the previous results show that 
estimates of total blood c.p.m* remain at approximately 100% over 
this period of 4 hours* The decrease in specific activity may fee 
the result of parasite replication; indeed such a reduction would 
represent a parasite doubling time of approximately 6*5 hr*
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Table 4.5 Elution of radioactivity during vitro
75
incubation of Se --labelled T. brucei
Time
(hr)
75
% release of Se -activity
Tube 1 Tube 2 Tube 3 Tube 4 x
3.7 3.7 2.8 5.1 3.8 - 0.5
5,6 4.8 6.3 5.8 5,6 - 0.3
12.610.7 10.4
13.0 10.1
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Table 4.6 The estimated total blood radioactivity 1 hr and
75
4 hr after the infection of Se -labelled T. brucei
Time Estimated total 
blood activity 
c.p.m.
% injected activity
1 hr 
4 hr
3148 - 109
3096 - 80
100
98
Table 4.7 The reduction in specific activity of 10 trypanosomes
during in vitro incubation
Time c.p.m./lO trypanosomes % injected activity
1 hr 3860 - 156 100
4 hr 2600 - 193 67.4
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7 5Re-utilisation of Se-labelled metabolites by trypanosomes^ The
previous results show that there was a decrease in the specific
activity of labelled trypanosomes iji vivo* To ensure that any 
75
Se-activity that may be released into the plasma was not re- 
utilised by circulating trypanosomes the following experiment was 
undertaken ;~
75
A homogenate prepared from Se-labelled trypanosomes
-f 8
(4328 “ 67 cpm) equivalent to 1 x 10 trypanosomes was injected 
i,Vo into rats with fulminating infections„
The results demonstrated that trypanosomes recovered after
751 hr from rats injected with the homogenate of Se-labelled trypano- 
somes did not incorporate a significant amount of the available 
activity ( 5 - 2  CoPoino/lO^ trypanosomes).,
From the results presented above it was decided to stand-
Vy 5
ardise the labelling procedure as an injection of 50 pCi of ' Sei- 
methionine followed 20 hr later by DEAE cellulose chromatography of 
the infected blood*
75
Tissue distribution of Se-labelled trypanosomes at various times
in normal and immunised mice:
75Having established that no appreciable loss of Se- 
activity occurred over 4 hr either in vitro or in vivo, the distri­
bution of labelled trypanosomes in normal mice and mice immunised 
against the particular variant used in these experiments V7as 
measured at 2, 15, 30, 60, 90 and 120 min* In particular, the 
radioactivity of the spleen, liver, lungs, kidneys, heart and blood 
was measured*
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75
The tissue distribution of Se-labelled Trypanosoma
brucei at various times after their injection into mice is shown
in Fig 4o2* The most striking feature was the rapid reduction in 
75
Se-activity from the blood of immune mice, i*e* 3% compared to
67% of the injected activity in normal mice* This reduction in
7 5
blood activity was associated with a rise in hepatic Se-activity*
75
The transient Se-activity at 2 and 15 min after the injection of 
radiolabelled parasites in the lung of normal mice is thought to 
reflect the passage of trypanosomes through the pulmonary circu­
lation* This is in contrast to the continual rise in the hepatic 
75
Se-activity of immune mice which reaches a maximum value at 30 
min after the injection of radiolabelled trypanosomes, i*e„ approx­
imately 65% after which time the values remain at this level *
75
The tissue distribution of Se-labelled trypanosomes
in normal mice does not alter over the time course of the experiment*
Furthermore, the hepatic uptake is considerably less than is seen
in the immunised mice, i,e* 9% compared to 65% and this is parallelled
by a high blood activity* It would therefore appear that the
75
hepatic localisation of Se-activity is closely associated with the 
immune response of the host and probably reflects labelled trypano­
somes being retained within the hepatic vasculature* The increase 
in hepatic uptake seen in immune animals is not a reflection of 
hepatomegaly as in these animals the liver weight, when expressed
as a percentage of the total body weight, was 7*1 - 0*2 compared 
•f
to 6*3 - 0*2 in control animals* Similarly, there was no signifi-
-f
cant degree of splenomegaly in immune animals, i*e* 0*9 - 0*1 
H-compared to 0*6 - 0*1*
FÎR 4.2
75The tissue distribution of Se-labelled 
trypanosomes at intervals after injection into immunised 
(I) and control (C) mice.
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75
In general the tissue distribution of ' Se-labelled 
To brucei in the kidney and heart of both Immune and normal mice 
was less than 3%,
7 5
The tissue distribution of Se-activity following the injection of 
75
free Sc -methionine, into normal and Immune mice:
To confirm that the radioactivity values obtained in the
previous experiment were not the result of increased hepatic uptake 
75
of free Se -methionine in immune mice the following experiment 
was undertakeiio
A group of normal mice and a group of immune mice were
r75given 10 [iCi of free ^ Se 1-methionine by i*Vo injection and 1 hour
7 ')
later the tissue distribution of 'Se-activity recorded. Table 
4*8 shows that the tissue distribution of ^^^Sej-methionine 1 hr 
after its injection into normal and immune mice is the same. The 
majority of the activity is located in the liver. However this 
can be explained as a consequence of both the size of the liver 
when compared to the spleen and also to the importance of the liver 
in protein biosynthesis.
The hepatic activity although higher than in normal mice
75
given Se-T, brucei does not approach the values of hepatic uptake 
seen in immune mice,
75
The effect of hyperimmune serum on clearance of Se-labelled 
T, brucei in normal mice:
75
The rapid removal of Se-labelled T , bry^ '^Gi from the 
circulation of immune mice, demonstrated above, was principally
186
Table 4.8 Tissue distribution of | Se;-methionine in normal
and immune mice
tissue distribution (% injected activity) 
spleen liver
Control < 3 . 0  16.5 ± 1.6
Immune < 3 . 0  15.7 ± 1.1
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achieved by the liver. The role of antibody in this process was 
investigated both in vivo and in vitro using HIS prepared in rats. 
Firstly the effect of HIS was assessed in vivo by injecting normal 
mice with labelled trypanosornes followed 15 min later by various 
icVo doses of HIS, The results presented in Fig 4,3 show that a 
level of circulating antibody could readily be obtained by passive 
immunisation which facilitated hepatic uptake of trypanosomes to 
a degree similar to that of actively immunised mice. Indeed only 
very small quantities of HIS were required to produce this uptake, 
i,e. an injection of HIS greater than 0,01 ml produces approximately 
60% hepatic uptake.
By injecting whole serum i,v, it is difficult Lo assess 
whether hepatic uptake occurs as a result of opsonisation of the 
trypanosome or is mediated through cytophilic antibody attached to 
macrophages in the liver. Thus the effect of pre-treatment of 
labelled trypanosomes with HIS in vitro prior to their injection 
into normal mice was investigated. In an attempt to differentiate 
between opsonic and cytophilic antibody, unbound HIS was removed 
by washing the trypanosomes in PBGS three times prior to their 
ioVo injection into normal mice. The results presented in Table 
4,9 clearly indicate that such treatment can induce levels of 
hepatic uptake which were similar to those of either actively or 
passively Immunised mice. Furthermore, washing free HIS from the 
trypanosomes prior to their injection did not diminish the hepatic 
uptake.
Fig 4.3
75The tissue distribution of Se-labelled trypanosomes 
in mice passively immunised with various doses of hyperimmune 
serum.
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Table 4.9 The effect of jai vitro treatment with hyperimmune serum
75
on the tissue distribution of Se -labelled trypanosomes 
in normal mice
Treatment
HIS
HIS washed
NMS
NMS washed
Tissue distribution (% injected activity) 
Spleen Liver
< 3.0
< 3.0
< 3,0 
5.2
59.4 ± 1.8 
64.6 ± 3.7 
9.5 ± 0.5 
11.0 ± 0.3
Blood
< 3.0
< 3.0
69.2 ± 5,6
69.2 ± 4.2
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Macrophage function in the absence of antibody; The previous
experiment showed that hepatic macrophages without experience of
trypanosome antigen prior to the injection of labelled trypanosomes
were as efficacious in trypanosome removal in the presence of
passively acquired HIS as those of actively immunised mice. It
was thought useful however to investigate the phagocytic efficiency
of antigen-experienced macrophages in the absence of antibody.
In this experiment groups of mice were irnmuno-suppressed by sub-
lethal irradiation with 650 rad. One day later these mice and
normal controls were infected. After three days the animals were
75cured with Berenil and a further 4 days later inj'ected with Se- 
labelled T, brucei.
The results presented in Table 4,10 show that the immun­
isation procedure of infection and chemotherapy resulted in high 
hepatic clearance of trypanosomes which was not a drug induced 
artefact, as mice given only Berenil failed to produce these high 
hepatic uptakes. However, those mice which were irradiated prior 
to their infection had markedly reduced clearance values to levels 
only slightly above those of normal mice.
There are two possible explanations for this result; 
first, prior irradiation may have damaged the phagocytic ability of 
the macrophages. Secondly, irradiation may have prevented the 
production of effective antibody levels.
The first possibility was examined in a group of 20 normal
mice, some of which were irradiated with 650 rad and 8 days later 
75
injected with Se-labelled trypanosomes followed 15 min later with
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Table 4.10 The effect of prior irradiation on the tissue distribution
75 ,
of Se -labelled trypanosomes in actively immunised and
normal mice
Treatment
Tissue distribution C% injected activity)
Spleen Liver Blood
irradiated immune 3.8 - 0.3 13.2 ± 3.1 55.3 ± 7.7
non-irradiated
immune < 3 . 0 49.3 ± 1.8 < 3 . 0
irradiated drug
control 4.7 ± 1.7 8.3 ± 0.6 67.6 ± 8,9
non-irradiated
drug control 4.5 ± 0,3 9.2 ± 0.3 73.9 ± 5.7
irradiated control <  3.0 8.3 ± 0.5 61.7 ± 6.0
non-irradiated
control 3.2 ± 0.6 6.5 ± 0.7 68.5 ± 2.9
Table 4.11 The effect of prior irradiation on the tissue distribul
of Se -labelled trypanosomes in passively immunised
normal mice
Tissue distribution (% injected activity)
Spleen Liver Blood
irradiated immune <  3.0 77.8 ± 1.6 < 3 . 0
non-irradiated
immune <  3.0 67.4 ± 2.4 <  3.0
irradiated non-
immune < 3 . 0 14.3 ± 1.2 80.6 ± 5.9
non-irradiated non- 
immune < 3 . 0 11.0 ± 0.7 77.5 ± 3.2
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Op2 rnl of a 1:8 dilution of HXS, The results presented in Table 
4,11 show that prior irradiation does not impair the phagocytic 
function of hepatic macrophages and therefore does not affect 
hepatic uptake.
The absence of antitrypanosomal antibody was confirmed by 
trypanosome agglutination tests. In such tests pooled sera from 
irradiated mice failed to produce agglutination of trypanosomes 
either before or after Berenil therapy. In contrast, similar non- 
irradiated mice treated with Berenil produced a strong agglutination 
of the parasite, approximately 1/128,
75The effect of MP S acti vation phagocy t i c r eino va^  ^ f _Se 1 a bjs H. e d
trypanosomes,
Since expansion and the activation of the MPS is a 
characteristic feature of trypanosome-infected animals (Murray, 
Murray, Jennings, Fisher and Urquhart, 1974; Stevens and Moulton, 
1978), it is possible that apart from antibody-induced clearance, 
trypanosomes may also be removed from the circulation in such 
animals by a non-specific phagocytosis.
To test this, the clearance of trypanosomes from the 
circulation was measured in normal mice which had previously 
received either BCG or C, parvum as non-specific modulators of the
,« u MUM. Il I mi
MPS, Both have been shown to cause increases in liver and spleen 
weights associated with hyperactivity of their macrophages and 
increased phagocytosis of carbon particles and bacterial cells 
(Stiffel, Mouton and Biozzi, 1970),
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The results presented in Table 4,12 show that prior 
treatment wi th either BCG or C, parvum was associated wi th increases 
in hepatic and splenic weights. This was reflected by proportionate 
increases in trypanosome uptake by both organs. However, the level 
of hepatic uptake was very much less than that obtained with HIS, 
i,e, less than 11% compared to approximately 60% (see Table 4,9),
Role of complement in linmune cl^ar^ce.
The experiments so far described have clearly demonstrated 
that antibodies are essential in inducing blood clearance of trypano- 
somes. However, these results do not show whether whole opsonised. 
trypanosomes can be removed or if a complement dependent mechanism 
is an essential pre-requisite for phagocytosis. In order to 
investigate this latter possibility, the following experiments vzere 
done.
Immune clearance in C5-deficient and C3~depleted mice: The in vivo
clearance ability of passively immunised mice, which were either
genetically deficient in C5 or depleted of C3 by prior treatment
with CVF was measured. The former mice permit an investigation of
the terminal lytic pathway of complement activation, whereas the
latter should reveal the role of C3 opsonisation in immune clearance,
IiTimune clearance was measured in passively immunised mice by i,v,
75
injection of Se-labelled T, brucei followed 15 min later by an 
injection of 0,2 ml HIS, Groups of mice received either undiluted 
serum or a 1:8 dilution in PBGS, The results presented in Table 
4,13 shov7 that C5 deficient mice had hepatic uptakes only slightly
Treatment
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Table 4.12 The effect of non-specific stimulation of the HPS on
75
the tissue distribution of Se -labelled trypanosomes
Tissue distribution (% injected activity)
Spleen Liver Blood
BCG 5.5 ± 0.5 
(0.81 ± 0.15)*
8.8 ± 0.5 
(6.99 ± 0.12)
63.9 ± 2.9
C. parvum 13.3 ± 1.1 
(2.25 ± 0.11)
10.2 ± 0.7 
(13.15 ± 0.37)
49.3 ± 2.6
non-treated 3.2 ± 0.65 6.5 ± 0.7
(0.37 ± 0.02) (6.27 ± 0.21)
68.5 ± 2.9
■figures in parenthesis are organ weights in grams
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\ 75
Table 4 .13 Tlie tissue distribution of Se -labelled trypanosomes
in passively immunised normal C5 deficient and C3 depleted
m i c e
T i s s u e  d i s t r i b u t i o n  (% i n j e c t e d  a c t i v i t y )
T r e a t m e n t
C5 deficient 
1:8 HIS
C5 deficient
C3 depleted HIS
C3 depleted 
1:8 HIS
Control HIS
Control 1:8 HIS
Control
Spleen
< 3.0
< 3.0
< 3.0
8.7 ± 0.8
< 3.0
< 3.0 
6.4 ± 1.1
Liver
54.7 ± 3.1 
11.1 ± 1 . 3
74.0 ± 2.6
10.1 ± 0.8 
60.0 ± 2.1
67.4 ± 2.5 
11.0 ± 0.7
Blood
20.8 ± 3.6
73.7 ± 5.6
< 3.0
58.3 ± 3.2
< 3.0
< 3.0
77.5 ± 3,2
75
T a b l e  4 .14 T h e  t i s s u e  d i s t r i b u t i o n  o f  Se - l a b e l l e d  t r y p a n o s o m e s
i n  a c t i v e l y  i m m u n i s e d  C3 d e p l e t e d  m i c e
T i s s u e  d i s t r i b u t i o n  (% i n j e c t e d  a c t i v i t y )
Spleen Liver Blood
C3 depleted immune <3.0 
Immune <3.0
Control 7.9 ± 0.2
79.2 ± 3.7 
63.8 ± 3.4 
8.6 ± 0.2
< 3.0
< 3.0 
68.1 ± 2.4
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lower than those of passively immunised normal mice at both levels 
of HIS administration. However, in passively immunised C3-- 
depleted mice in which C3 was reduced by 75% of normal circulating 
levels, two levels of hepatic uptake were observed. Those mice 
receiving undiluted HIS gave hepatic uptakes similar to passively 
immunised normal mice. However, in mice receiving 0.2 ml of a 
1/8 dilution of HIS, the hepatic uptake remained at non-irmmunised 
levels.
Immune clearance in actively immunised C3-■ dep 1.eted mice. Immune 
clearance was measured in actively immunised mice depleted of C3 
by CVF treatment. The results presented in Table 4,14 shew that 
actively immunised mice can achieve high hepatic uptake even in 
the abs'ence of C3, i,e, approximately 64% and 79% respectively 
compared to a control value of approximately 9%,
196
DISCUSSION
L-selcnomethionine is a rare natural analogue of the more 
common sulphur-containing methionine, and since there is only little 
difference in the uptake of both amino acids in vivo and in tissue
O b  nculture (Pan, Natori and Tarver, 1964),I Seiselenomethionine (Blau 
and Bender, 1962) has been routinely employed for more than 15 
years in clinical diagnosis in animals and in humans (Spencer, 
Montana, Scanlon and Evans, 1967; Herrera, Gonzalez, Schwartz,
Diggs and Belsky, 1965) and in protein turnover studies (Waterlow, 
Garrow and Millward, 1969),
Methionine is important in animal protein biosynthesis
2
because of their failure to use H„S or SO. in the formation of
I 4
cysteine which is an essential amino-acid. In addition, methionine 
is the starting amino-acid for all proteins in the form of N-formyl 
methionine. Indeed the formation of tRNA in the nucleoplasm is 
essential to the formation of proteins. Therefore the formation
T75 1of an amino-acid analogue, ^  Sek methionine, which has been shown 
to be readily incorporated into newly synthesised proteins was 
clearly of great experimental value (Awad 1966),
Its application to the radiolabelling of parasites has
until recently been limited to fascioliasis (Mulligan, Cuperlovic,
Borojevic and I.alic, 1972) and schistosomiasis (Christensen, 1977)
75
where the parasites were labelled in vitro. The ' Se-labelled 
schistosomula were used to follow the migration of this parasite
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(*75 \
through the host, \ Se|-methionine has also been used in gut 
metabolite studies during the immune expulsion of Nippostrongylus 
brasiliensis (Maclean, 1977), The present study has shown that
175 n\ Se I-methionine can be used effectively to radiolabel African
trypanosomes, These radiolabelled parasites can be used
successfully for in vivo clearance studies, A possible disadvantage
of the technique is the low specific activity of the trypanosomes
and this obviously limited their use to situations where relatively
large numbers of parasites can be used. However, the present
technique has several important advantages over previously
described techniques in that it fulfils most of the criteria for
a trace label - (a) the organisms are still viable and pathogenic;
(b) there is an insignificant and accountable release of ^^Se-activity
over several hours ; (c) as a gamma-emitting isotope, with a half
[*75 ']
life of 120 days \ Sej-methionine is easily counted with the 
minimum of sample preparation; and (d) the relatively short 
labelling period enables specific populations of trypanosomes to 
be labelled.
The preparation of labelled trypanosomes is apparently
dependent both on the time at which the isotope is given during an
infection and on the quantity of isotope used. In order for the
parasite to take up sufficient isotope to become usefully labelled,
they must be present in high numbers. Failing this requirement,
as has been shown by Am-7aà et al (1966), the h  ^ Sel-methionine isL. J
rapidly removed from the circulation and incorporated into plasma 
proteins. This is given some support by the failure of trypano-
1.9 {
somes, incubated with the isotope over the duration of the infection, 
to take up significant levels of isotope. It is likely that the 
^^^Sej-methionine had been incorporated into plasma proteins before 
the parasites were present in sufficient numbers, It is also of 
interest to note that the failure of these parasites, incubated 
over the duration of infection, to take up isotope may imply 
indirectly that pinocytosis of plasma proteins, if it occurs in 
bloodstream trypanosomes (Brown, Armstrong and Valentine, 1965; 
Langreth and Balber, 1975) does not contribute to the labelling.
The ability of the quantity of isotope administered to infl.uence 
the specific activity gives some support to the isotope's 
metabolic incorporation. Furthermore, approximately 95% of the 
trypanosome activity can be precipitated vzith 10% T,C, A,, showing
r 7 5 1
that the Sej-methionine is firmly bound to newly synthesised 
protein.
It has already been suggested that pinocytosis of macro­
molecules does not play an important role in the labelling but it 
was important to clarify the ability of the parasites to adsorb 
labelled host plasma protein on to their surface. This has been 
showai to occur by several authors (Ketteridge, 1970; Vickerman,
1972; Seed, 1974; Diffley, 1978) and the surface labelling that
T75 1may result from the adsorption of 1 Sel-methionine labelled host
plasma proteins on to the surface of trypanosomes may be easily
removed and limit the technique's applications. Although 95% of 
75
Se “trypanosome activity could be precipitated using T,C,A,, it 
did not differentiate between trypanosome-bound activity and host
199
p l a s m a  p r o t e i n  a c t i v i t y  a d s o r b e d  o n  to the p a r a s i t e  s u r f a c e .  T h e  
75
Se-activity of trypanosomas was confirmed to be associated with
trypanosornal p r o t e i n  b y  b o t h  D E A E  c e l l u l o s e  c h r o m a t o g r a p h y  a n d  b y
e l e c t r o p h o r e s i s ,  D E A E  c e l l u l o s e  c h r o m a t o g r a p h y  s h o w e d  t h a t  t h e  
75
Se-activity was associated with several protein peaks originating
from trypanosornes rather than from host serum proteins. This
7 9
a s s o c i a t i o n  w a s  c o n f i r m e d  b y  e l e c t r o p h o r e s i s  in  w h i c h  t h e  ‘ Se-
trypanosome hoinogenate was run in parallel with serum proteins.
T h i s  s h o w e d  t h a t  the m a j o r i t y  o f  the t r y p a n o s o m a  a c t i v i t y  m i g r a t e d
at the same rate as the serum albumin band, whilst the latter
contained little ^^Se-activity, In contrast, the majority of
serum protein activity w'^ as associated with its globulin bands.
As t h e  d o n o r  r a t s  u s e d  to p r o d u c e  l a b e l l e d  p a r a s i t e s  w e r e  a l w a y s
sub-lethally irradiated, it is unlikely that a significant amount
o f  h o s t  g l o b u l i n  as a n t i b o d y  w o u l d  b e  t a k e n  u p  as l a b e l .  It is
therefore improbable that the -methionine labelling of host
plasma proteins, and in particular globulins, plays a significant 
(”75 \
role in the SeJ-methionine labelling of trypanosornes. Also
Aiwad e_t jil (1966) have shown that incubation of serum proteins 
("75 1
in vitro with \ SeJ-methionine does not produce labelled proteins,
thus further supporting its incorporation during the biosynthesis
of plasma proteins.
I n  s u p p o r t  o f  f i n d i n g s  p r e s e n t e d  i n  t h i s  c h a p t e r ,  B l a c k
and Hewitt (1980) have recently labelled T, brucei in vitro with 
r75 1
SeJ-methionine, in the absence of serum proteins, and have 
achieved high specific activities.
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If the p a r a s i t e s  f r o m  the p r e s e n t  e x p e r i m e n t s  a r e  to be
used for immunological clearance studies, it is important that 
75
the Se-activity remains firmly bound to the trypanosoma. The
75
results show that trypanosorae-bound Se-activity does remain 
firmly bound both in vitro and more importantly in vivo* The 
release of activity in vivo is higher than in y l tro, although this 
would not be unexpected. During the parasite’s passage through 
the circulation of the host some parasites may be destroyed by 
mechanical damage. It is also expected that some activity may be 
lost as a result of surface coat secretion (Weitz, 1960; Macadam 
and Herbert, 1970b) although Black and Hewitt (1980) have shown 
that no appreciable loss of surface coat occurs in their system.
The most probable cause for the reduction in specific activity 
is parasite replication. Such a loss of activity would correspond 
to a doubling time of approximately 6,5 hr.
It was important to ensure that any apparent loss of
75
Se-activity from the parasites was not re-utilised by other
7 5circulating parasites. The injection of homogenised Se-labelled
trypanosornes into mice with fulminating infections in an attempt to
label the circulating trypanosornes clearly demonstrated that little
75
re-utilisation of Se-metabolites occurs. This would not be 
entirely unexpected in a system with a labelling efficiency of 
0,04%,
75
The tissue distribution of Se-labelled trypanosornes in 
normal and immune mice demonstrated the value of this technique in 
immunological studies, Miereas normal mice retain the majority
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75
o f  i n j e c t e d  S e - l a b e l l e d  T, t h e i r  c i r c u l a t i o n ,  t h e y
r a p i d l y  d i s a p p e a r  f r o m  t he c i r c u l a t i o n  of i m m u n e  m i c e .  T h e  
p r i n c i p a l  s i t e  o f  this r e m o v a l  w a s  the l i v e r .  T h e  t r a n s i e n t  
u p t a k e  i n  the l u n g s  o f  i m m u n e  m i c e ,  b u t  n o t  in n o r m a l  m i c e ,  is 
t h o u g h t  to r e p r e s e n t  t r y p a n o s o m e s  in t he p u l m o n a r y  c i r c u l a t i o n .
It is, however, possible that it may reflect a sensitization of 
the macrophages in the lung to trypanosome antigen,
75
Se~labelled trypanosomes clearly have several advant­
ages when compared with previously reported techniques in exploring 
the role of macrophages and antibody in the immune response to 
trypanosomeso For example, while foreign red cells, colloidal 
carbon and various other colloids can be used to measure phagocytic 
function in infected mice (Souhami, 1972; Murray, Jennings, Murray 
and Urquhart, 1974), these results do not necessarily reflect the 
host’s ability to remove trypanosomes from the circulation*
Tests of antibody function such as agglutination, complement 
fixation and trypanolysis, are subject to the similar criticisms*
In contrast, the removal of labelled parasites from the circulation 
provides a direct index of the host’s capacity to eliminate specific 
populations of trypanosomes* Furthermore, it enables the site of 
phagocytosis to be determined with certainty*
[3 2 !
Recently Ferrante and Jenkin (1978) using Pj-ortho­
phosphate in an in vitro system and Stevens and Moulton (1978)
using -adenine in an in vivo labelling technique, have incor­
porated these isotopes into T* lewisi and T* brucei respectively,
32
The former have measured the tissue distribution of ' P-labelled
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To lewis 1 and confirmed the importance of the liver in parasite 
removal, while both show the importance of a specific immune 
response in macrophage uptake of trypanosomeso
r?5 *1
Thus, the incorporation of ^  Sej-methionine has been 
shown to be a reliable and simple technique for the jni yiv^ 
labelling of Trypanosoma brucei* In addition, ^^Se-labelied
T* brucei have been successfully used to study the fate of circu­
lating parasites in immune and normal mice, and have demonstrated 
the importance of the liver in trypanosome removal*
Thus by 60 minutes after the injection of labelled 
trypanosomes, the majority of the injected activity appears in the 
liver of immune animals, approximately 60% compared with approxi­
mately 8% in normal mice* In contrast, the majority of the 
activity in normal mice remains in their circulation*
In theory the removal of trypanosomes from the circu­
lation may be achieved by the uptake of antibody-coated whole 
trypanosomes; particulate trypanosome antigen resulting from 
trypanosome disruption by immune lysis; cytophilic antibody 
present on the surface of the sinusoidal cells (Kupffer cells) as 
a result of previous exposure to trypanosome antigen; or, finally, 
as a result of an expanded and/or an activated MPS*
From the results shown in Fig 4,3, it is apparent that 
the amount of passively acquired circulating antibody is closely 
related to the degree of hepatic uptake and that blood clearance 
levels as high as those observed in actively immunised mice can 
readily be achieved*
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The fact that the activity retained by these organs does 
not completely account for all the injected activity suggests 
that some labelled trypanosomes are absent from the main systemic 
circulation* This may be either as a result of trapping in small 
capillaries (Goodwin, 1970) or of non-specific phagocytosis of low 
numbers of trypanosomes throughout the body*
The importance of antibody in the hepatic up ta Ice of radio­
labelled trypanosomes was confirmed following their exposure to 
HIS in v itrOo On injection into normal mice, these pre-treated 
trypanosomes produced a degree of hepatic uptake similar to that 
of actively or passively immunised mice* Furthermore, washing 
unbound HIS from the trypanosome suspension prior to their injection 
failed to reduce their hepatic uptake* Thus antibody is apparently 
directed against the parasite and is presumably acting as an opsonin 
rather than as a cytophilic antibody on the surface of hepatic 
macrophages *
The minor contribution of macrophages activated by trypano­
some infection or by immunostimulants in the hepatic uptake of 
radiolabelled trypanosomes was demonstrated in two studies in which 
macrophage activity in the absence of specific anti-trypanosome 
antibody was evaluated* In the first, the suppression of antibody 
production by prior irradiation at a level which did not impair 
phagocytic function abolished the ability of infected and treated 
mice to remove high levels of radiolabelled parasites. In the 
second, MPS activation by-non-specific stimulants BCG and C* parvum
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only marginally increased clearance values above those of control 
animals, and this was closely correlated with the degree of hepato­
megaly and splenomegaly induced by these agents*
However the macrophage is important in the removal of 
suitably opsonised parasites from the circulation and this process 
is probably dependent upon Fc and C3 receptors on the surface of 
the macrophage (Mantovani et al, 1972; Bianco, Griffin and Silver- 
stein, 1975; Hopf et ^1, 1976; Alexander, Andrews, Leslie and 
Wood, 1978; Shaw and Griffin, 1981) which may bind exposed Fc and 
C3 components on the surface of circulating trypanosomes (Diffley, 
1978; Diffley and Honigberg, 1978; Rickman and Cox, 1979)*
Complement mediated lysis of trypanosomes did not appear 
to be important in the removal of circulating parasites* This 
was demonstrated by the ability of passively immunised C5-deficient 
mice to remove a radiolabelled trypanosome challenge* Thus the 
terminal lytic pathway does not appear to be required for trypano­
some removal*
In contrast, at low levels of passive immunisation of 
C3-depleted mice, i*e. 1:8 dilution of HIS, C3 appears to be 
required to initiate hepatic uptake* No such correlation existed 
at high levels of passive immunisation, i*e* undiluted HIS, or in 
actively immunised C3 depleted mice* C3 and its degradation 
products are kno-t*m to be opsonic and the localisation of these 
components on to the surface of antigens is knowni to promote their 
attachment to C3 receptors on the surface of macrophages (Pepys,
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1976; Shaw and Griffin, 1981)* Thus, it is therefore possible 
that at low antibody titre, C3 may have an important role in 
increasing the opsonic capability of the available antibody, 
facilitating trypanosome removal via C3 as well as Fc. receptors *
It is also of interest that studies of T* muscull 
infections in C5-deficient, C3-depleted and normal mice showed that 
C3 depletion prolonged the infection whilst C5 deficient mice 
responded in a similar manner to normal mice (Jarvinen and Dalrnasso, 
1977)* As a result of these studies, they concluded that comple­
ment mediated lysis was not involved in the control of T* musculi ■ 
infections, and suggested that a complement mediated opsonisation 
was probably responsible for the elimination* In contrast, with 
the closely related parasite T * lewisi, the course of infection did 
not alter in C3-depleted or C5-deficient mice suggesting that 
complement was not essential for the elimination of the circulating 
parasite (Jarvinen and Dalrnasso, 1976)* Similar findings have 
been reported for T* brucei infections in chronically C3-depleted 
mice (Shirazi, Holman, Hudson, Klaus and Terry, 1980)* Shirazi 
et a l (1980) found no alteration in the pattern and the course of 
the infection and have suggested that IgM antibodies alone are 
probably adequate to control bloodstream infections*
In conclusion, the results presented in this chapter show 
that the removal of T * brucei from the circulation of immunised mice 
is largely accomplished by antibody mediated hepatic, uptake* This 
is dependent on C3 at low anti-trypanosome antibody titres* No 
evidence was found to suggest that lysis is a prerequisite to
206
macrophage uptake or that trypanosome sensitised or non-specific 
activation of macrophages were involved in immune clearance*
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Appendix I
The trypanosomes used in the experiments described in this 
thesis are described below.
A* Trypanozoon* These were kindly supplied by Dr* A*R« Gray 
from the Centre for Tropical Veterinary Medicine, Edinburgh* The 
original isolates were numbered Trypanosome Research Edinburgh 
University (TREU) 226 and 667, and both were described as 
Trypanosoma brucei brucei* TREU 226 was originally Isolated from 
an infected cow in June 1961 at the East African Trypanosome Research 
Organisation, Tororo as EATRO 38,
EATRO 38
V
TREU 16
V
TREU 55
TREU 62
W
TREU 70
V
TREU 87
V
TREU 164 
TREU 226
3 days mice
3, 3, 3 days
2, 3, 3, 2, 2 days
3, 3, 3, 2, 2, 3, 2 days
3, 2, 2, 3, 2, 2, 3 days
3 days
3 days
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This parasite causes a rapidly fulminating paras itaemia with 
death occurring within 5-6 days.
TREU 667 was originally isolated during the Edinburgh 
Veterinary Expedition of 1966 in Busoga district, Uganda* The 
primary isolate was designated Busoga/66/EVE/lO, and was from a 
naturally infected cow*
TREU 62
V
TREU 667
Busoga/66/EVE/lO 
22 d (rats)
This parasite produces an infection in mice of 6-12 weeks and in 
rats 5-8 weeks*
The. third Trypanosoma brucei brucei stabilate was originally 
provided by Professor W*H.R* Lumsden, London School of Tropical 
Medicine, and was numbered LUMP 1001 (London University Medical 
Parasitology)* The primary isolate SlO was from a naturally 
infected wildebeest in the Serengeti in 1966*
SlO
V
stabilate
V
LUMP 22
V
LUMP 43
• V
LUMP 68
LUMP 1001
6, 12 days rat
3 days mouse
3 days mouse
42 days mouse
10 days mouse
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This parasite produces in CFLP mice an infection of 4-6 weeks’ 
duration*
B. Nannomonaso This parasite was kindly provided by Professor
Ko Vickerrnan as Glasgow University Protozoology (G*UoP*) 93*
The origin of this stabilate is unknovm, and was described as 
To Congolense on the basis of its morphology* T* congolense GVK 1 
(Glasgow Veterinary Research) was a working stabilate derived from 
this after 4 days in irradiated mice (650 rad)* T* congolense 
G\Tl 1 produces 2 distinct patterns of parasitaemia (Chapter 3) 
depending on the strain of its host* In CFLP mice the infection 
is acute and fulminating and causes death in 8-12 days, whereas 
in C57B1 mice a chronic infection associated with periods of 
remission and relapsing parasitaemia results*
From all of the above stabilates, which themselves were 
kept in liquid nitrogen as reserve stabilates, working material 
was grown up in irradiated mice and cryopreserved in liquid 
nitrogen in silicon tubing (Portex Ltd*, Kent) using glycerol as 
the preservative at a final concentration of 10% (v/v) (Taylor, 
1972), This material was used in all experiments to initiate 
infections.
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